
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml"
      xmlns:dc="http://purl.org/dc/terms/"
      xmlns:doi="http://dx.doi.org/"
      lang="en" xml:lang="en"
      itemscope itemtype="http://schema.org/Article"
      class="no-js">



<head prefix="og: http://ogp.me/ns#">
  <title>Elevated Maspin Expression Is Associated with Better Overall Survival in Esophageal Squamous Cell Carcinoma (ESCC)</title>




<link rel="stylesheet" href="/resource/css/screen.css?e8097f76cb8c3b543f00c9cde49751d6"/>
  <!-- allows for  extra head tags -->


<!-- hello -->
<link rel="stylesheet" type="text/css"
      href="https://fonts.googleapis.com/css?family=Open+Sans:400,400i,600">

<link media="print" rel="stylesheet" type="text/css"  href="/resource/css/print.css"/>
    <script type="text/javascript">
        var siteUrlPrefix = "/plosone/";
    </script>
  <script src="/resource/js/vendor/modernizr-v2.7.1.js" type="text/javascript"></script>
  <script src="/resource/js/vendor/detectizr.min.js" type="text/javascript"></script>

  <link rel="shortcut icon" href="/resource/img/favicon.ico" type="image/x-icon"/>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>






  <link rel="canonical" href="https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0063581" />
  <meta name="description" content="Tumor suppressor maspin is a differentially regulated gene in the progression of many types of cancer. While the biological function of maspin in blocking tumor invasion and metastasis is consistent with the loss of maspin expression at the late stage of tumor progression, the differential expression and the biological significance of maspin in early stage of tumor progression appear to be complex and remain to be elucidated. In the current study, we examined the expression of maspin in 84 esophageal squamous cell carcinoma (ESCC) cases (stages I&ndash;III) and 55 non-tumor adjacent esophageal tissue specimens by immunohistochemical (IHC) staining. The correlation of maspin with clinicopathological parameters was analyzed. Compared to normal esophageal squamous tissue where 80% (47/55) of the cases expressed maspin at a low to moderate level, all ESCC specimens (100% (84/84)) were positive for maspin expression at a moderate to high level. ESCC with low or moderate maspin expression had significantly shorter postoperative survival rates compared to those that had high maspin expression (p&lt;0.001). Since the correlation of maspin with ESCC histology and the correlation of maspin with ESCC prognosis seem to be at odds, we further investigated the biological function of maspin in ESCC using the established ESCC cell lines. The expression of maspin in five human esophageal squamous cancer cell lines (T12, E450, KYSE150, EC109, and KYSE510) was examined by the Western blot. ESCC cell line KYSE510 that did not express maspin and was stably transfected by maspin cDNA or an empty vector. The resulting transfected cells were characterized in vitro. Maspin expression significantly inhibited cell proliferation, motility and matrigel invasion. Taken together, our data suggest that the transient up-regulation of maspin in the early development of ESCC may be a defense mechanism against further transition towards more malignant phenotypes, ultimately slowing down ESCC tumor progression." />

  <meta name="citation_abstract" content="Tumor suppressor maspin is a differentially regulated gene in the progression of many types of cancer. While the biological function of maspin in blocking tumor invasion and metastasis is consistent with the loss of maspin expression at the late stage of tumor progression, the differential expression and the biological significance of maspin in early stage of tumor progression appear to be complex and remain to be elucidated. In the current study, we examined the expression of maspin in 84 esophageal squamous cell carcinoma (ESCC) cases (stages I&ndash;III) and 55 non-tumor adjacent esophageal tissue specimens by immunohistochemical (IHC) staining. The correlation of maspin with clinicopathological parameters was analyzed. Compared to normal esophageal squamous tissue where 80% (47/55) of the cases expressed maspin at a low to moderate level, all ESCC specimens (100% (84/84)) were positive for maspin expression at a moderate to high level. ESCC with low or moderate maspin expression had significantly shorter postoperative survival rates compared to those that had high maspin expression (p&lt;0.001). Since the correlation of maspin with ESCC histology and the correlation of maspin with ESCC prognosis seem to be at odds, we further investigated the biological function of maspin in ESCC using the established ESCC cell lines. The expression of maspin in five human esophageal squamous cancer cell lines (T12, E450, KYSE150, EC109, and KYSE510) was examined by the Western blot. ESCC cell line KYSE510 that did not express maspin and was stably transfected by maspin cDNA or an empty vector. The resulting transfected cells were characterized in vitro. Maspin expression significantly inhibited cell proliferation, motility and matrigel invasion. Taken together, our data suggest that the transient up-regulation of maspin in the early development of ESCC may be a defense mechanism against further transition towards more malignant phenotypes, ultimately slowing down ESCC tumor progression.">


  <meta name="keywords" content="Squamous cell carcinoma,Breast cancer,Lung and intrathoracic tumors,Cytoplasmic staining,Esophageal cancer,Prostate cancer,Gastric cancer,Gastrointestinal cancers" />


<meta name="citation_doi" content="10.1371/journal.pone.0063581"/>
<meta name="citation_author" content="Yang Wang"/>
  <meta name="citation_author_institution" content="Thoracic Surgery, Key Laboratory of Carcinogenesis and Translational Research Ministry of Education, Peking University School of Oncology, Beijing Cancer Hospital & Institute, Beijing, China"/>
<meta name="citation_author" content="Shijie Sheng"/>
  <meta name="citation_author_institution" content="Department of Pathology, Wayne State University School of Medicine, Tumor and Microenvironment Program of Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States of America"/>
<meta name="citation_author" content="Jianzhi Zhang"/>
  <meta name="citation_author_institution" content="Thoracic Surgery, Key Laboratory of Carcinogenesis and Translational Research Ministry of Education, Peking University School of Oncology, Beijing Cancer Hospital & Institute, Beijing, China"/>
<meta name="citation_author" content="Sijana Dzinic"/>
  <meta name="citation_author_institution" content="Department of Pathology, Wayne State University School of Medicine, Tumor and Microenvironment Program of Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States of America"/>
<meta name="citation_author" content="Shaolei Li"/>
  <meta name="citation_author_institution" content="Thoracic Surgery, Key Laboratory of Carcinogenesis and Translational Research Ministry of Education, Peking University School of Oncology, Beijing Cancer Hospital & Institute, Beijing, China"/>
<meta name="citation_author" content="Fang Fang"/>
  <meta name="citation_author_institution" content="Thoracic Surgery, Key Laboratory of Carcinogenesis and Translational Research Ministry of Education, Peking University School of Oncology, Beijing Cancer Hospital & Institute, Beijing, China"/>
<meta name="citation_author" content="Nan Wu"/>
  <meta name="citation_author_institution" content="Thoracic Surgery, Key Laboratory of Carcinogenesis and Translational Research Ministry of Education, Peking University School of Oncology, Beijing Cancer Hospital & Institute, Beijing, China"/>
<meta name="citation_author" content="Qingfeng Zheng"/>
  <meta name="citation_author_institution" content="Thoracic Surgery, Key Laboratory of Carcinogenesis and Translational Research Ministry of Education, Peking University School of Oncology, Beijing Cancer Hospital & Institute, Beijing, China"/>
<meta name="citation_author" content="Yue Yang"/>
  <meta name="citation_author_institution" content="Thoracic Surgery, Key Laboratory of Carcinogenesis and Translational Research Ministry of Education, Peking University School of Oncology, Beijing Cancer Hospital & Institute, Beijing, China"/>

<meta name="citation_title" content="Elevated Maspin Expression Is Associated with Better Overall Survival in Esophageal Squamous Cell Carcinoma (ESCC)"/>
<meta itemprop="name" content="Elevated Maspin Expression Is Associated with Better Overall Survival in Esophageal Squamous Cell Carcinoma (ESCC)"/>
<meta name="citation_journal_title" content="PLOS ONE"/>
<meta name="citation_journal_abbrev" content="PLOS ONE"/>
<meta name="citation_date" content="May 22, 2013"/>
<meta name="citation_firstpage" content="e63581"/>
<meta name="citation_issue" content="5"/>
<meta name="citation_volume" content="8"/>
<meta name="citation_issn" content="1932-6203"/>
<meta name="citation_publisher" content="Public Library of Science"/>

  <meta name="citation_pdf_url" content="https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0063581&type=printable">

  <meta name="citation_article_type" content="Research Article">

<meta name="dc.identifier" content="10.1371/journal.pone.0063581" />


  <meta name="twitter:card" content="summary" />
  <meta name="twitter:site" content="plosone"/>
    <meta name="twitter:title" content="Elevated Maspin Expression Is Associated with Better Overall Survival in Esophageal Squamous Cell Carcinoma (ESCC)" />
    <meta property="twitter:description" content="Tumor suppressor maspin is a differentially regulated gene in the progression of many types of cancer. While the biological function of maspin in blocking tumor invasion and metastasis is consistent with the loss of maspin expression at the late stage of tumor progression, the differential expression and the biological significance of maspin in early stage of tumor progression appear to be complex and remain to be elucidated. In the current study, we examined the expression of maspin in 84 esophageal squamous cell carcinoma (ESCC) cases (stages I&ndash;III) and 55 non-tumor adjacent esophageal tissue specimens by immunohistochemical (IHC) staining. The correlation of maspin with clinicopathological parameters was analyzed. Compared to normal esophageal squamous tissue where 80% (47/55) of the cases expressed maspin at a low to moderate level, all ESCC specimens (100% (84/84)) were positive for maspin expression at a moderate to high level. ESCC with low or moderate maspin expression had significantly shorter postoperative survival rates compared to those that had high maspin expression (p&lt;0.001). Since the correlation of maspin with ESCC histology and the correlation of maspin with ESCC prognosis seem to be at odds, we further investigated the biological function of maspin in ESCC using the established ESCC cell lines. The expression of maspin in five human esophageal squamous cancer cell lines (T12, E450, KYSE150, EC109, and KYSE510) was examined by the Western blot. ESCC cell line KYSE510 that did not express maspin and was stably transfected by maspin cDNA or an empty vector. The resulting transfected cells were characterized in vitro. Maspin expression significantly inhibited cell proliferation, motility and matrigel invasion. Taken together, our data suggest that the transient up-regulation of maspin in the early development of ESCC may be a defense mechanism against further transition towards more malignant phenotypes, ultimately slowing down ESCC tumor progression." />
    <meta property="twitter:image" content="https://journals.plos.org/plosone/article/figure/image?id=10.1371/journal.pone.0063581.g006&size=inline" />

<meta property="og:type" content="article" />
<meta property="og:url" content="https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0063581"/>
<meta property="og:title" content="Elevated Maspin Expression Is Associated with Better Overall Survival in Esophageal Squamous Cell Carcinoma (ESCC)"/>
<meta property="og:description" content="Tumor suppressor maspin is a differentially regulated gene in the progression of many types of cancer. While the biological function of maspin in blocking tumor invasion and metastasis is consistent with the loss of maspin expression at the late stage of tumor progression, the differential expression and the biological significance of maspin in early stage of tumor progression appear to be complex and remain to be elucidated. In the current study, we examined the expression of maspin in 84 esophageal squamous cell carcinoma (ESCC) cases (stages I&ndash;III) and 55 non-tumor adjacent esophageal tissue specimens by immunohistochemical (IHC) staining. The correlation of maspin with clinicopathological parameters was analyzed. Compared to normal esophageal squamous tissue where 80% (47/55) of the cases expressed maspin at a low to moderate level, all ESCC specimens (100% (84/84)) were positive for maspin expression at a moderate to high level. ESCC with low or moderate maspin expression had significantly shorter postoperative survival rates compared to those that had high maspin expression (p&lt;0.001). Since the correlation of maspin with ESCC histology and the correlation of maspin with ESCC prognosis seem to be at odds, we further investigated the biological function of maspin in ESCC using the established ESCC cell lines. The expression of maspin in five human esophageal squamous cancer cell lines (T12, E450, KYSE150, EC109, and KYSE510) was examined by the Western blot. ESCC cell line KYSE510 that did not express maspin and was stably transfected by maspin cDNA or an empty vector. The resulting transfected cells were characterized in vitro. Maspin expression significantly inhibited cell proliferation, motility and matrigel invasion. Taken together, our data suggest that the transient up-regulation of maspin in the early development of ESCC may be a defense mechanism against further transition towards more malignant phenotypes, ultimately slowing down ESCC tumor progression."/>
<meta property="og:image" content="https://journals.plos.org/plosone/article/figure/image?id=10.1371/journal.pone.0063581.g006&size=inline"/>

<meta name="citation_reference" content="citation_title=Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world;citation_author=F Kamangar;citation_author=GM Dores;citation_author=WF Anderson;citation_journal_title=J Clin Oncol;citation_volume=24;citation_number=24;citation_first_page=2137;citation_last_page=2150;citation_publication_date=2006;"/>    
<meta name="citation_reference" content="citation_title=Cancer burden in the year 2000. The global picture;citation_author=DM Parkin;citation_author=FI Bray;citation_author=SS Devesa;citation_journal_title=Eur J Cancer;citation_volume=37;citation_number=37;citation_first_page=S4;citation_last_page=66;citation_publication_date=2001;"/>    
<meta name="citation_reference" content="citation_title=Genetic polymorphisms and esophageal cancer risk;citation_author=T Hiyama;citation_author=M Yoshihara;citation_author=S Tanaka;citation_author=K Chayama;citation_journal_title=Int J Cancer;citation_volume=121;citation_number=121;citation_first_page=1643;citation_last_page=1658;citation_publication_date=2007;"/>    
<meta name="citation_reference" content="citation_title=Genetic polymorphisms and susceptibility to esophageal cancer among Chinese population (Review);citation_author=DY Xing;citation_author=W Tan;citation_author=DX Lin;citation_journal_title=Oncology Reports;citation_volume=10;citation_number=10;citation_first_page=1615;citation_last_page=1623;citation_publication_date=2003;"/>    
<meta name="citation_reference" content="citation_title=Multiple management modalities in esophageal cancer: combined modality management approaches;citation_author=M Koshy;citation_author=N Esiashvilli;citation_author=JC Landry;citation_author=CR Thomas Jr;citation_author=RH Matthews;citation_journal_title=Oncologist;citation_volume=9;citation_number=9;citation_first_page=147;citation_last_page=159;citation_publication_date=2004;"/>    
<meta name="citation_reference" content="citation_title=Incidence and survival trends of esophageal carcinoma in the United States: racial and gender differences by histological type;citation_author=M Younes;citation_author=DE Henson;citation_author=A Ertan;citation_author=CC Miller;citation_journal_title=Scand J Gastroenterol;citation_volume=37;citation_number=37;citation_first_page=1359;citation_last_page=1365;citation_publication_date=2002;"/>    
<meta name="citation_reference" content="citation_title=Expression profiling of esophageal squamous cell carcinoma patients treated with definitive chemoradiotherapy: Clinical implications;citation_author=A Ashida;citation_author=N Boku;citation_author=K Aoyagi;citation_author=H Sato;citation_author=Y Tsubosa;citation_journal_title=International Journal of Oncology;citation_volume=28;citation_number=28;citation_first_page=1345;citation_last_page=1352;citation_publication_date=2006;"/>    
<meta name="citation_reference" content="citation_title=Protein alterations in ESCC and clinical implications: a review;citation_author=DC Lin;citation_author=XL Du;citation_author=MR Wang;citation_journal_title=Diseases of the Esophagus;citation_volume=22;citation_number=22;citation_first_page=9;citation_last_page=20;citation_publication_date=2009;"/>    
<meta name="citation_reference" content="citation_title=Expression of HLA-G is associated with prognosis on esophageau squamous cell carcinoma;citation_author=SM Yie;citation_author=H Yang;citation_author=SR Ye;citation_author=K Li;citation_author=DD Dong;citation_journal_title=American Journal of Clinical Pathology;citation_volume=128;citation_number=128;citation_first_page=1002;citation_last_page=1009;citation_publication_date=2007;"/>    
<meta name="citation_reference" content="citation_title=Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells;citation_author=Z Zou;citation_author=A Anisowicz;citation_author=MJ Hendrix;citation_author=A Thor;citation_author=M Neveu;citation_journal_title=Science;citation_volume=263;citation_number=263;citation_first_page=526;citation_last_page=529;citation_publication_date=1994;"/>    
<meta name="citation_reference" content="citation_title=Maspin regulates hypoxia-mediated stimulation of uPA/uPAR complex in invasive breast cancer cells;citation_author=S Amir;citation_author=NV Margaryan;citation_author=V Odero-Marah;citation_author=Z Khalkhali-Ellis;citation_author=MJC Hendrix;citation_journal_title=Cancer Biology &amp; Therapy;citation_volume=4;citation_number=4;citation_first_page=400;citation_last_page=406;citation_publication_date=2005;"/>    
<meta name="citation_reference" content="citation_title=The surface of prostate carcinoma DU145 cells mediates the inhibition of urokinase-type plasminogen activator by maspin;citation_author=R McGowen;citation_author=H Biliran Jr;citation_author=R Sager;citation_author=S Sheng;citation_journal_title=Cancer Res;citation_volume=60;citation_number=60;citation_first_page=4771;citation_last_page=4778;citation_publication_date=2000;"/>    
<meta name="citation_reference" content="citation_title=Endogenous inhibition of histone deacetylase 1 by tumor-suppressive maspin;citation_author=X Li;citation_author=S Yin;citation_author=Y Meng;citation_author=W Sakr;citation_author=S Sheng;citation_journal_title=Cancer Res;citation_volume=66;citation_number=66;citation_first_page=9323;citation_last_page=9329;citation_publication_date=2006;"/>    
<meta name="citation_reference" content="citation_title=Prognostic value of maspin mRNA expression in ER alpha-positive postmenopausal breast carcinomas;citation_author=I Bieche;citation_author=I Girault;citation_author=JC Sabourin;citation_author=S Tozlu;citation_author=K Driouch;citation_journal_title=British Journal of Cancer;citation_volume=88;citation_number=88;citation_first_page=863;citation_last_page=870;citation_publication_date=2003;"/>    
<meta name="citation_reference" content="citation_title=Expression of maspin predicts poor prognosis in breast cancer patients;citation_author=Y Umekita;citation_author=Y Ohi;citation_author=Y Sagara;citation_author=H Yoshida;citation_journal_title=International Journal of Cancer;citation_volume=100;citation_number=100;citation_first_page=452;citation_last_page=455;citation_publication_date=2002;"/>    
<meta name="citation_reference" content="citation_title=The paradoxical expression of maspin in ovarian carcinoma;citation_author=AK Sood;citation_author=MS Fletcher;citation_author=LM Gruman;citation_author=JE Coffin;citation_author=S Jabbari;citation_journal_title=Clin Cancer Res;citation_volume=8;citation_number=8;citation_first_page=2924;citation_last_page=2932;citation_publication_date=2002;"/>    
<meta name="citation_reference" content="citation_title=Prognostic significance of maspin in pancreatic ductal adenocarcinoma: tissue microarray analysis of 223 surgically resected cases;citation_author=DF Cao;citation_author=Q Zhang;citation_author=LSF Wu;citation_author=SN Salaria;citation_author=JW Winter;citation_journal_title=Modern Pathology;citation_volume=20;citation_number=20;citation_first_page=570;citation_last_page=578;citation_publication_date=2007;"/>    
<meta name="citation_reference" content="citation_title=Human pancreatic carcinoma cells activate maspin expression through loss of epigenetic control;citation_author=M Fitzgerald;citation_author=M Oshiro;citation_author=N Holtan;citation_author=K Krager;citation_author=JJ Cullen;citation_journal_title=Neoplasia;citation_volume=5;citation_number=5;citation_first_page=427;citation_last_page=436;citation_publication_date=2003;"/>    
<meta name="citation_reference" content="citation_title=Nuclear, compared with combined nuclear and cytoplasmic expression of maspin, is linked in lung adenocarcinoma to reduced VEGF-A levels and in Stage I, improved survival;citation_author=A Frey;citation_author=AO Soubani;citation_author=AK Adam;citation_author=S Sheng;citation_author=HI Pass;citation_journal_title=Histopathology;citation_volume=54;citation_number=54;citation_first_page=590;citation_last_page=597;citation_publication_date=2009;"/>    
<meta name="citation_reference" content="citation_title=High tumoral maspin expression is associated with improved survival of patients with oral squamous cell carcinoma;citation_author=WY Xia;citation_author=YK Lau;citation_author=MCT Hu;citation_author=L Li;citation_author=DA Johnston;citation_journal_title=Oncogene;citation_volume=19;citation_number=19;citation_first_page=2398;citation_last_page=2403;citation_publication_date=2000;"/>    
<meta name="citation_reference" content="citation_title=Nuclear and cytoplasmic Maspin expression in primary non-small cell lung cancer;citation_author=M Woenckhaus;citation_author=L Bubendorf;citation_author=P Dalquen;citation_author=J Foerster;citation_author=H Blaszyk;citation_journal_title=Journal of Clinical Pathology;citation_volume=60;citation_number=60;citation_first_page=483;citation_last_page=486;citation_publication_date=2007;"/>    
<meta name="citation_reference" content="citation_title=Tumor suppressive maspin and epithelial homeostasis;citation_author=J Lockett;citation_author=S Yin;citation_author=X Li;citation_author=Y Meng;citation_author=S Sheng;citation_journal_title=J Cell Biochem;citation_volume=97;citation_number=97;citation_first_page=651;citation_last_page=660;citation_publication_date=2006;"/>    
<meta name="citation_reference" content="citation_title=Maspin expression in invasive breast cancer: association with other prognostic factors;citation_author=SK Mohsin;citation_author=M Zhang;citation_author=GM Clark;citation_author=D Craig Allred;citation_journal_title=J Pathol;citation_volume=199;citation_number=199;citation_first_page=432;citation_last_page=435;citation_publication_date=2003;"/>    
<meta name="citation_reference" content="citation_title=Overexpression of aurora-A contributes to malignant development of human esophageal squamous cell carcinoma;citation_author=T Tong;citation_author=YL Zhong;citation_author=JP Kong;citation_author=LJ Dong;citation_author=YM Song;citation_journal_title=Clinical Cancer Research;citation_volume=10;citation_number=10;citation_first_page=7304;citation_last_page=7310;citation_publication_date=2004;"/>    
<meta name="citation_reference" content="citation_title=Critical Analysis of Simultaneous Blockage of Histone Deacetylase and Multiple Receptor Tyrosine Kinase in the Treatment of Prostate Cancer;citation_author=S Wedel;citation_author=L Hudak;citation_author=JM Seibel;citation_author=E Juengel;citation_author=E Oppermann;citation_journal_title=Prostate;citation_volume=71;citation_number=71;citation_first_page=722;citation_last_page=735;citation_publication_date=2011;"/>    
<meta name="citation_reference" content="citation_title=Maspin expression inhibits osteolysis, tumor growth, and angiogenesis in a model of prostate cancer bone metastasis;citation_author=ML Cher;citation_author=HR Biliran;citation_author=S Bhagat;citation_author=YH Meng;citation_author=MX Che;citation_journal_title=Proceedings of the National Academy of Sciences of the United States of America;citation_volume=100;citation_number=100;citation_first_page=7847;citation_last_page=7852;citation_publication_date=2003;"/>    
<meta name="citation_reference" content="citation_title=Maspin Regulates Endothelial Cell Adhesion and Migration through an Integrin Signaling Pathway;citation_author=L Qin;citation_author=M Zhang;citation_journal_title=Journal of Biological Chemistry;citation_volume=285;citation_number=285;citation_first_page=32360;citation_last_page=32369;citation_publication_date=2010;"/>    
<meta name="citation_reference" content="citation_title=Maspin is an angiogenesis inhibitor;citation_author=M Zhang;citation_author=O Volpert;citation_author=YH Shi;citation_author=N Bouck;citation_journal_title=Nature Medicine;citation_volume=6;citation_number=6;citation_first_page=196;citation_last_page=199;citation_publication_date=2000;"/>    
<meta name="citation_reference" content="citation_title=Maspin reprograms the gene expression profile of prostate carcinoma cells for differentiation;citation_author=MM Bernardo;citation_author=Y Meng;citation_author=J Lockett;citation_author=G Dyson;citation_author=A Dombkowski;citation_journal_title=Genes Cancer;citation_volume=2;citation_number=2;citation_first_page=1009;citation_last_page=1022;citation_publication_date=2011;"/>    
<meta name="citation_reference" content="citation_title=Tumor-suppressive maspin regulates cell response to oxidative stress by direct interaction with glutathione S-transferase;citation_author=SP Yin;citation_author=XH Li;citation_author=YH Meng;citation_author=RL Finley;citation_author=W Sakr;citation_journal_title=Journal of Biological Chemistry;citation_volume=280;citation_number=280;citation_first_page=34985;citation_last_page=34996;citation_publication_date=2005;"/>    
<meta name="citation_reference" content="citation_title=Pleiotrophic inhibition of pericellular urokinase-type plasminogen activator system by endogenous tumor suppressive maspin;citation_author=H Biliran Jr;citation_author=S Sheng;citation_journal_title=Cancer Res;citation_volume=61;citation_number=61;citation_first_page=8676;citation_last_page=8682;citation_publication_date=2001;"/>    
<meta name="citation_reference" content="citation_title=Maspin retards cell detachment via a novel interaction with the urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor system;citation_author=S Yin;citation_author=J Lockett;citation_author=Y Meng;citation_author=H Biliran Jr;citation_author=GE Blouse;citation_journal_title=Cancer Res;citation_volume=66;citation_number=66;citation_first_page=4173;citation_last_page=4181;citation_publication_date=2006;"/>    
<meta name="citation_reference" content="citation_title=Maspin regulates hypoxia-mediated stimulation of uPA/uPAR complex in invasive breast cancer cells;citation_author=S Amir;citation_author=NV Margaryan;citation_author=V Odero-Marah;citation_author=Z Khalkhali-Ellis;citation_author=MJ Hendrix;citation_journal_title=Cancer Biol Ther;citation_volume=4;citation_number=4;citation_first_page=400;citation_last_page=406;citation_publication_date=2005;"/>    
<meta name="citation_reference" content="citation_title=Maspin expression in oral squamous cell carcinoma;citation_author=G Lezzi;citation_author=A Piattelli;citation_author=C Rubini;citation_author=G Goteri;citation_author=L Artese;citation_journal_title=Journal of Craniofacial Surgery;citation_volume=18;citation_number=18;citation_first_page=1039;citation_last_page=1043;citation_publication_date=2007;"/>    
<meta name="citation_reference" content="citation_title=High expression of maspin is associated with early tumor relapse in breast cancer;citation_author=KM Joensuu;citation_author=MHK Leidenius;citation_author=LC Andersson;citation_author=PS Heikkila;citation_journal_title=Human Pathology;citation_volume=40;citation_number=40;citation_first_page=1143;citation_last_page=1151;citation_publication_date=2009;"/>    
<meta name="citation_reference" content="citation_title=The myoepithelial cell: its role in normal mammary glands and breast cancer;citation_author=M Sopel;citation_journal_title=Folia Morphologica;citation_volume=69;citation_number=69;citation_first_page=1;citation_last_page=14;citation_publication_date=2010;"/>    
<meta name="citation_reference" content="citation_title=Maspin is up-regulated in premalignant prostate epithelia;citation_author=CR Pierson;citation_author=R McGowen;citation_author=D Grignon;citation_author=W Sakr;citation_author=J Dey;citation_journal_title=Prostate;citation_volume=53;citation_number=53;citation_first_page=255;citation_last_page=262;citation_publication_date=2002;"/>    
<meta name="citation_reference" content="citation_title=Loss of maspin expression contributes to a more invasive potential in malignant melanoma;citation_author=AE Denk;citation_author=M Bettstetter;citation_author=PJ Wild;citation_author=K Hoek;citation_author=F Bataille;citation_journal_title=Pigment Cell Res;citation_volume=20;citation_number=20;citation_first_page=112;citation_last_page=119;citation_publication_date=2007;"/>    
<meta name="citation_reference" content="citation_title=Clinical significance of Maspin promoter methylation and loss of its protein expression in invasive ductal breast carcinoma: correlation with VEGF-A and MTA1 expression;citation_author=G Sharma;citation_author=S Mirza;citation_author=R Parshad;citation_author=A Srivastava;citation_author=SD Gupta;citation_journal_title=Tumour Biol;citation_volume=32;citation_number=32;citation_first_page=23;citation_last_page=32;citation_publication_date=2011;"/>    
<meta name="citation_reference" content="citation_title=Loss of maspin is a negative prognostic factor for invasion and metastasis in oral squamous cell carcinoma;citation_author=K Yoshizawa;citation_author=S Nozaki;citation_author=A Okamune;citation_author=H Kitahara;citation_author=T Ohara;citation_journal_title=Journal of Oral Pathology &amp; Medicine;citation_volume=38;citation_number=38;citation_first_page=535;citation_last_page=539;citation_publication_date=2009;"/>    

<meta name="citation_reference" content="MacDougall R (2012) Vogelstein Considers Cancer Genome at Trent Lecture. NIH Record."/>

<meta name="citation_reference" content="Ozaki T, Nakagawara A (2011) p53: The Attractive Tumor Suppressor in the Cancer Research Field. Journal of Biomedicine and Biotechnology."/>
<meta name="citation_reference" content="citation_title=Mutant p53: one name, many proteins;citation_author=WA Freed-Pastor;citation_author=C Prives;citation_journal_title=Genes &amp; Development;citation_volume=26;citation_number=26;citation_first_page=1268;citation_last_page=1286;citation_publication_date=2012;"/>    
<meta name="citation_reference" content="citation_title=Maspin polymorphism associated with apoptosis susceptibility and in vivo tumorigenesis;citation_author=HL Jang;citation_author=E Nam;citation_author=KH Lee;citation_author=S Yeom;citation_author=JH Son;citation_journal_title=International Journal of Molecular Medicine;citation_volume=22;citation_number=22;citation_first_page=333;citation_last_page=338;citation_publication_date=2008;"/>    
<meta name="citation_reference" content="citation_title=Maspin: molecular mechanisms and therapeutic implications;citation_author=TM Bodenstine;citation_author=REB Seftor;citation_author=Z Khalkhali-Ellis;citation_author=EA Seftor;citation_author=PA Pemberton;citation_journal_title=Cancer and Metastasis Reviews;citation_volume=31;citation_number=31;citation_first_page=529;citation_last_page=551;citation_publication_date=2012;"/>    
<meta name="citation_reference" content="citation_title=Nuclear localization of maspin is essential for its inhibition of tumor growth and metastasis;citation_author=B Goulet;citation_author=W Kennette;citation_author=A Ablack;citation_author=CO Postenka;citation_author=MN Hague;citation_journal_title=Laboratory Investigation;citation_volume=91;citation_number=91;citation_first_page=1181;citation_last_page=1187;citation_publication_date=2011;"/>    
<meta name="citation_reference" content="citation_title=Nuclear localization of maspin is essential for its inhibition of tumor growth and metastasis;citation_author=B Goulet;citation_author=W Kennette;citation_author=A Ablack;citation_author=CO Postenka;citation_author=N Hague;citation_journal_title=Biochemistry and Cell Biology-Biochimie Et Biologie Cellulaire;citation_volume=90;citation_number=90;citation_first_page=109;citation_last_page=109;citation_publication_date=2012;"/>    
<meta name="citation_reference" content="citation_title=Tissue-type plasminogen activator is a target of the tumor suppressor gene maspin;citation_author=SJ Sheng;citation_author=B Truong;citation_author=D Fredrickson;citation_author=RL Wu;citation_author=AB Pardee;citation_journal_title=Proceedings of the National Academy of Sciences of the United States of America;citation_volume=95;citation_number=95;citation_first_page=499;citation_last_page=504;citation_publication_date=1998;"/>    
<meta name="citation_reference" content="citation_title=Maspin regulates different signaling pathways for motility and adhesion in aggressive breast cancer cells;citation_author=VA Odero-Marah;citation_author=Z Khalkhali-Ellis;citation_author=J Chunthapong;citation_author=S Amir;citation_author=REB Seftor;citation_journal_title=Cancer Biology &amp; Therapy;citation_volume=2;citation_number=2;citation_first_page=398;citation_last_page=403;citation_publication_date=2003;"/>    


<!-- DoubleClick overall ad setup script -->
<script type='text/javascript'>
  var googletag = googletag || {};
  googletag.cmd = googletag.cmd || [];
  (function() {
    var gads = document.createElement('script');
    gads.async = true;
    gads.type = 'text/javascript';
    var useSSL = 'https:' == document.location.protocol;
    gads.src = (useSSL ? 'https:' : 'http:') +
        '//www.googletagservices.com/tag/js/gpt.js';
    var node = document.getElementsByTagName('script')[0];
    node.parentNode.insertBefore(gads, node);
  })();
</script>

<!-- DoubleClick ad slot setup script -->

  <script id="doubleClickSetupScript" type='text/javascript'>
    googletag.cmd.push(function() {
  googletag.defineSlot('/75507958/PONE_728x90_ATF', [728, 90], 'div-gpt-ad-1458247671871-0').addService(googletag.pubads());
  googletag.defineSlot('/75507958/PONE_160x600_BTF', [160, 600], 'div-gpt-ad-1458247671871-1').addService(googletag.pubads());
      var personalizedAds = window.plosCookieConsent && window.plosCookieConsent.hasConsented('advertising');
      googletag.pubads().setRequestNonPersonalizedAds(personalizedAds ? 0 : 1);
      googletag.pubads().enableSingleRequest();
      googletag.enableServices();
    });
  </script>



<script type="text/javascript">
    var WombatConfig = WombatConfig || {};
    WombatConfig.journalKey = "PLoSONE";
    WombatConfig.figurePath = "/plosone/article/figure/image";
    WombatConfig.figShareInstitutionString = "plos";
    WombatConfig.doiResolverPrefix = "https://dx.plos.org/";
</script>

<script type="text/javascript">
  var WombatConfig = WombatConfig || {};
  WombatConfig.metrics = WombatConfig.metrics || {};
  WombatConfig.metrics.referenceUrl      = "http://lagotto.io/plos";
  WombatConfig.metrics.googleScholarUrl  = "https://scholar.google.com/scholar";
  WombatConfig.metrics.googleScholarCitationUrl  = WombatConfig.metrics.googleScholarUrl + "?hl=en&lr=&q=";
  WombatConfig.metrics.crossrefUrl  = "https://www.crossref.org";
</script>
<script defer="defer" src="/resource/js/defer.js?df22e765dd76f625eb58"></script><script src="/resource/js/sync.js?df22e765dd76f625eb58"></script>
<script src="https://ajax.googleapis.com/ajax/libs/jquery/2.1.4/jquery.min.js"></script>

          <script type="text/javascript" src="https://widgets.figshare.com/static/figshare.js"></script>

<script src="/resource/js/vendor/fastclick/lib/fastclick.js" type="text/javascript"></script>
<script src="/resource/js/vendor/foundation/foundation.js" type="text/javascript"></script>
<script src="/resource/js/vendor/underscore-min.js" type="text/javascript"></script>
<script src="/resource/js/vendor/underscore.string.min.js" type="text/javascript"></script>
<script src="/resource/js/vendor/moment.js" type="text/javascript"></script>


<script src="/resource/js/vendor/jquery-ui-effects.min.js" type="text/javascript"></script>

<script src="/resource/js/vendor/foundation/foundation.tooltip.js" type="text/javascript"></script>
<script src="/resource/js/vendor/foundation/foundation.dropdown.js" type="text/javascript"></script>
<script src="/resource/js/vendor/foundation/foundation.tab.js" type="text/javascript"></script>
<script src="/resource/js/vendor/foundation/foundation.reveal.js" type="text/javascript"></script>
<script src="/resource/js/vendor/foundation/foundation.slider.js" type="text/javascript"></script>

<script src="/resource/js/util/utils.js" type="text/javascript"></script>
<script src="/resource/js/components/toggle.js" type="text/javascript"></script>
<script src="/resource/js/components/truncate_elem.js" type="text/javascript"></script>
<script src="/resource/js/components/tooltip_hover.js" type="text/javascript"></script>
<script src="/resource/js/vendor/jquery.dotdotdot.js" type="text/javascript"></script>

<!--For Google Tag manager to be able to track site information  -->
<script>

  dataLayer = [{
    'mobileSite': 'false',
    'desktopSite': 'true'
  }];

</script>

</head>

<body class="article plosone">


<!-- Google Tag Manager -->
<script>
  var gaDisable = 'ga-disable-UA-76325259-';
  var consented = !(window.plosCookieConsent && window.plosCookieConsent.hasConsented('analytics'));
  for(var i=0;i<100;i++) { //This will break if we ever support 100+ journals (*insert Oh no! Anyway... meme*)
    window[gaDisable + i] = consented;
  }
</script>
<noscript><iframe src="//www.googletagmanager.com/ns.html?id=GTM-TP26BH"
                  height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
<script>
  (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
    new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
    j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
    '//www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
})(window,document,'script','dataLayer','GTM-TP26BH');
</script>

<noscript><iframe src="//www.googletagmanager.com/ns.html?id=GTM-MQQMGF"
                  height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
<script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
    new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
    j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
    '//www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
})(window,document,'script','dataLayer','GTM-MQQMGF');</script>
<!-- End Google Tag Manager -->

<!-- New Relic -->
<script type="text/javascript">
  ;window.NREUM||(NREUM={});NREUM.init={distributed_tracing:{enabled:true},privacy:{cookies_enabled:true},ajax:{deny_list:["bam.nr-data.net"]}};
  window.NREUM||(NREUM={}),__nr_require=function(t,e,n){function r(n){if(!e[n]){var o=e[n]={exports:{}};t[n][0].call(o.exports,function(e){var o=t[n][1][e];return r(o||e)},o,o.exports)}return e[n].exports}if("function"==typeof __nr_require)return __nr_require;for(var o=0;o<n.length;o++)r(n[o]);return r}({1:[function(t,e,n){function r(t){try{s.console&&console.log(t)}catch(e){}}var o,i=t("ee"),a=t(32),s={};try{o=localStorage.getItem("__nr_flags").split(","),console&&"function"==typeof console.log&&(s.console=!0,o.indexOf("dev")!==-1&&(s.dev=!0),o.indexOf("nr_dev")!==-1&&(s.nrDev=!0))}catch(c){}s.nrDev&&i.on("internal-error",function(t){r(t.stack)}),s.dev&&i.on("fn-err",function(t,e,n){r(n.stack)}),s.dev&&(r("NR AGENT IN DEVELOPMENT MODE"),r("flags: "+a(s,function(t,e){return t}).join(", ")))},{}],2:[function(t,e,n){function r(t,e,n,r,s){try{l?l-=1:o(s||new UncaughtException(t,e,n),!0)}catch(f){try{i("ierr",[f,c.now(),!0])}catch(d){}}return"function"==typeof u&&u.apply(this,a(arguments))}function UncaughtException(t,e,n){this.message=t||"Uncaught error with no additional information",this.sourceURL=e,this.line=n}function o(t,e){var n=e?null:c.now();i("err",[t,n])}var i=t("handle"),a=t(33),s=t("ee"),c=t("loader"),f=t("gos"),u=window.onerror,d=!1,p="nr@seenError";if(!c.disabled){var l=0;c.features.err=!0,t(1),window.onerror=r;try{throw new Error}catch(h){"stack"in h&&(t(14),t(13),"addEventListener"in window&&t(7),c.xhrWrappable&&t(15),d=!0)}s.on("fn-start",function(t,e,n){d&&(l+=1)}),s.on("fn-err",function(t,e,n){d&&!n[p]&&(f(n,p,function(){return!0}),this.thrown=!0,o(n))}),s.on("fn-end",function(){d&&!this.thrown&&l>0&&(l-=1)}),s.on("internal-error",function(t){i("ierr",[t,c.now(),!0])})}},{}],3:[function(t,e,n){var r=t("loader");r.disabled||(r.features.ins=!0)},{}],4:[function(t,e,n){function r(){U++,L=g.hash,this[u]=y.now()}function o(){U--,g.hash!==L&&i(0,!0);var t=y.now();this[h]=~~this[h]+t-this[u],this[d]=t}function i(t,e){E.emit("newURL",[""+g,e])}function a(t,e){t.on(e,function(){this[e]=y.now()})}var s="-start",c="-end",f="-body",u="fn"+s,d="fn"+c,p="cb"+s,l="cb"+c,h="jsTime",m="fetch",v="addEventListener",w=window,g=w.location,y=t("loader");if(w[v]&&y.xhrWrappable&&!y.disabled){var x=t(11),b=t(12),E=t(9),R=t(7),O=t(14),T=t(8),P=t(15),S=t(10),M=t("ee"),N=M.get("tracer"),C=t(23);t(17),y.features.spa=!0;var L,U=0;M.on(u,r),b.on(p,r),S.on(p,r),M.on(d,o),b.on(l,o),S.on(l,o),M.buffer([u,d,"xhr-resolved"]),R.buffer([u]),O.buffer(["setTimeout"+c,"clearTimeout"+s,u]),P.buffer([u,"new-xhr","send-xhr"+s]),T.buffer([m+s,m+"-done",m+f+s,m+f+c]),E.buffer(["newURL"]),x.buffer([u]),b.buffer(["propagate",p,l,"executor-err","resolve"+s]),N.buffer([u,"no-"+u]),S.buffer(["new-jsonp","cb-start","jsonp-error","jsonp-end"]),a(T,m+s),a(T,m+"-done"),a(S,"new-jsonp"),a(S,"jsonp-end"),a(S,"cb-start"),E.on("pushState-end",i),E.on("replaceState-end",i),w[v]("hashchange",i,C(!0)),w[v]("load",i,C(!0)),w[v]("popstate",function(){i(0,U>1)},C(!0))}},{}],5:[function(t,e,n){function r(){var t=new PerformanceObserver(function(t,e){var n=t.getEntries();s(v,[n])});try{t.observe({entryTypes:["resource"]})}catch(e){}}function o(t){if(s(v,[window.performance.getEntriesByType(w)]),window.performance["c"+p])try{window.performance[h](m,o,!1)}catch(t){}else try{window.performance[h]("webkit"+m,o,!1)}catch(t){}}function i(t){}if(window.performance&&window.performance.timing&&window.performance.getEntriesByType){var a=t("ee"),s=t("handle"),c=t(14),f=t(13),u=t(6),d=t(23),p="learResourceTimings",l="addEventListener",h="removeEventListener",m="resourcetimingbufferfull",v="bstResource",w="resource",g="-start",y="-end",x="fn"+g,b="fn"+y,E="bstTimer",R="pushState",O=t("loader");if(!O.disabled){O.features.stn=!0,t(9),"addEventListener"in window&&t(7);var T=NREUM.o.EV;a.on(x,function(t,e){var n=t[0];n instanceof T&&(this.bstStart=O.now())}),a.on(b,function(t,e){var n=t[0];n instanceof T&&s("bst",[n,e,this.bstStart,O.now()])}),c.on(x,function(t,e,n){this.bstStart=O.now(),this.bstType=n}),c.on(b,function(t,e){s(E,[e,this.bstStart,O.now(),this.bstType])}),f.on(x,function(){this.bstStart=O.now()}),f.on(b,function(t,e){s(E,[e,this.bstStart,O.now(),"requestAnimationFrame"])}),a.on(R+g,function(t){this.time=O.now(),this.startPath=location.pathname+location.hash}),a.on(R+y,function(t){s("bstHist",[location.pathname+location.hash,this.startPath,this.time])}),u()?(s(v,[window.performance.getEntriesByType("resource")]),r()):l in window.performance&&(window.performance["c"+p]?window.performance[l](m,o,d(!1)):window.performance[l]("webkit"+m,o,d(!1))),document[l]("scroll",i,d(!1)),document[l]("keypress",i,d(!1)),document[l]("click",i,d(!1))}}},{}],6:[function(t,e,n){e.exports=function(){return"PerformanceObserver"in window&&"function"==typeof window.PerformanceObserver}},{}],7:[function(t,e,n){function r(t){for(var e=t;e&&!e.hasOwnProperty(u);)e=Object.getPrototypeOf(e);e&&o(e)}function o(t){s.inPlace(t,[u,d],"-",i)}function i(t,e){return t[1]}var a=t("ee").get("events"),s=t("wrap-function")(a,!0),c=t("gos"),f=XMLHttpRequest,u="addEventListener",d="removeEventListener";e.exports=a,"getPrototypeOf"in Object?(r(document),r(window),r(f.prototype)):f.prototype.hasOwnProperty(u)&&(o(window),o(f.prototype)),a.on(u+"-start",function(t,e){var n=t[1];if(null!==n&&("function"==typeof n||"object"==typeof n)){var r=c(n,"nr@wrapped",function(){function t(){if("function"==typeof n.handleEvent)return n.handleEvent.apply(n,arguments)}var e={object:t,"function":n}[typeof n];return e?s(e,"fn-",null,e.name||"anonymous"):n});this.wrapped=t[1]=r}}),a.on(d+"-start",function(t){t[1]=this.wrapped||t[1]})},{}],8:[function(t,e,n){function r(t,e,n){var r=t[e];"function"==typeof r&&(t[e]=function(){var t=i(arguments),e={};o.emit(n+"before-start",[t],e);var a;e[m]&&e[m].dt&&(a=e[m].dt);var s=r.apply(this,t);return o.emit(n+"start",[t,a],s),s.then(function(t){return o.emit(n+"end",[null,t],s),t},function(t){throw o.emit(n+"end",[t],s),t})})}var o=t("ee").get("fetch"),i=t(33),a=t(32);e.exports=o;var s=window,c="fetch-",f=c+"body-",u=["arrayBuffer","blob","json","text","formData"],d=s.Request,p=s.Response,l=s.fetch,h="prototype",m="nr@context";d&&p&&l&&(a(u,function(t,e){r(d[h],e,f),r(p[h],e,f)}),r(s,"fetch",c),o.on(c+"end",function(t,e){var n=this;if(e){var r=e.headers.get("content-length");null!==r&&(n.rxSize=r),o.emit(c+"done",[null,e],n)}else o.emit(c+"done",[t],n)}))},{}],9:[function(t,e,n){var r=t("ee").get("history"),o=t("wrap-function")(r);e.exports=r;var i=window.history&&window.history.constructor&&window.history.constructor.prototype,a=window.history;i&&i.pushState&&i.replaceState&&(a=i),o.inPlace(a,["pushState","replaceState"],"-")},{}],10:[function(t,e,n){function r(t){function e(){f.emit("jsonp-end",[],l),t.removeEventListener("load",e,c(!1)),t.removeEventListener("error",n,c(!1))}function n(){f.emit("jsonp-error",[],l),f.emit("jsonp-end",[],l),t.removeEventListener("load",e,c(!1)),t.removeEventListener("error",n,c(!1))}var r=t&&"string"==typeof t.nodeName&&"script"===t.nodeName.toLowerCase();if(r){var o="function"==typeof t.addEventListener;if(o){var a=i(t.src);if(a){var d=s(a),p="function"==typeof d.parent[d.key];if(p){var l={};u.inPlace(d.parent,[d.key],"cb-",l),t.addEventListener("load",e,c(!1)),t.addEventListener("error",n,c(!1)),f.emit("new-jsonp",[t.src],l)}}}}}function o(){return"addEventListener"in window}function i(t){var e=t.match(d);return e?e[1]:null}function a(t,e){var n=t.match(l),r=n[1],o=n[3];return o?a(o,e[r]):e[r]}function s(t){var e=t.match(p);return e&&e.length>=3?{key:e[2],parent:a(e[1],window)}:{key:t,parent:window}}var c=t(23),f=t("ee").get("jsonp"),u=t("wrap-function")(f);if(e.exports=f,o()){var d=/[?&](?:callback|cb)=([^&#]+)/,p=/(.*)\.([^.]+)/,l=/^(\w+)(\.|$)(.*)$/,h=["appendChild","insertBefore","replaceChild"];Node&&Node.prototype&&Node.prototype.appendChild?u.inPlace(Node.prototype,h,"dom-"):(u.inPlace(HTMLElement.prototype,h,"dom-"),u.inPlace(HTMLHeadElement.prototype,h,"dom-"),u.inPlace(HTMLBodyElement.prototype,h,"dom-")),f.on("dom-start",function(t){r(t[0])})}},{}],11:[function(t,e,n){var r=t("ee").get("mutation"),o=t("wrap-function")(r),i=NREUM.o.MO;e.exports=r,i&&(window.MutationObserver=function(t){return this instanceof i?new i(o(t,"fn-")):i.apply(this,arguments)},MutationObserver.prototype=i.prototype)},{}],12:[function(t,e,n){function r(t){var e=i.context(),n=s(t,"executor-",e,null,!1),r=new f(n);return i.context(r).getCtx=function(){return e},r}var o=t("wrap-function"),i=t("ee").get("promise"),a=t("ee").getOrSetContext,s=o(i),c=t(32),f=NREUM.o.PR;e.exports=i,f&&(window.Promise=r,["all","race"].forEach(function(t){var e=f[t];f[t]=function(n){function r(t){return function(){i.emit("propagate",[null,!o],a,!1,!1),o=o||!t}}var o=!1;c(n,function(e,n){Promise.resolve(n).then(r("all"===t),r(!1))});var a=e.apply(f,arguments),s=f.resolve(a);return s}}),["resolve","reject"].forEach(function(t){var e=f[t];f[t]=function(t){var n=e.apply(f,arguments);return t!==n&&i.emit("propagate",[t,!0],n,!1,!1),n}}),f.prototype["catch"]=function(t){return this.then(null,t)},f.prototype=Object.create(f.prototype,{constructor:{value:r}}),c(Object.getOwnPropertyNames(f),function(t,e){try{r[e]=f[e]}catch(n){}}),o.wrapInPlace(f.prototype,"then",function(t){return function(){var e=this,n=o.argsToArray.apply(this,arguments),r=a(e);r.promise=e,n[0]=s(n[0],"cb-",r,null,!1),n[1]=s(n[1],"cb-",r,null,!1);var c=t.apply(this,n);return r.nextPromise=c,i.emit("propagate",[e,!0],c,!1,!1),c}}),i.on("executor-start",function(t){t[0]=s(t[0],"resolve-",this,null,!1),t[1]=s(t[1],"resolve-",this,null,!1)}),i.on("executor-err",function(t,e,n){t[1](n)}),i.on("cb-end",function(t,e,n){i.emit("propagate",[n,!0],this.nextPromise,!1,!1)}),i.on("propagate",function(t,e,n){this.getCtx&&!e||(this.getCtx=function(){if(t instanceof Promise)var e=i.context(t);return e&&e.getCtx?e.getCtx():this})}),r.toString=function(){return""+f})},{}],13:[function(t,e,n){var r=t("ee").get("raf"),o=t("wrap-function")(r),i="equestAnimationFrame";e.exports=r,o.inPlace(window,["r"+i,"mozR"+i,"webkitR"+i,"msR"+i],"raf-"),r.on("raf-start",function(t){t[0]=o(t[0],"fn-")})},{}],14:[function(t,e,n){function r(t,e,n){t[0]=a(t[0],"fn-",null,n)}function o(t,e,n){this.method=n,this.timerDuration=isNaN(t[1])?0:+t[1],t[0]=a(t[0],"fn-",this,n)}var i=t("ee").get("timer"),a=t("wrap-function")(i),s="setTimeout",c="setInterval",f="clearTimeout",u="-start",d="-";e.exports=i,a.inPlace(window,[s,"setImmediate"],s+d),a.inPlace(window,[c],c+d),a.inPlace(window,[f,"clearImmediate"],f+d),i.on(c+u,r),i.on(s+u,o)},{}],15:[function(t,e,n){function r(t,e){d.inPlace(e,["onreadystatechange"],"fn-",s)}function o(){var t=this,e=u.context(t);t.readyState>3&&!e.resolved&&(e.resolved=!0,u.emit("xhr-resolved",[],t)),d.inPlace(t,y,"fn-",s)}function i(t){x.push(t),m&&(E?E.then(a):w?w(a):(R=-R,O.data=R))}function a(){for(var t=0;t<x.length;t++)r([],x[t]);x.length&&(x=[])}function s(t,e){return e}function c(t,e){for(var n in t)e[n]=t[n];return e}t(7);var f=t("ee"),u=f.get("xhr"),d=t("wrap-function")(u),p=t(23),l=NREUM.o,h=l.XHR,m=l.MO,v=l.PR,w=l.SI,g="readystatechange",y=["onload","onerror","onabort","onloadstart","onloadend","onprogress","ontimeout"],x=[];e.exports=u;var b=window.XMLHttpRequest=function(t){var e=new h(t);try{u.emit("new-xhr",[e],e),e.addEventListener(g,o,p(!1))}catch(n){try{u.emit("internal-error",[n])}catch(r){}}return e};if(c(h,b),b.prototype=h.prototype,d.inPlace(b.prototype,["open","send"],"-xhr-",s),u.on("send-xhr-start",function(t,e){r(t,e),i(e)}),u.on("open-xhr-start",r),m){var E=v&&v.resolve();if(!w&&!v){var R=1,O=document.createTextNode(R);new m(a).observe(O,{characterData:!0})}}else f.on("fn-end",function(t){t[0]&&t[0].type===g||a()})},{}],16:[function(t,e,n){function r(t){if(!s(t))return null;var e=window.NREUM;if(!e.loader_config)return null;var n=(e.loader_config.accountID||"").toString()||null,r=(e.loader_config.agentID||"").toString()||null,f=(e.loader_config.trustKey||"").toString()||null;if(!n||!r)return null;var h=l.generateSpanId(),m=l.generateTraceId(),v=Date.now(),w={spanId:h,traceId:m,timestamp:v};return(t.sameOrigin||c(t)&&p())&&(w.traceContextParentHeader=o(h,m),w.traceContextStateHeader=i(h,v,n,r,f)),(t.sameOrigin&&!u()||!t.sameOrigin&&c(t)&&d())&&(w.newrelicHeader=a(h,m,v,n,r,f)),w}function o(t,e){return"00-"+e+"-"+t+"-01"}function i(t,e,n,r,o){var i=0,a="",s=1,c="",f="";return o+"@nr="+i+"-"+s+"-"+n+"-"+r+"-"+t+"-"+a+"-"+c+"-"+f+"-"+e}function a(t,e,n,r,o,i){var a="btoa"in window&&"function"==typeof window.btoa;if(!a)return null;var s={v:[0,1],d:{ty:"Browser",ac:r,ap:o,id:t,tr:e,ti:n}};return i&&r!==i&&(s.d.tk=i),btoa(JSON.stringify(s))}function s(t){return f()&&c(t)}function c(t){var e=!1,n={};if("init"in NREUM&&"distributed_tracing"in NREUM.init&&(n=NREUM.init.distributed_tracing),t.sameOrigin)e=!0;else if(n.allowed_origins instanceof Array)for(var r=0;r<n.allowed_origins.length;r++){var o=h(n.allowed_origins[r]);if(t.hostname===o.hostname&&t.protocol===o.protocol&&t.port===o.port){e=!0;break}}return e}function f(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.enabled}function u(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.exclude_newrelic_header}function d(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&NREUM.init.distributed_tracing.cors_use_newrelic_header!==!1}function p(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.cors_use_tracecontext_headers}var l=t(29),h=t(18);e.exports={generateTracePayload:r,shouldGenerateTrace:s}},{}],17:[function(t,e,n){function r(t){var e=this.params,n=this.metrics;if(!this.ended){this.ended=!0;for(var r=0;r<p;r++)t.removeEventListener(d[r],this.listener,!1);e.aborted||(n.duration=a.now()-this.startTime,this.loadCaptureCalled||4!==t.readyState?null==e.status&&(e.status=0):i(this,t),n.cbTime=this.cbTime,s("xhr",[e,n,this.startTime,this.endTime,"xhr"],this))}}function o(t,e){var n=c(e),r=t.params;r.hostname=n.hostname,r.port=n.port,r.protocol=n.protocol,r.host=n.hostname+":"+n.port,r.pathname=n.pathname,t.parsedOrigin=n,t.sameOrigin=n.sameOrigin}function i(t,e){t.params.status=e.status;var n=v(e,t.lastSize);if(n&&(t.metrics.rxSize=n),t.sameOrigin){var r=e.getResponseHeader("X-NewRelic-App-Data");r&&(t.params.cat=r.split(", ").pop())}t.loadCaptureCalled=!0}var a=t("loader");if(a.xhrWrappable&&!a.disabled){var s=t("handle"),c=t(18),f=t(16).generateTracePayload,u=t("ee"),d=["load","error","abort","timeout"],p=d.length,l=t("id"),h=t(24),m=t(22),v=t(19),w=t(23),g=NREUM.o.REQ,y=window.XMLHttpRequest;a.features.xhr=!0,t(15),t(8),u.on("new-xhr",function(t){var e=this;e.totalCbs=0,e.called=0,e.cbTime=0,e.end=r,e.ended=!1,e.xhrGuids={},e.lastSize=null,e.loadCaptureCalled=!1,e.params=this.params||{},e.metrics=this.metrics||{},t.addEventListener("load",function(n){i(e,t)},w(!1)),h&&(h>34||h<10)||t.addEventListener("progress",function(t){e.lastSize=t.loaded},w(!1))}),u.on("open-xhr-start",function(t){this.params={method:t[0]},o(this,t[1]),this.metrics={}}),u.on("open-xhr-end",function(t,e){"loader_config"in NREUM&&"xpid"in NREUM.loader_config&&this.sameOrigin&&e.setRequestHeader("X-NewRelic-ID",NREUM.loader_config.xpid);var n=f(this.parsedOrigin);if(n){var r=!1;n.newrelicHeader&&(e.setRequestHeader("newrelic",n.newrelicHeader),r=!0),n.traceContextParentHeader&&(e.setRequestHeader("traceparent",n.traceContextParentHeader),n.traceContextStateHeader&&e.setRequestHeader("tracestate",n.traceContextStateHeader),r=!0),r&&(this.dt=n)}}),u.on("send-xhr-start",function(t,e){var n=this.metrics,r=t[0],o=this;if(n&&r){var i=m(r);i&&(n.txSize=i)}this.startTime=a.now(),this.listener=function(t){try{"abort"!==t.type||o.loadCaptureCalled||(o.params.aborted=!0),("load"!==t.type||o.called===o.totalCbs&&(o.onloadCalled||"function"!=typeof e.onload))&&o.end(e)}catch(n){try{u.emit("internal-error",[n])}catch(r){}}};for(var s=0;s<p;s++)e.addEventListener(d[s],this.listener,w(!1))}),u.on("xhr-cb-time",function(t,e,n){this.cbTime+=t,e?this.onloadCalled=!0:this.called+=1,this.called!==this.totalCbs||!this.onloadCalled&&"function"==typeof n.onload||this.end(n)}),u.on("xhr-load-added",function(t,e){var n=""+l(t)+!!e;this.xhrGuids&&!this.xhrGuids[n]&&(this.xhrGuids[n]=!0,this.totalCbs+=1)}),u.on("xhr-load-removed",function(t,e){var n=""+l(t)+!!e;this.xhrGuids&&this.xhrGuids[n]&&(delete this.xhrGuids[n],this.totalCbs-=1)}),u.on("xhr-resolved",function(){this.endTime=a.now()}),u.on("addEventListener-end",function(t,e){e instanceof y&&"load"===t[0]&&u.emit("xhr-load-added",[t[1],t[2]],e)}),u.on("removeEventListener-end",function(t,e){e instanceof y&&"load"===t[0]&&u.emit("xhr-load-removed",[t[1],t[2]],e)}),u.on("fn-start",function(t,e,n){e instanceof y&&("onload"===n&&(this.onload=!0),("load"===(t[0]&&t[0].type)||this.onload)&&(this.xhrCbStart=a.now()))}),u.on("fn-end",function(t,e){this.xhrCbStart&&u.emit("xhr-cb-time",[a.now()-this.xhrCbStart,this.onload,e],e)}),u.on("fetch-before-start",function(t){function e(t,e){var n=!1;return e.newrelicHeader&&(t.set("newrelic",e.newrelicHeader),n=!0),e.traceContextParentHeader&&(t.set("traceparent",e.traceContextParentHeader),e.traceContextStateHeader&&t.set("tracestate",e.traceContextStateHeader),n=!0),n}var n,r=t[1]||{};"string"==typeof t[0]?n=t[0]:t[0]&&t[0].url?n=t[0].url:window.URL&&t[0]&&t[0]instanceof URL&&(n=t[0].href),n&&(this.parsedOrigin=c(n),this.sameOrigin=this.parsedOrigin.sameOrigin);var o=f(this.parsedOrigin);if(o&&(o.newrelicHeader||o.traceContextParentHeader))if("string"==typeof t[0]||window.URL&&t[0]&&t[0]instanceof URL){var i={};for(var a in r)i[a]=r[a];i.headers=new Headers(r.headers||{}),e(i.headers,o)&&(this.dt=o),t.length>1?t[1]=i:t.push(i)}else t[0]&&t[0].headers&&e(t[0].headers,o)&&(this.dt=o)}),u.on("fetch-start",function(t,e){this.params={},this.metrics={},this.startTime=a.now(),this.dt=e,t.length>=1&&(this.target=t[0]),t.length>=2&&(this.opts=t[1]);var n,r=this.opts||{},i=this.target;"string"==typeof i?n=i:"object"==typeof i&&i instanceof g?n=i.url:window.URL&&"object"==typeof i&&i instanceof URL&&(n=i.href),o(this,n);var s=(""+(i&&i instanceof g&&i.method||r.method||"GET")).toUpperCase();this.params.method=s,this.txSize=m(r.body)||0}),u.on("fetch-done",function(t,e){this.endTime=a.now(),this.params||(this.params={}),this.params.status=e?e.status:0;var n;"string"==typeof this.rxSize&&this.rxSize.length>0&&(n=+this.rxSize);var r={txSize:this.txSize,rxSize:n,duration:a.now()-this.startTime};s("xhr",[this.params,r,this.startTime,this.endTime,"fetch"],this)})}},{}],18:[function(t,e,n){var r={};e.exports=function(t){if(t in r)return r[t];var e=document.createElement("a"),n=window.location,o={};e.href=t,o.port=e.port;var i=e.href.split("://");!o.port&&i[1]&&(o.port=i[1].split("/")[0].split("@").pop().split(":")[1]),o.port&&"0"!==o.port||(o.port="https"===i[0]?"443":"80"),o.hostname=e.hostname||n.hostname,o.pathname=e.pathname,o.protocol=i[0],"/"!==o.pathname.charAt(0)&&(o.pathname="/"+o.pathname);var a=!e.protocol||":"===e.protocol||e.protocol===n.protocol,s=e.hostname===document.domain&&e.port===n.port;return o.sameOrigin=a&&(!e.hostname||s),"/"===o.pathname&&(r[t]=o),o}},{}],19:[function(t,e,n){function r(t,e){var n=t.responseType;return"json"===n&&null!==e?e:"arraybuffer"===n||"blob"===n||"json"===n?o(t.response):"text"===n||""===n||void 0===n?o(t.responseText):void 0}var o=t(22);e.exports=r},{}],20:[function(t,e,n){function r(){}function o(t,e,n,r){return function(){return u.recordSupportability("API/"+e+"/called"),i(t+e,[f.now()].concat(s(arguments)),n?null:this,r),n?void 0:this}}var i=t("handle"),a=t(32),s=t(33),c=t("ee").get("tracer"),f=t("loader"),u=t(25),d=NREUM;"undefined"==typeof window.newrelic&&(newrelic=d);var p=["setPageViewName","setCustomAttribute","setErrorHandler","finished","addToTrace","inlineHit","addRelease"],l="api-",h=l+"ixn-";a(p,function(t,e){d[e]=o(l,e,!0,"api")}),d.addPageAction=o(l,"addPageAction",!0),d.setCurrentRouteName=o(l,"routeName",!0),e.exports=newrelic,d.interaction=function(){return(new r).get()};var m=r.prototype={createTracer:function(t,e){var n={},r=this,o="function"==typeof e;return i(h+"tracer",[f.now(),t,n],r),function(){if(c.emit((o?"":"no-")+"fn-start",[f.now(),r,o],n),o)try{return e.apply(this,arguments)}catch(t){throw c.emit("fn-err",[arguments,this,t],n),t}finally{c.emit("fn-end",[f.now()],n)}}}};a("actionText,setName,setAttribute,save,ignore,onEnd,getContext,end,get".split(","),function(t,e){m[e]=o(h,e)}),newrelic.noticeError=function(t,e){"string"==typeof t&&(t=new Error(t)),u.recordSupportability("API/noticeError/called"),i("err",[t,f.now(),!1,e])}},{}],21:[function(t,e,n){function r(t){if(NREUM.init){for(var e=NREUM.init,n=t.split("."),r=0;r<n.length-1;r++)if(e=e[n[r]],"object"!=typeof e)return;return e=e[n[n.length-1]]}}e.exports={getConfiguration:r}},{}],22:[function(t,e,n){e.exports=function(t){if("string"==typeof t&&t.length)return t.length;if("object"==typeof t){if("undefined"!=typeof ArrayBuffer&&t instanceof ArrayBuffer&&t.byteLength)return t.byteLength;if("undefined"!=typeof Blob&&t instanceof Blob&&t.size)return t.size;if(!("undefined"!=typeof FormData&&t instanceof FormData))try{return JSON.stringify(t).length}catch(e){return}}}},{}],23:[function(t,e,n){var r=!1;try{var o=Object.defineProperty({},"passive",{get:function(){r=!0}});window.addEventListener("testPassive",null,o),window.removeEventListener("testPassive",null,o)}catch(i){}e.exports=function(t){return r?{passive:!0,capture:!!t}:!!t}},{}],24:[function(t,e,n){var r=0,o=navigator.userAgent.match(/Firefox[\/\s](\d+\.\d+)/);o&&(r=+o[1]),e.exports=r},{}],25:[function(t,e,n){function r(t,e){var n=[a,t,{name:t},e];return i("storeMetric",n,null,"api"),n}function o(t,e){var n=[s,t,{name:t},e];return i("storeEventMetrics",n,null,"api"),n}var i=t("handle"),a="sm",s="cm";e.exports={constants:{SUPPORTABILITY_METRIC:a,CUSTOM_METRIC:s},recordSupportability:r,recordCustom:o}},{}],26:[function(t,e,n){function r(){return s.exists&&performance.now?Math.round(performance.now()):(i=Math.max((new Date).getTime(),i))-a}function o(){return i}var i=(new Date).getTime(),a=i,s=t(34);e.exports=r,e.exports.offset=a,e.exports.getLastTimestamp=o},{}],27:[function(t,e,n){function r(t){return!(!t||!t.protocol||"file:"===t.protocol)}e.exports=r},{}],28:[function(t,e,n){function r(t,e){var n=t.getEntries();n.forEach(function(t){"first-paint"===t.name?p("timing",["fp",Math.floor(t.startTime)]):"first-contentful-paint"===t.name&&p("timing",["fcp",Math.floor(t.startTime)])})}function o(t,e){var n=t.getEntries();if(n.length>0){var r=n[n.length-1];if(c&&c<r.startTime)return;p("lcp",[r])}}function i(t){t.getEntries().forEach(function(t){t.hadRecentInput||p("cls",[t])})}function a(t){if(t instanceof v&&!g){var e=Math.round(t.timeStamp),n={type:t.type};e<=l.now()?n.fid=l.now()-e:e>l.offset&&e<=Date.now()?(e-=l.offset,n.fid=l.now()-e):e=l.now(),g=!0,p("timing",["fi",e,n])}}function s(t){"hidden"===t&&(c=l.now(),p("pageHide",[c]))}if(!("init"in NREUM&&"page_view_timing"in NREUM.init&&"enabled"in NREUM.init.page_view_timing&&NREUM.init.page_view_timing.enabled===!1)){var c,f,u,d,p=t("handle"),l=t("loader"),h=t(31),m=t(23),v=NREUM.o.EV;if("PerformanceObserver"in window&&"function"==typeof window.PerformanceObserver){f=new PerformanceObserver(r);try{f.observe({entryTypes:["paint"]})}catch(w){}u=new PerformanceObserver(o);try{u.observe({entryTypes:["largest-contentful-paint"]})}catch(w){}d=new PerformanceObserver(i);try{d.observe({type:"layout-shift",buffered:!0})}catch(w){}}if("addEventListener"in document){var g=!1,y=["click","keydown","mousedown","pointerdown","touchstart"];y.forEach(function(t){document.addEventListener(t,a,m(!1))})}h(s)}},{}],29:[function(t,e,n){function r(){function t(){return e?15&e[n++]:16*Math.random()|0}var e=null,n=0,r=window.crypto||window.msCrypto;r&&r.getRandomValues&&(e=r.getRandomValues(new Uint8Array(31)));for(var o,i="xxxxxxxx-xxxx-4xxx-yxxx-xxxxxxxxxxxx",a="",s=0;s<i.length;s++)o=i[s],"x"===o?a+=t().toString(16):"y"===o?(o=3&t()|8,a+=o.toString(16)):a+=o;return a}function o(){return a(16)}function i(){return a(32)}function a(t){function e(){return n?15&n[r++]:16*Math.random()|0}var n=null,r=0,o=window.crypto||window.msCrypto;o&&o.getRandomValues&&Uint8Array&&(n=o.getRandomValues(new Uint8Array(31)));for(var i=[],a=0;a<t;a++)i.push(e().toString(16));return i.join("")}e.exports={generateUuid:r,generateSpanId:o,generateTraceId:i}},{}],30:[function(t,e,n){function r(t,e){if(!o)return!1;if(t!==o)return!1;if(!e)return!0;if(!i)return!1;for(var n=i.split("."),r=e.split("."),a=0;a<r.length;a++)if(r[a]!==n[a])return!1;return!0}var o=null,i=null,a=/Version\/(\S+)\s+Safari/;if(navigator.userAgent){var s=navigator.userAgent,c=s.match(a);c&&s.indexOf("Chrome")===-1&&s.indexOf("Chromium")===-1&&(o="Safari",i=c[1])}e.exports={agent:o,version:i,match:r}},{}],31:[function(t,e,n){function r(t){function e(){t(s&&document[s]?document[s]:document[i]?"hidden":"visible")}"addEventListener"in document&&a&&document.addEventListener(a,e,o(!1))}var o=t(23);e.exports=r;var i,a,s;"undefined"!=typeof document.hidden?(i="hidden",a="visibilitychange",s="visibilityState"):"undefined"!=typeof document.msHidden?(i="msHidden",a="msvisibilitychange"):"undefined"!=typeof document.webkitHidden&&(i="webkitHidden",a="webkitvisibilitychange",s="webkitVisibilityState")},{}],32:[function(t,e,n){function r(t,e){var n=[],r="",i=0;for(r in t)o.call(t,r)&&(n[i]=e(r,t[r]),i+=1);return n}var o=Object.prototype.hasOwnProperty;e.exports=r},{}],33:[function(t,e,n){function r(t,e,n){e||(e=0),"undefined"==typeof n&&(n=t?t.length:0);for(var r=-1,o=n-e||0,i=Array(o<0?0:o);++r<o;)i[r]=t[e+r];return i}e.exports=r},{}],34:[function(t,e,n){e.exports={exists:"undefined"!=typeof window.performance&&window.performance.timing&&"undefined"!=typeof window.performance.timing.navigationStart}},{}],ee:[function(t,e,n){function r(){}function o(t){function e(t){return t&&t instanceof r?t:t?f(t,c,a):a()}function n(n,r,o,i,a){if(a!==!1&&(a=!0),!l.aborted||i){t&&a&&t(n,r,o);for(var s=e(o),c=m(n),f=c.length,u=0;u<f;u++)c[u].apply(s,r);var p=d[y[n]];return p&&p.push([x,n,r,s]),s}}function i(t,e){g[t]=m(t).concat(e)}function h(t,e){var n=g[t];if(n)for(var r=0;r<n.length;r++)n[r]===e&&n.splice(r,1)}function m(t){return g[t]||[]}function v(t){return p[t]=p[t]||o(n)}function w(t,e){l.aborted||u(t,function(t,n){e=e||"feature",y[n]=e,e in d||(d[e]=[])})}var g={},y={},x={on:i,addEventListener:i,removeEventListener:h,emit:n,get:v,listeners:m,context:e,buffer:w,abort:s,aborted:!1};return x}function i(t){return f(t,c,a)}function a(){return new r}function s(){(d.api||d.feature)&&(l.aborted=!0,d=l.backlog={})}var c="nr@context",f=t("gos"),u=t(32),d={},p={},l=e.exports=o();e.exports.getOrSetContext=i,l.backlog=d},{}],gos:[function(t,e,n){function r(t,e,n){if(o.call(t,e))return t[e];var r=n();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(t,e,{value:r,writable:!0,enumerable:!1}),r}catch(i){}return t[e]=r,r}var o=Object.prototype.hasOwnProperty;e.exports=r},{}],handle:[function(t,e,n){function r(t,e,n,r){o.buffer([t],r),o.emit(t,e,n)}var o=t("ee").get("handle");e.exports=r,r.ee=o},{}],id:[function(t,e,n){function r(t){var e=typeof t;return!t||"object"!==e&&"function"!==e?-1:t===window?0:a(t,i,function(){return o++})}var o=1,i="nr@id",a=t("gos");e.exports=r},{}],loader:[function(t,e,n){function r(){if(!P++){var t=T.info=NREUM.info,e=v.getElementsByTagName("script")[0];if(setTimeout(f.abort,3e4),!(t&&t.licenseKey&&t.applicationID&&e))return f.abort();c(R,function(e,n){t[e]||(t[e]=n)});var n=a();s("mark",["onload",n+T.offset],null,"api"),s("timing",["load",n]);var r=v.createElement("script");0===t.agent.indexOf("http://")||0===t.agent.indexOf("https://")?r.src=t.agent:r.src=h+"://"+t.agent,e.parentNode.insertBefore(r,e)}}function o(){"complete"===v.readyState&&i()}function i(){s("mark",["domContent",a()+T.offset],null,"api")}var a=t(26),s=t("handle"),c=t(32),f=t("ee"),u=t(30),d=t(27),p=t(21),l=t(23),h=p.getConfiguration("ssl")===!1?"http":"https",m=window,v=m.document,w="addEventListener",g="attachEvent",y=m.XMLHttpRequest,x=y&&y.prototype,b=!d(m.location);NREUM.o={ST:setTimeout,SI:m.setImmediate,CT:clearTimeout,XHR:y,REQ:m.Request,EV:m.Event,PR:m.Promise,MO:m.MutationObserver};var E=""+location,R={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",agent:"js-agent.newrelic.com/nr-spa-1212.min.js"},O=y&&x&&x[w]&&!/CriOS/.test(navigator.userAgent),T=e.exports={offset:a.getLastTimestamp(),now:a,origin:E,features:{},xhrWrappable:O,userAgent:u,disabled:b};if(!b){t(20),t(28),v[w]?(v[w]("DOMContentLoaded",i,l(!1)),m[w]("load",r,l(!1))):(v[g]("onreadystatechange",o),m[g]("onload",r)),s("mark",["firstbyte",a.getLastTimestamp()],null,"api");var P=0}},{}],"wrap-function":[function(t,e,n){function r(t,e){function n(e,n,r,c,f){function nrWrapper(){var i,a,u,p;try{a=this,i=d(arguments),u="function"==typeof r?r(i,a):r||{}}catch(l){o([l,"",[i,a,c],u],t)}s(n+"start",[i,a,c],u,f);try{return p=e.apply(a,i)}catch(h){throw s(n+"err",[i,a,h],u,f),h}finally{s(n+"end",[i,a,p],u,f)}}return a(e)?e:(n||(n=""),nrWrapper[p]=e,i(e,nrWrapper,t),nrWrapper)}function r(t,e,r,o,i){r||(r="");var s,c,f,u="-"===r.charAt(0);for(f=0;f<e.length;f++)c=e[f],s=t[c],a(s)||(t[c]=n(s,u?c+r:r,o,c,i))}function s(n,r,i,a){if(!h||e){var s=h;h=!0;try{t.emit(n,r,i,e,a)}catch(c){o([c,n,r,i],t)}h=s}}return t||(t=u),n.inPlace=r,n.flag=p,n}function o(t,e){e||(e=u);try{e.emit("internal-error",t)}catch(n){}}function i(t,e,n){if(Object.defineProperty&&Object.keys)try{var r=Object.keys(t);return r.forEach(function(n){Object.defineProperty(e,n,{get:function(){return t[n]},set:function(e){return t[n]=e,e}})}),e}catch(i){o([i],n)}for(var a in t)l.call(t,a)&&(e[a]=t[a]);return e}function a(t){return!(t&&t instanceof Function&&t.apply&&!t[p])}function s(t,e){var n=e(t);return n[p]=t,i(t,n,u),n}function c(t,e,n){var r=t[e];t[e]=s(r,n)}function f(){for(var t=arguments.length,e=new Array(t),n=0;n<t;++n)e[n]=arguments[n];return e}var u=t("ee"),d=t(33),p="nr@original",l=Object.prototype.hasOwnProperty,h=!1;e.exports=r,e.exports.wrapFunction=s,e.exports.wrapInPlace=c,e.exports.argsToArray=f},{}]},{},["loader",2,17,5,3,4]);
  ;NREUM.loader_config={accountID:"804283",trustKey:"804283",agentID:"402703674",licenseKey:"cf99e8d2a3",applicationID:"402703674"}
  ;NREUM.info={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",licenseKey:"cf99e8d2a3",
    // Modified this value from the generated script, to pass prod vs dev
    applicationID: window.location.hostname.includes('journals.plos.org') ? "402703674" : "402694889",
    sa:1}
</script>
<!-- End New Relic -->






<header>
  <div id="topslot" class="head-top">

<div class="center">
<div class="title">Advertisement</div>
<!-- DoubleClick Ad Zone -->
  <div class='advertisement' id='div-gpt-ad-1458247671871-0' style='width:728px; height:90px;'>
    <script type='text/javascript'>
      googletag.cmd.push(function() { googletag.display('div-gpt-ad-1458247671871-0'); });
    </script>
  </div>
</div>
  </div>

  <div id="user" class="nav" data-user-management-url="https://community.plos.org">
  </div>
  <div id="pagehdr">

    <nav class="nav-main">




<h1 class="logo">
  <a href="/plosone/.">PLOS ONE</a>
</h1>

<section class="top-bar-section"> 

<ul class="nav-elements">


    <li class="multi-col-parent menu-section-header has-dropdown" id="publish">
    Publish
      <div class="dropdown mega ">
        <ul class="multi-col" id="publish-dropdown-list">

  <li class="menu-section-header " id="submissions">
    <span class="menu-section-header-title">  Submissions </span>

    <ul class="menu-section "
        id="submissions-dropdown-list">
      <li>
    <a href="/plosone/s/getting-started" >Getting Started</a>
  </li>

      <li>
    <a href="/plosone/s/submission-guidelines" >Submission Guidelines</a>
  </li>

      <li>
    <a href="/plosone/s/figures" >Figures</a>
  </li>

      <li>
    <a href="/plosone/s/tables" >Tables</a>
  </li>

      <li>
    <a href="/plosone/s/supporting-information" >Supporting Information</a>
  </li>

      <li>
    <a href="/plosone/s/latex" >LaTeX</a>
  </li>

      <li>
    <a href="/plosone/s/what-we-publish" >What We Publish</a>
  </li>

      <li>
    <a href="/plosone/s/preprints" >Preprints</a>
  </li>

      <li>
    <a href="/plosone/s/revising-your-manuscript" >Revising Your Manuscript</a>
  </li>

      <li>
    <a href="/plosone/s/submit-now" >Submit Now</a>
  </li>

      <li>
    <a href="https://collections.plos.org/s/calls-for-papers" >Calls for Papers</a>
  </li>

    </ul>

  </li>


  <li class="menu-section-header " id="policies">
    <span class="menu-section-header-title">  Policies </span>

    <ul class="menu-section "
        id="policies-dropdown-list">
      <li>
    <a href="/plosone/s/best-practices-in-research-reporting" >Best Practices in Research Reporting</a>
  </li>

      <li>
    <a href="/plosone/s/human-subjects-research" >Human Subjects Research</a>
  </li>

      <li>
    <a href="/plosone/s/animal-research" >Animal Research</a>
  </li>

      <li>
    <a href="/plosone/s/competing-interests" >Competing Interests</a>
  </li>

      <li>
    <a href="/plosone/s/disclosure-of-funding-sources" >Disclosure of Funding Sources</a>
  </li>

      <li>
    <a href="/plosone/s/licenses-and-copyright" >Licenses and Copyright</a>
  </li>

      <li>
    <a href="/plosone/s/data-availability" >Data Availability</a>
  </li>

      <li>
    <a href="/plosone/s/complementary-research" >Complementary Research</a>
  </li>

      <li>
    <a href="/plosone/s/materials-software-and-code-sharing" >Materials, Software and Code Sharing</a>
  </li>

      <li>
    <a href="/plosone/s/ethical-publishing-practice" >Ethical Publishing Practice</a>
  </li>

      <li>
    <a href="/plosone/s/authorship" >Authorship</a>
  </li>

      <li>
    <a href="/plosone/s/corrections-expressions-of-concern-and-retractions" >Corrections, Expressions of Concern, and Retractions</a>
  </li>

    </ul>

  </li>


  <li class="menu-section-header " id="manuscript-review-and-publication">
    <span class="menu-section-header-title">  Manuscript Review and Publication </span>

    <ul class="menu-section "
        id="manuscript-review-and-publication-dropdown-list">
      <li>
    <a href="/plosone/s/criteria-for-publication" >Criteria for Publication</a>
  </li>

      <li>
    <a href="/plosone/s/editorial-and-peer-review-process" >Editorial and Peer Review Process</a>
  </li>

      <li>
    <a href="https://plos.org/resources/editor-center" >Editor Center</a>
  </li>

      <li>
    <a href="/plosone/s/resources-for-editors" >Resources for Editors</a>
  </li>

      <li>
    <a href="/plosone/s/reviewer-guidelines" >Guidelines for Reviewers</a>
  </li>

      <li>
    <a href="/plosone/s/accepted-manuscripts" >Accepted Manuscripts</a>
  </li>

      <li>
    <a href="/plosone/s/comments" >Comments</a>
  </li>

    </ul>

  </li>
        </ul>
          <div class="calloutcontainer">



  <h3 class="callout-headline">Submit Your Manuscript</h3>

  <div class="action-contain">
  <p class="callout-content">
  Discover a faster, simpler path to publishing in a high-quality journal. <em>PLOS ONE</em> promises fair, rigorous peer review,
  broad scope, and wide readership  a perfect fit for your research every time.
  </p>

  <p class="button-contain special">
    <a class="button button-default" href="/plosone/static/publish">
     Learn More
    </a>
    <a class="button-link" href="https://www.editorialmanager.com/pone/default.asp">
      Submit Now
    </a>
  </p>
  </div>  <!-- opens in siteMenuCalloutDescription -->


          </div>
      </div>
    </li>



  <li class="menu-section-header has-dropdown " id="about">
    <span class="menu-section-header-title">  About </span>

    <ul class="menu-section dropdown "
        id="about-dropdown-list">
      <li>
    <a href="/plosone/static/publish" >Why Publish with PLOS ONE</a>
  </li>

      <li>
    <a href="/plosone/s/journal-information" >Journal Information</a>
  </li>

      <li>
    <a href="/plosone/s/staff-editors" >Staff Editors</a>
  </li>

      <li>
    <a href="/plosone/static/editorial-board" >Editorial Board</a>
  </li>

      <li>
    <a href="/plosone/s/section-editors" >Section Editors</a>
  </li>

      <li>
    <a href="/plosone/s/advisory-groups" >Advisory Groups</a>
  </li>

      <li>
    <a href="/plosone/s/find-and-read-articles" >Find and Read Articles</a>
  </li>

      <li>
    <a href="/plosone/s/publishing-information" >Publishing Information</a>
  </li>

      <li>
    <a href="https://plos.org/publication-fees" >Publication Fees</a>
  </li>

      <li>
    <a href="https://plos.org/press-and-media" >Press and Media</a>
  </li>

      <li>
    <a href="/plosone/s/contact" >Contact</a>
  </li>

    </ul>

  </li>

  <li data-js-tooltip-hover="trigger" class="subject-area menu-section-header">
  Browse
  </li>

<script src="/resource/js/vendor/jquery.hoverIntent.js" type="text/javascript"></script>
<script src="/resource/js/components/menu_drop.js" type="text/javascript"></script>
<script src="/resource/js/components/hover_delay.js" type="text/javascript"></script>
      <li id="navsearch" class="head-search">


    <form name="searchForm" action="/plosone/search" method="get">
      <fieldset>
        <legend>Search</legend>
        <label for="search">Search</label>
        <div class="search-contain">
          <input id="search" type="text" name="q" placeholder="SEARCH" required/>
          <button id="headerSearchButton" type="submit" aria-label="Submit search">
            <i title="Submit search" class="search-icon"></i>
          </button>
        </div>
      </fieldset>
      <input type="hidden" name="filterJournals" value="PLoSONE"/>
    </form>

    <a id="advSearch"
       href="/plosone/search">
      advanced search
    </a>




<script src="/resource/js/components/placeholder_style.js" type="text/javascript"></script>
      </li>

      </ul>     
      </section>  
    </nav>
  </div>

</header>
<section id="taxonomyContainer">

<script src="/resource/js/taxonomy-browser.js" type="text/javascript"></script>
<div id="taxonomy-browser" class="areas" data-search-url="/plosone/browse">
  <div class="wrapper">
    <div class="taxonomy-header">
      Browse Subject Areas
      <div id="subjInfo">?</div>
      <div id="subjInfoText">
        <p>Click through the PLOS taxonomy to find articles in your field.</p>
        <p>For more information about PLOS Subject Areas, click
          <a href="https://github.com/PLOS/plos-thesaurus/blob/master/README.md" target="_blank" title="Link opens in new window">here</a>.
        </p>
      </div>
    </div>
    <div class="levels">
      <div class="levels-container cf">
        <div class="levels-position"></div>
      </div>
      <a href="#" class="prev"></a>
      <a href="#" class="next active"></a>
    </div>
  </div>
  <div class="taxonomy-browser-border-bottom"></div>
</div>
</section>
<main> <div class="set-grid">

<header class="title-block">



<script src="/resource/js/components/signposts.js" type="text/javascript"></script>

<ul id="almSignposts" class="signposts">
  <li id="loadingMetrics">
    <p>Loading metrics</p>
  </li>
</ul>

<script type="text/template" id="signpostsGeneralErrorTemplate">
  <li id="metricsError">Article metrics are unavailable at this time. Please try again later.</li>
</script>

<script type="text/template" id="signpostsNewArticleErrorTemplate">
  <li></li><li></li><li id="tooSoon">Article metrics are unavailable for recently published articles.</li>
</script>

<script type="text/template" id="signpostsTemplate">
    <li id="almSaves">
      <%= s.numberFormat(saveCount, 0) %>
      <div class="tools" data-js-tooltip-hover="trigger">
        <a class="metric-term" href="/plosone/article/metrics?id=10.1371/journal.pone.0063581#savedHeader">Save</a>
        <p class="saves-tip" data-js-tooltip-hover="target"><a href="/plosone/article/metrics?id=10.1371/journal.pone.0063581#savedHeader">Total Mendeley and Citeulike bookmarks.</a></p>
      </div>
    </li>

    <li id="almCitations">
      <%= s.numberFormat(citationCount, 0) %>
      <div class="tools" data-js-tooltip-hover="trigger">
        <a class="metric-term" href="/plosone/article/metrics?id=10.1371/journal.pone.0063581#citedHeader">Citation</a>
        <p class="citations-tip" data-js-tooltip-hover="target"><a href="/plosone/article/metrics?id=10.1371/journal.pone.0063581#citedHeader">Paper's citation count computed by Dimensions.</a></p>
      </div>
    </li>

    <li id="almViews">
      <%= s.numberFormat(viewCount, 0) %>
      <div class="tools" data-js-tooltip-hover="trigger">
        <a class="metric-term" href="/plosone/article/metrics?id=10.1371/journal.pone.0063581#viewedHeader">View</a>
        <p class="views-tip" data-js-tooltip-hover="target"><a href="/plosone/article/metrics?id=10.1371/journal.pone.0063581#viewedHeader">PLOS views and downloads.</a></p>
      </div>
    </li>

    <li id="almShares">
      <%= s.numberFormat(shareCount, 0) %>
      <div class="tools" data-js-tooltip-hover="trigger">
        <a class="metric-term" href="/plosone/article/metrics?id=10.1371/journal.pone.0063581#discussedHeader">Share</a>
        <p class="shares-tip" data-js-tooltip-hover="target"><a href="/plosone/article/metrics?id=10.1371/journal.pone.0063581#discussedHeader">Sum of Facebook, Twitter, Reddit and Wikipedia activity.</a></p>
      </div>
    </li>
</script>

    <div class="article-meta">

<div class="classifications">
  <p class="license-short" id="licenseShort">Open Access</p>
  <p class="peer-reviewed" id="peerReviewed">Peer-reviewed</p>

<div class="article-type" >
  <p class="type-article" id="artType">Research Article</p>
</div>


</div>


    </div>
    <div class="article-title-etc">



<div class="title-authors">
  <h1 id="artTitle"><?xml version="1.0" encoding="UTF-8"?>Elevated Maspin Expression Is Associated with Better Overall Survival in Esophageal Squamous Cell Carcinoma (ESCC)</h1>

<ul class="author-list clearfix"  data-js-tooltip="tooltip_container" id="author-list">



<li
  data-js-tooltip="tooltip_trigger"
  
>
   <a  data-author-id="0" class="author-name" >
Yang Wang,</a>    <div id="author-meta-0" class="author-info" data-js-tooltip="tooltip_target">

  
  
  <p id="authAffiliations-0"><span class="type">Affiliation</span>
    Thoracic Surgery, Key Laboratory of Carcinogenesis and Translational Research Ministry of Education, Peking University School of Oncology, Beijing Cancer Hospital & Institute, Beijing, China
  </p>

      <a data-js-tooltip="tooltip_close" class="close" id="tooltipClose0"> &#x02A2F; </a>
    </div>
</li>

<li
  data-js-tooltip="tooltip_trigger"
  
>
   <a  data-author-id="1" class="author-name" >
Shijie Sheng <span class="email">  </span>,</a>    <div id="author-meta-1" class="author-info" data-js-tooltip="tooltip_target">

  
  <p id="authCorresponding-1"> <span class="email">* E-mail:</span> <a href="mailto:ssheng@med.wayne.edu">ssheng@med.wayne.edu</a> (SS); <a href="mailto:zlyangyue@bjmu.edu.cn">zlyangyue@bjmu.edu.cn</a> (YY)</p>
  <p id="authAffiliations-1"><span class="type">Affiliation</span>
    Department of Pathology, Wayne State University School of Medicine, Tumor and Microenvironment Program of Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States of America
  </p>

      <a data-js-tooltip="tooltip_close" class="close" id="tooltipClose1"> &#x02A2F; </a>
    </div>
</li>

<li
  data-js-tooltip="tooltip_trigger"
  
>
   <a  data-author-id="2" class="author-name" >
Jianzhi Zhang,</a>    <div id="author-meta-2" class="author-info" data-js-tooltip="tooltip_target">

  
  
  <p id="authAffiliations-2"><span class="type">Affiliation</span>
    Thoracic Surgery, Key Laboratory of Carcinogenesis and Translational Research Ministry of Education, Peking University School of Oncology, Beijing Cancer Hospital & Institute, Beijing, China
  </p>

      <a data-js-tooltip="tooltip_close" class="close" id="tooltipClose2"> &#x02A2F; </a>
    </div>
</li>

<li
  data-js-tooltip="tooltip_trigger"
  
>
   <a  data-author-id="3" class="author-name" >
Sijana Dzinic,</a>    <div id="author-meta-3" class="author-info" data-js-tooltip="tooltip_target">

  
  
  <p id="authAffiliations-3"><span class="type">Affiliation</span>
    Department of Pathology, Wayne State University School of Medicine, Tumor and Microenvironment Program of Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States of America
  </p>

      <a data-js-tooltip="tooltip_close" class="close" id="tooltipClose3"> &#x02A2F; </a>
    </div>
</li>

<li
  data-js-tooltip="tooltip_trigger"
  
>
   <a  data-author-id="4" class="author-name" >
Shaolei Li,</a>    <div id="author-meta-4" class="author-info" data-js-tooltip="tooltip_target">

  
  
  <p id="authAffiliations-4"><span class="type">Affiliation</span>
    Thoracic Surgery, Key Laboratory of Carcinogenesis and Translational Research Ministry of Education, Peking University School of Oncology, Beijing Cancer Hospital & Institute, Beijing, China
  </p>

      <a data-js-tooltip="tooltip_close" class="close" id="tooltipClose4"> &#x02A2F; </a>
    </div>
</li>

<li
  data-js-tooltip="tooltip_trigger"
  
>
   <a  data-author-id="5" class="author-name" >
Fang Fang,</a>    <div id="author-meta-5" class="author-info" data-js-tooltip="tooltip_target">

  
  
  <p id="authAffiliations-5"><span class="type">Affiliation</span>
    Thoracic Surgery, Key Laboratory of Carcinogenesis and Translational Research Ministry of Education, Peking University School of Oncology, Beijing Cancer Hospital & Institute, Beijing, China
  </p>

      <a data-js-tooltip="tooltip_close" class="close" id="tooltipClose5"> &#x02A2F; </a>
    </div>
</li>

<li
  data-js-tooltip="tooltip_trigger"
  
>
   <a  data-author-id="6" class="author-name" >
Nan Wu,</a>    <div id="author-meta-6" class="author-info" data-js-tooltip="tooltip_target">

  
  
  <p id="authAffiliations-6"><span class="type">Affiliation</span>
    Thoracic Surgery, Key Laboratory of Carcinogenesis and Translational Research Ministry of Education, Peking University School of Oncology, Beijing Cancer Hospital & Institute, Beijing, China
  </p>

      <a data-js-tooltip="tooltip_close" class="close" id="tooltipClose6"> &#x02A2F; </a>
    </div>
</li>

<li
  data-js-tooltip="tooltip_trigger"
  
>
   <a  data-author-id="7" class="author-name" >
Qingfeng Zheng,</a>    <div id="author-meta-7" class="author-info" data-js-tooltip="tooltip_target">

  
  
  <p id="authAffiliations-7"><span class="type">Affiliation</span>
    Thoracic Surgery, Key Laboratory of Carcinogenesis and Translational Research Ministry of Education, Peking University School of Oncology, Beijing Cancer Hospital & Institute, Beijing, China
  </p>

      <a data-js-tooltip="tooltip_close" class="close" id="tooltipClose7"> &#x02A2F; </a>
    </div>
</li>

<li
  data-js-tooltip="tooltip_trigger"
  
>
   <a  data-author-id="8" class="author-name" >
Yue Yang <span class="email">  </span></a>    <div id="author-meta-8" class="author-info" data-js-tooltip="tooltip_target">

  
  <p id="authCorresponding-8"> <span class="email">* E-mail:</span> <a href="mailto:ssheng@med.wayne.edu">ssheng@med.wayne.edu</a> (SS); <a href="mailto:zlyangyue@bjmu.edu.cn">zlyangyue@bjmu.edu.cn</a> (YY)</p>
  <p id="authAffiliations-8"><span class="type">Affiliation</span>
    Thoracic Surgery, Key Laboratory of Carcinogenesis and Translational Research Ministry of Education, Peking University School of Oncology, Beijing Cancer Hospital & Institute, Beijing, China
  </p>

      <a data-js-tooltip="tooltip_close" class="close" id="tooltipClose8"> &#x02A2F; </a>
    </div>
</li>

</ul>
<script src="/resource/js/components/tooltip.js" type="text/javascript"></script>

</div>


<div id="floatTitleTop" data-js-floater="title_author" class="float-title">
  <div class="set-grid">
    <div class="float-title-inner">
      <h1><?xml version="1.0" encoding="UTF-8"?>Elevated Maspin Expression Is Associated with Better Overall Survival in Esophageal Squamous Cell Carcinoma (ESCC)</h1>

<ul id="floatAuthorList" data-js-floater="floated_authors">

  <li data-float-index="1">Yang Wang,&nbsp;

  </li>
  <li data-float-index="2">Shijie Sheng,&nbsp;

  </li>
  <li data-float-index="3">Jianzhi Zhang,&nbsp;

  </li>
  <li data-float-index="4">Sijana Dzinic,&nbsp;

  </li>
  <li data-float-index="5">Shaolei Li,&nbsp;

  </li>
  <li data-float-index="6">Fang Fang,&nbsp;

  </li>
  <li data-float-index="7">Nan Wu,&nbsp;

  </li>
  <li data-float-index="8">Qingfeng Zheng,&nbsp;

  </li>
  <li data-float-index="9">Yue Yang

  </li>

</ul>



    </div>
    <div class="logo-close" id="titleTopCloser">
      <img src="/resource/img/logo-plos.png" style="height: 2em" alt="PLOS" />
      <div class="close-floater" title="close">x</div>
    </div>
  </div>
</div>

      <ul class="date-doi">
        <li id="artPubDate">Published: May 22, 2013</li>
        <li id="artDoi">
<a   href="https://doi.org/10.1371/journal.pone.0063581">https://doi.org/10.1371/journal.pone.0063581</a>
        </li>
        <li class="flex-spacer"></li>
      </ul>

    </div>
  <div>

  </div>
</header>
  <section class="article-body">



<ul class="article-tabs">

          <li class="tab-title active" id="tabArticle">
            <a href="/plosone/article?id=10.1371/journal.pone.0063581" class="article-tab-1">Article</a>
        </li>


              <li class="tab-title " id="tabAuthors">
            <a href="/plosone/article/authors?id=10.1371/journal.pone.0063581" class="article-tab-2">Authors</a>
        </li>


          <li class="tab-title " id="tabMetrics">
            <a href="/plosone/article/metrics?id=10.1371/journal.pone.0063581" class="article-tab-3">Metrics</a>
        </li>


          <li class="tab-title " id="tabComments">
            <a href="/plosone/article/comments?id=10.1371/journal.pone.0063581" class="article-tab-4">Comments</a>
        </li>

  <li class="tab-title" id="tabRelated">
    <a class="article-tab-5" id="tabRelated-link">Media Coverage</a> 
    <script>$(document).ready(function() { $.getMediaLink("10.1371/journal.pone.0063581").then(function (url) { $("#tabRelated-link").attr("href", url) } ) })</script>
  </li>
</ul>

    <div class="article-container">


<div id="nav-article">
  <ul class="nav-secondary">

    <li class="nav-comments" id="nav-comments">
      <a href="article/comments?id=10.1371/journal.pone.0063581">Reader Comments</a>
    </li>

    <li id="nav-figures"><a href="#" data-doi="10.1371/journal.pone.0063581">Figures</a></li>
  </ul>
</div>
<script src="/resource/js/components/scroll.js" type="text/javascript"></script>
<script src="/resource/js/components/nav_builder.js" type="text/javascript"></script>
<script src="/resource/js/components/floating_nav.js" type="text/javascript"></script>

<div id="figure-lightbox-container"></div>

<script id="figure-lightbox-template" type="text/template">
  <div id="figure-lightbox" class="reveal-modal full" data-reveal aria-hidden="true"
       role="dialog">
    <div class="lb-header">
      <h1 id="lb-title"><%= articleTitle %></h1>

      <div id="lb-authors">
              <span>Yang Wang</span>
              <span>Shijie Sheng</span>
          <a class="more-authors" href="/plosone/article/authors?id=10.1371/journal.pone.0063581">...</a>
          <span>Yue Yang</span>
      </div>

      <div class="lb-close" title="close">&nbsp;</div>
    </div>
    <div class="img-container">
      <div class="loader"> <i class="fa-spinner"></i> </div>
      <img class="main-lightbox-image" src=""/>
      <aside id="figures-list">
        <% figureList.each(function (ix, figure) { %>
        <div class="change-img" data-doi="<%= figure.getAttribute('data-doi') %>">
          <img class="aside-figure" src="/plosone/article/figure/image?size=inline&id=<%= figure.getAttribute('data-doi') %>" />
        </div>
        <% }) %>
        <div class="dummy-figure">
        </div>
      </aside>
    </div>
    <div id="lightbox-footer">

      <div id="btns-container" class="lightbox-row <% if(figureList.length <= 1) { print('one-figure-only') } %>">
        <div class="fig-btns-container reset-zoom-wrapper left">
          <span class="fig-btn reset-zoom-btn">Reset zoom</span>
        </div>
        <div class="zoom-slider-container">
          <div class="range-slider-container">
            <span id="lb-zoom-min"></span>
            <div class="range-slider round" data-slider data-options="start: 20; end: 200; initial: 20;">
              <span class="range-slider-handle" role="slider" tabindex="0"></span>
              <span class="range-slider-active-segment"></span>
              <input type="hidden">
            </div>
            <span id="lb-zoom-max"></span>
          </div>
        </div>
        <% if(figureList.length > 1) { %>
        <div class="fig-btns-container">
          <span class="fig-btn all-fig-btn"><i class="icon icon-all"></i> All Figures</span>
          <span class="fig-btn next-fig-btn"><i class="icon icon-next"></i> Next</span>
          <span class="fig-btn prev-fig-btn"><i class="icon icon-prev"></i> Previous</span>
        </div>
        <% } %>
      </div>
      <div id="image-context">
      </div>
    </div>
  </div>
</script>

<script id="image-context-template" type="text/template">
  <div class="footer-text">
    <div id="figure-description-wrapper">
      <div id="view-more-wrapper" style="<% descriptionExpanded? print('display:none;') : '' %>">
        <span id="figure-title"><%= title %></span>
        <p id="figure-description">
          <%= description %>&nbsp;&nbsp;
        </p>
        <span id="view-more">show more<i class="icon-arrow-right"></i></span>

      </div>
      <div id="view-less-wrapper" style="<% descriptionExpanded? print('display:inline-block;') : '' %>" >
        <span id="figure-title"><%= title %></span>
        <p id="full-figure-description">
          <%= description %>&nbsp;&nbsp;
          <span id="view-less">show less<i class="icon-arrow-left"></i></span>
        </p>
      </div>
    </div>
  </div>
  <div id="show-context-container">
    <a class="btn show-context" href="<%= showInContext(strippedDoi) %>">Show in Context</a>
  </div>
  <div id="download-buttons">
    <h3>Download:</h3>
    <div class="item">
      <a href="/plosone/article/figure/image?size=original&download=&id=<%= doi %>" title="original image">
        <span class="download-btn">TIFF</span>
      </a>
      <span class="file-size"><%= fileSizes.original %></span>
    </div>
    <div class="item">
      <a href="/plosone/article/figure/image?size=large&download=&id=<%= doi %>" title="large image">
        <span class="download-btn">PNG</span>
      </a>
      <span class="file-size"><%= fileSizes.large %></span>
    </div>
    <div class="item">
      <a href="/plosone/article/figure/powerpoint?id=<%= doi %>" title="PowerPoint slide">
        <span class="download-btn">PPT</span>
      </a>
    </div>

  </div>
</script>
      <div class="article-content">




  <div class="amendment amendment-correction toc-section">
  <a data-toc="amendment-0" title="Correction" id="amendment-0" name="amendment-0"></a>

  <h2>Correction</h2>
    <div class="amendment-citation">
      <p>
          <span class="amendment-date">
            7 Aug 2014:
          </span>


The PLOS ONE Staff


  (2014)

    <?xml version="1.0" encoding="UTF-8"?>Correction: Elevated Maspin Expression Is Associated with Better Overall Survival in Esophageal Squamous Cell Carcinoma (ESCC).

PLOS ONE  9(8): e104715.

<a   href="https://doi.org/10.1371/journal.pone.0104715">https://doi.org/10.1371/journal.pone.0104715</a>


            <span class="link-separator"> </span>
            <a href="/plosone/article?id=10.1371/journal.pone.0104715" class="amendment-link">
              View 
  correction

            </a>
      </p>
    </div>
  </div>


<div id="figure-carousel-section">
  <h2>Figures</h2>

  <div id="figure-carousel">

    <div class="carousel-wrapper">
      <div class="slider">

          <div class="carousel-item lightbox-figure" data-doi="10.1371/journal.pone.0063581.g001">

                <img src="/plosone/article/figure/image?size=inline&amp;id=10.1371/journal.pone.0063581.g001"
                     loading="lazy"
                     alt="Figure 1"
                />

            </div>

          <div class="carousel-item lightbox-figure" data-doi="10.1371/journal.pone.0063581.t001">

                <img src="/plosone/article/figure/image?size=inline&amp;id=10.1371/journal.pone.0063581.t001"
                     loading="lazy"
                     alt="Table 1"
                />

            </div>

          <div class="carousel-item lightbox-figure" data-doi="10.1371/journal.pone.0063581.t002">

                <img src="/plosone/article/figure/image?size=inline&amp;id=10.1371/journal.pone.0063581.t002"
                     loading="lazy"
                     alt="Table 2"
                />

            </div>

          <div class="carousel-item lightbox-figure" data-doi="10.1371/journal.pone.0063581.g002">

                <img src="/plosone/article/figure/image?size=inline&amp;id=10.1371/journal.pone.0063581.g002"
                     loading="lazy"
                     alt="Figure 2"
                />

            </div>

          <div class="carousel-item lightbox-figure" data-doi="10.1371/journal.pone.0063581.g003">

                <img src="/plosone/article/figure/image?size=inline&amp;id=10.1371/journal.pone.0063581.g003"
                     loading="lazy"
                     alt="Figure 3"
                />

            </div>

          <div class="carousel-item lightbox-figure" data-doi="10.1371/journal.pone.0063581.g004">

                <img src="/plosone/article/figure/image?size=inline&amp;id=10.1371/journal.pone.0063581.g004"
                     loading="lazy"
                     alt="Figure 4"
                />

            </div>

          <div class="carousel-item lightbox-figure" data-doi="10.1371/journal.pone.0063581.g005">

                <img src="/plosone/article/figure/image?size=inline&amp;id=10.1371/journal.pone.0063581.g005"
                     loading="lazy"
                     alt="Figure 5"
                />

            </div>

          <div class="carousel-item lightbox-figure" data-doi="10.1371/journal.pone.0063581.g006">

                <img src="/plosone/article/figure/image?size=inline&amp;id=10.1371/journal.pone.0063581.g006"
                     loading="lazy"
                     alt="Figure 6"
                />

            </div>
      </div>
    </div>

    <div class="carousel-control">
      <span class="button previous"></span>
      <span class="button next"></span>
    </div>
    <div class="carousel-page-buttons">

    </div>
  </div>
</div>
<script src="/resource/js/vendor/jquery.touchswipe.js" type="text/javascript"></script>
<script src="/resource/js/components/figure_carousel.js" type="text/javascript"></script>
<script src="/resource/js/vendor/jquery.dotdotdot.js" type="text/javascript"></script>


        <div class="article-text" id="artText">
          



<div xmlns:plos="http://plos.org" class="abstract toc-section abstract-type-"><a id="abstract0" name="abstract0" data-toc="abstract0" class="link-target" title="Abstract"></a><h2>Abstract</h2><div class="abstract-content"><a id="article1.front1.article-meta1.abstract1.p1" name="article1.front1.article-meta1.abstract1.p1" class="link-target"></a><p>Tumor suppressor maspin is a differentially regulated gene in the progression of many types of cancer. While the biological function of maspin in blocking tumor invasion and metastasis is consistent with the loss of maspin expression at the late stage of tumor progression, the differential expression and the biological significance of maspin in early stage of tumor progression appear to be complex and remain to be elucidated. In the current study, we examined the expression of maspin in 84 esophageal squamous cell carcinoma (ESCC) cases (stages IIII) and 55 non-tumor adjacent esophageal tissue specimens by immunohistochemical (IHC) staining. The correlation of maspin with clinicopathological parameters was analyzed. Compared to normal esophageal squamous tissue where 80% (47/55) of the cases expressed maspin at a low to moderate level, all ESCC specimens (100% (84/84)) were positive for maspin expression at a moderate to high level. ESCC with low or moderate maspin expression had significantly shorter postoperative survival rates compared to those that had high maspin expression (p&lt;0.001). Since the correlation of maspin with ESCC histology and the correlation of maspin with ESCC prognosis seem to be at odds, we further investigated the biological function of maspin in ESCC using the established ESCC cell lines. The expression of maspin in five human esophageal squamous cancer cell lines (T12, E450, KYSE150, EC109, and KYSE510) was examined by the Western blot. ESCC cell line KYSE510 that did not express maspin and was stably transfected by maspin cDNA or an empty vector. The resulting transfected cells were characterized in vitro. Maspin expression significantly inhibited cell proliferation, motility and matrigel invasion. Taken together, our data suggest that the transient up-regulation of maspin in the early development of ESCC may be a defense mechanism against further transition towards more malignant phenotypes, ultimately slowing down ESCC tumor progression.</p>
</div></div>


<div xmlns:plos="http://plos.org" class="articleinfo"><p><strong>Citation: </strong>Wang Y, Sheng S, Zhang J, Dzinic S, Li S, Fang F, et al.  (2013) Elevated Maspin Expression Is Associated with Better Overall Survival in Esophageal Squamous Cell Carcinoma (ESCC). PLoS ONE 8(5):
           e63581.
        
        https://doi.org/10.1371/journal.pone.0063581</p><p><strong>Editor: </strong>Daotai Nie, Southern Illinois University School of Medicine, United States of America</p><p><strong>Received: </strong>December 5, 2012; <strong>Accepted: </strong>April 4, 2013; <strong>Published: </strong> May 22, 2013</p><p><strong>Copyright: </strong>  2013 Wang et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</p><p><strong>Funding: </strong>This work was supported in part by NIH grants (CA15431 and CA084176) and the Ruth Sager Memorial Fund (to S. Sheng). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p><p><strong>Competing interests: </strong> The authors have declared that no competing interests exist.</p></div>





<div xmlns:plos="http://plos.org" id="section1" class="section toc-section"><a id="s1" name="s1" data-toc="s1" class="link-target" title="Introduction"></a><h2>Introduction</h2><a id="article1.body1.sec1.p1" name="article1.body1.sec1.p1" class="link-target"></a><p>Esophageal carcinoma, one of the most aggressive carcinomas of the gastrointestinal tract, is the eighth most common cause of cancer-related death worldwide <a href="#pone.0063581-Kamangar1" class="ref-tip">[1]</a>, <a href="#pone.0063581-Parkin1" class="ref-tip">[2]</a>. The two main subtypes of esophageal carcinoma are adenocarcinoma and squamous cell carcinoma (ESCC), while the most commonly diagnosed esophageal cancer in China and other Asian countries is ESCC <a href="#pone.0063581-Hiyama1" class="ref-tip">[3]</a>, <a href="#pone.0063581-Xing1" class="ref-tip">[4]</a>. Despite the rapid advancement in combined chemotherapy and radiation therapy for ESCC, the average 5-year overall survival has remained steady at 1020% <a href="#pone.0063581-Parkin1" class="ref-tip">[2]</a>, <a href="#pone.0063581-Koshy1" class="ref-tip">[5]</a>, <a href="#pone.0063581-Younes1" class="ref-tip">[6]</a>. Unfortunately, the prediction of clinical prognosis of patients with ESCC based on conventional pathological variables, such as the tumor size, tumor grade, and the tumor stage is highly empirical <a href="#pone.0063581-Ashida1" class="ref-tip">[7]</a><a href="#pone.0063581-Yie1" class="ref-tip">[9]</a>. Specific biomarkers that are mechanistically involved in the progression of ESCC may significantly improve the accuracy of the prediction of patients survival. To this end, it is important to note that many of the molecular markers that are associated with specific pathological grades (diagnosis) have failed to serve as prognostic markers. It is well appreciated that tumor progression is a continuum of dynamic molecular and cellular changes. The link of a molecular profile with a phenotype may not reflect whether the former is driver or a passenger of the latter, and may not predict whether this association is consequential for further tumor progression. Some molecular changes may be suppressive steps that may eventually give way to the predominant oncogenic changes. The capacity of tumor cells to turn on tumor suppressive mechanisms, even though transitory, may translate into delayed tumor progression, and prolonged patients survival.</p>
<a id="article1.body1.sec1.p2" name="article1.body1.sec1.p2" class="link-target"></a><p>Maspin is an epithelial-specific tumor suppressor that is differentially regulated during tumor progression. It is a member of the serine protease inhibitor (serpin) superfamily <a href="#pone.0063581-Zou1" class="ref-tip">[10]</a> but with functions that are deviant from those of classical serine protease-inhibiting serpins. Accumulated evidence suggests that maspin may play a key role in the maintenance of epithelial homeostasis by blocking serine protease-like enzymes such as the zymogen form of urokinase-type plasminogen activator <a href="#pone.0063581-Amir1" class="ref-tip">[11]</a>, <a href="#pone.0063581-McGowen1" class="ref-tip">[12]</a> and histone deacetylase 1 <a href="#pone.0063581-Li1" class="ref-tip">[13]</a>. Consistent with its anti-invasion and anti-metastasis properties, maspin expression is found to be down regulated in the progression of many types of cancer at the step of tumor invasion and metastasis.</p>
<a id="article1.body1.sec1.p3" name="article1.body1.sec1.p3" class="link-target"></a><p>As a tumor suppressor, maspin is not immediately down-regulated in the early development of cancer. In fact, accumulated evidence demonstrates a transient up-regulation of maspin in non-invasive cancer of breast <a href="#pone.0063581-Bieche1" class="ref-tip">[14]</a>, <a href="#pone.0063581-Umekita1" class="ref-tip">[15]</a>, ovary <a href="#pone.0063581-Sood1" class="ref-tip">[16]</a>, and pancreas <a href="#pone.0063581-Cao1" class="ref-tip">[17]</a>, <a href="#pone.0063581-Fitzgerald1" class="ref-tip">[18]</a>. In adenocarcinomas, this up-regulation of maspin is also associated with its translocation from the nucleus to the cytoplasm. In squamous cell carcinomas, however, maspin is always distributed to both nucleus and cytoplasm. The biological significance of these distinct differential patterns is a subject of current investigation. Based on our earlier studies, the translocation of maspin from the nucleus to the cytoplasm in early stage adenocarcinoma correlates with significantly better survival of lung cancer <a href="#pone.0063581-Frey1" class="ref-tip">[19]</a>. On the other hand, elevated maspin expression in early stage squamous cell carcinoma both, nuclear and cytosolic, correlates with significantly better survival of oral squamous cell carcinoma <a href="#pone.0063581-Xia1" class="ref-tip">[20]</a>. These data suggest that the prognosis of cancer subtypes may be distinctly stratified based on maspin differential expression.</p>
<a id="article1.body1.sec1.p4" name="article1.body1.sec1.p4" class="link-target"></a><p>In this paper, we report the first clinical evidence that maspin was significantly elevated in a subpopulation of stage I-III ESCC specimens. The level of maspin expression correlated with better overall survival of ESCC patients. We further investigated the biological function of maspin using established ESCC cell lines and showed an inhibitory effect of maspin on cell proliferation, motility, and invasion. These data suggest that ESCC with an ability to up-regulate maspin may be protected against further malignant progression.</p>
</div>

<div xmlns:plos="http://plos.org" id="section2" class="section toc-section"><a id="s2" name="s2" data-toc="s2" class="link-target" title="Materials and Methods"></a><h2>Materials and Methods</h2>
<div id="section1" class="section toc-section"><a id="s2a" name="s2a" class="link-target" title="Tissue Specimens"></a>
<h3>Tissue Specimens</h3>
<a id="article1.body1.sec2.sec1.p1" name="article1.body1.sec2.sec1.p1" class="link-target"></a><p>This research involves 84 archived formalin-fixed and paraffin-embedded human stage IIII esophageal squamous cell carcinoma (ESCC) tissue specimens, from patients who were eligible for and underwent surgical resection between 2003 and 2007 at the Department of Surgery, Beijing Cancer Hospital (China). In addition, tumor-adjacent normal tissue specimens were collected from 55 of these patients. Prior to the tissue collection, the clinical protocol was approved by the ethics review board of Peking University Health Sciences Center. Informed written consents were obtained from the patients. The consents were saved as scanned PDF files, and saved in patients records. The samples were de-identified to the research group. The 84 patients included 64 men and 20 women with a median age of 58 years (ranging from 43 to 73 years).</p>
</div>

<div id="section2" class="section toc-section"><a id="s2b" name="s2b" class="link-target" title="Immunohistochemical (IHC) Staining"></a>
<h3>Immunohistochemical (IHC) Staining</h3>
<a id="article1.body1.sec2.sec2.p1" name="article1.body1.sec2.sec2.p1" class="link-target"></a><p>Tissue sections on slides of 5 m thickness were subjected to hematoxylin and eosin (H&amp;E) staining, and IHC staining of maspin as described previously <a href="#pone.0063581-Sood1" class="ref-tip">[16]</a>. Monoclonal antibody against maspin (clone G16770; Pharmingen/BD Bioscience, San Diego, CA) was diluted 100-fold. The horse-reddish peroxidase (HRP) conjugated secondary antibody (Dako Cytomation, Cambridgeshire, UK) was detected by chromogenic reaction of HRP. For negative controls, the primary antibody was omitted. The tissue sections were examined and scored independently by the two pathologists who had no prior knowledge of the study aim or design. Maspin expression was semi-quantitatively evaluated by the percentage of maspin positive cells and the intensity of maspin staining on the scale of 03. The percentage of positive cells was categorically scored as following: 0 points (maspin positive in 05% of cells); 2 points (maspin positive in 650% of cells); 3 points (maspin positive in &gt;50% of cells). The staining intensity was categorically scored as follows: 1 point: negative or weak staining; 2 points: moderate staining; 3 points: strong staining. The overall maspin expression (OMS) was calculated as the sum of the percentage category points and the intensity category points in each case. Tumors were categorized into four groups: negative: 5% of cells stained, regardless of intensity; weak expression (OMS: 02 points); moderate expression (OMS: 34 points); and strong expression (OMS: 56 points). Maspin sub-cellular pattern of nuclear staining and cytoplasmic staining were assessed semi-quantitatively on the basis of the percentage of positive cells, as described previously <a href="#pone.0063581-Woenckhaus1" class="ref-tip">[21]</a>. Maspin nuclear immunoreactivity was defined as stronger nuclear staining than cytoplasmic staining in at least 10% of tumor cells. Maspin cytoplasmic immunoreactivity was defined as stronger cytoplasmic staining than nuclear staining in at least 10% of tumor cells.</p>
</div>

<div id="section3" class="section toc-section"><a id="s2c" name="s2c" class="link-target" title="Cell Lines and Cell Culture"></a>
<h3>Cell Lines and Cell Culture</h3>
<a id="article1.body1.sec2.sec3.p1" name="article1.body1.sec2.sec3.p1" class="link-target"></a><p>Five human ESCC cell lines (KYSE-510, KYSE-150, T12, E450 and EC-109) were purchased from Institute of Basic Medical Sciences Chinese Academy of Medical Sciences cell culture center (Beijing, China). The cells were maintained at 37C and 5% CO<sub>2</sub> in RPMI-1640 medium (GIBCO, US) supplemented with 10% heat-inactivated fetal bovine serum (FBS) and 1% penicillin-streptomycin.</p>
</div>

<div id="section4" class="section toc-section"><a id="s2d" name="s2d" class="link-target" title="Western Blotting"></a>
<h3>Western Blotting</h3>
<a id="article1.body1.sec2.sec4.p1" name="article1.body1.sec2.sec4.p1" class="link-target"></a><p>Cells were lysed with 1 RIPA buffer (Beyotime Institute of Biotechnology, Nantong, China) containing 25 g/mL leupeptin (Sigma Chemical Co., St. Louis, MO) and 10 g/mL aprotinin (Sigma Chemical Co.). Cells were removed from the dishes by cell scraping. The samples were then subjected to three cycles of freeze-thaw and centrifuged at 12,000 rpm for 20 min. The protein concentration of the samples was determined using a bicinchoninic acid Protein Assay Reagent kit, and whole cell lysates were analyzed by 10% SDS-PAGE and transferred onto a polyvinylidene fluoride (PVDF) membrane. The membrane was blocked in 5% skim milk for 1 hr at room temperature (RT) and then probed with primary antibodies against maspin (1500 diluted) and -actin (from SIGMA, 110,000 diluted), respectively. The HRP-conjugated anti-mouse secondary antibody was used at 12,500 dilutions. The bound secondary antibody was detected by chemiluminescence reaction (Millipore, Bedford, USA) and visualized by radiography.</p>
</div>

<div id="section5" class="section toc-section"><a id="s2e" name="s2e" class="link-target" title="Stable Transfection"></a>
<h3>Stable Transfection</h3>
<a id="article1.body1.sec2.sec5.p1" name="article1.body1.sec2.sec5.p1" class="link-target"></a><p>Sequence-verified maspin cDNA cloned into a vector for expression in mammalian cells <a href="#pone.0063581-Lockett1" class="ref-tip">[22]</a> was used to transfect approximately 60% confluent KYSE-510 using the Lipofectamine 2000 kit (Invitrogen, Carlsbad, CA). The empty vector DNA was used in parallel transfection as a negative control. For clonal selection, 24 hrs after transfection, G418 was added to the culture medium at the concentration of 400 g/mL. The cells were maintained in G418-containing medium for the next 4 weeks until individual clones were selected. The selected clones were subsequently maintained in the medium containing 200 g/mL of G418.</p>
</div>

<div id="section6" class="section toc-section"><a id="s2f" name="s2f" class="link-target" title="Cell Proliferation Assay"></a>
<h3>Cell Proliferation Assay</h3>
<a id="article1.body1.sec2.sec6.p1" name="article1.body1.sec2.sec6.p1" class="link-target"></a><p>To determine the effect of maspin on cell proliferation, cells with and without maspin were seeded into 96-well plate at a density of 410<sup>3</sup>/well/200 L in the maintenance medium. Viable cells were quantified at 24, 48, 72 and 96 hours (h) after the seeding by the chromogenic 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl-tetrazoliumbromide (MTT) assay according to the manufacturers instruction (Sigma, St. Louis, US). Each assay was performed in triplicates and repeated 3 times.</p>
</div>

<div id="section7" class="section toc-section"><a id="s2g" name="s2g" class="link-target" title="Colony Formation Assay"></a>
<h3>Colony Formation Assay</h3>
<a id="article1.body1.sec2.sec7.p1" name="article1.body1.sec2.sec7.p1" class="link-target"></a><p>Cells seeded in 6-well plates at a density of 400 cells/well/medium volume, were allowed to grow for 10 days to form colonies. The cells were washed twice with PBS, and treated with Giemsa for 10 min, and then photographed with a digital camera (OLYMPUS, SP350). The number of colonies and the number of cells in each colony was counted under the microscopy. The colonies which had more than 100 cells were defined as big colonies.</p>
</div>

<div id="section8" class="section toc-section"><a id="s2h" name="s2h" class="link-target" title="Wound-healing Assay"></a>
<h3>Wound-healing Assay</h3>
<a id="article1.body1.sec2.sec8.p1" name="article1.body1.sec2.sec8.p1" class="link-target"></a><p>The cells were added to six-well plates, allowed to form confluent monolayers and were serum starved overnight. An artificial wound was created in the cell monolayer with a sterile plastic 200 L micropipette tip to generate one homogeneous wound in each well. After wounding, the culture medium was removed, and cells were washed at least twice to eliminate detached cells. Wound closure was photographed at 0, 6, 12, and 24 h after wounding. Images of cells from the same field were acquired at the indicated time points, using an inverted microscope equipped with a digital camera. The number of cells in each colony was counted under microscope. Each measurement was performed in triplicate.</p>
</div>

<div id="section9" class="section toc-section"><a id="s2i" name="s2i" class="link-target" title="Matrigel Invasion Assay"></a>
<h3>Matrigel Invasion Assay</h3>
<a id="article1.body1.sec2.sec9.p1" name="article1.body1.sec2.sec9.p1" class="link-target"></a><p>Invasion assay was performed using 8 m PET pore size membrane coated with Matrigel (24-well, BD Biosciences, Bedford, MA). Cells were seeded at 210<sup>5</sup> cells per 500 L of growth medium on the Matrigel-coated membrane. The bottom wells were filled with the maintenance culture medium, and the chambers were incubated at 37C in a humidified 5% CO<sub>2</sub>. After 24 h, the Matrigel and non-invading cells in the upper chamber were removed by scraping. The cells on the bottom side of the membrane (invading cells) were stained with 1% crystal violet and counted under the microscope. Each experiment was performed in triplicate.</p>
</div>

<div id="section10" class="section toc-section"><a id="s2j" name="s2j" class="link-target" title="Statistical Analysis"></a>
<h3>Statistical Analysis</h3>
<a id="article1.body1.sec2.sec10.p1" name="article1.body1.sec2.sec10.p1" class="link-target"></a><p>Clinicopathological factors were analyzed separately using the chi-square test. The Kaplan-Meier method was used to estimate the patient survival and the log-rank test was used to determine the statistical significance. The associations between discrete variables were assessed using the chi-square test. All data were expressed as the mean  standard deviation. A <em>p</em>-value of less than 0.05 was considered to be statistically significant. Statistical calculations were performed using the Statistical Package for Social Sciences software version 11.0 (SPSS11.0).</p>
</div>
</div>

<div xmlns:plos="http://plos.org" id="section3" class="section toc-section"><a id="s3" name="s3" data-toc="s3" class="link-target" title="Results"></a><h2>Results</h2>
<div id="section1" class="section toc-section"><a id="s3a" name="s3a" class="link-target" title="Differential Maspin Expression in Human ESCC and Normal Adjacent Tissues"></a>
<h3>Differential Maspin Expression in Human ESCC and Normal Adjacent Tissues</h3>
<a id="article1.body1.sec3.sec1.p1" name="article1.body1.sec3.sec1.p1" class="link-target"></a><p>To investigate whether the level or subcellular localization of maspin helps predict the survival of ESCC patients, ESCC tissues were collected from 84 stage I-III patients who were eligible for and underwent surgical resection between 2003 and 2007. These patients were followed up for at least 5 years. IHC was performed to examine the expression of maspin in these tumor specimens, as well as 55 tumor-adjacent normal tissues, and the level of maspin expression was semi-quantified using the method described in the Materials and Methods section. Representative results are shown in <a href="#pone-0063581-g001"><strong>Figure 1</strong></a>. As summarized in <a href="#pone-0063581-t001"><strong>Table 1</strong></a>, among 55 cases of normal esophageal tissues, the positive immunoreactivity was associated with 85% of cases (47/55). The 8 patients had no maspin immunoreactivity, 37 cases had weak maspin staining, and 10 cases were associated with strong maspin staining. In contrast, all 84 ESCC specimens showed positive maspin staining. 33 tumor specimens were associated with weak maspin staining, whereas 51 cases had strong maspin staining. Overall, as compared to the corresponding normal esophageal tissues, ESCC tissues exhibited stronger maspin IHC signals and a higher percentage of maspin-strong cells (<em>p</em>&lt;0.001).</p>
<a class="link-target" id="pone-0063581-g001" name="pone-0063581-g001"></a><div class="figure" data-doi="10.1371/journal.pone.0063581.g001"><div class="img-box"><a title="Click for larger image" href="article/figure/image?size=medium&amp;id=10.1371/journal.pone.0063581.g001" data-doi="10.1371/journal.pone.0063581" data-uri="10.1371/journal.pone.0063581.g001"><img src="article/figure/image?size=inline&amp;id=10.1371/journal.pone.0063581.g001" alt="thumbnail" class="thumbnail" loading="lazy"></a><div class="expand"></div></div><div class="figure-inline-download">
          Download:
          <ul><li><a href="article/figure/powerpoint?id=10.1371/journal.pone.0063581.g001"><div class="definition-label">PPT</div><div class="definition-description">PowerPoint slide</div></a></li><li><a href="article/figure/image?download&amp;size=large&amp;id=10.1371/journal.pone.0063581.g001"><div class="definition-label">PNG</div><div class="definition-description">larger image</div></a></li><li><a href="article/figure/image?download&amp;size=original&amp;id=10.1371/journal.pone.0063581.g001"><div class="definition-label">TIFF</div><div class="definition-description">original image</div></a></li></ul></div><div class="figcaption"><span>Figure 1. </span> Representative IHC of maspin in matched normal and esophageal squamous cell carcinoma tissues.</div><p class="caption_target"><a id="article1.body1.sec3.sec1.fig1.caption1.p1" name="article1.body1.sec3.sec1.fig1.caption1.p1" class="link-target"></a><p>Top: (A) normal esophageal tissue with negative, (B) weak, (C) moderate, and (D) strong maspin staining. Bottom: (E) ESCC with weak overall maspin expression, (F) moderate overall maspin staining, (G) overall strong maspin staining, which is distributed more to the nucleus, and (H) overall strong maspin staining, which is distributed more to the cytoplasm. x200.</p>
</p><p class="caption_object"><a href="https://doi.org/10.1371/journal.pone.0063581.g001">
              https://doi.org/10.1371/journal.pone.0063581.g001</a></p></div><a class="link-target" id="pone-0063581-t001" name="pone-0063581-t001"></a><div class="figure" data-doi="10.1371/journal.pone.0063581.t001"><div class="img-box"><a title="Click for larger image" href="article/figure/image?size=medium&amp;id=10.1371/journal.pone.0063581.t001" data-doi="10.1371/journal.pone.0063581" data-uri="10.1371/journal.pone.0063581.t001"><img src="article/figure/image?size=inline&amp;id=10.1371/journal.pone.0063581.t001" alt="thumbnail" class="thumbnail" loading="lazy"></a><div class="expand"></div></div><div class="figure-inline-download">
          Download:
          <ul><li><a href="article/figure/powerpoint?id=10.1371/journal.pone.0063581.t001"><div class="definition-label">PPT</div><div class="definition-description">PowerPoint slide</div></a></li><li><a href="article/figure/image?download&amp;size=large&amp;id=10.1371/journal.pone.0063581.t001"><div class="definition-label">PNG</div><div class="definition-description">larger image</div></a></li><li><a href="article/figure/image?download&amp;size=original&amp;id=10.1371/journal.pone.0063581.t001"><div class="definition-label">TIFF</div><div class="definition-description">original image</div></a></li></ul></div><div class="figcaption"><span>Table 1. </span> Differential Maspin Expression in ESCC and Matched Normal Tissues.</div><p class="caption_target"></p><p class="caption_object"><a href="https://doi.org/10.1371/journal.pone.0063581.t001">
              https://doi.org/10.1371/journal.pone.0063581.t001</a></p></div><a id="article1.body1.sec3.sec1.p2" name="article1.body1.sec3.sec1.p2" class="link-target"></a><p>Based on the overall maspin expression, all the tumor specimens can be divided by the total level of maspin expression (low/moderate vs. strong), the level of nuclear maspin (weak/moderate vs. strong), and the level of cytoplasmic maspin (weak/moderate vs. strong). The stratification of these different groups with clinicopatholoigcal variables was evaluated. As summarized in <a href="#pone-0063581-t002"><strong>Table 2</strong></a>, there was no significant difference between the groups with respect to sex, age, pathologic grade and tumor stage. In addition, we also analyzed the association between subcellular localization of maspin and clinicopathological variables. Even though not statistically significant, we observed the following trends: poorly differentiated tumors were associated with weaker nuclear maspin staining and stronger cytoplasmic maspin staining. In addition, the lymph node metastasis was associated with a higher level of cytoplasmic maspin staining as compared to lymph node negative patients.</p>
<a class="link-target" id="pone-0063581-t002" name="pone-0063581-t002"></a><div class="figure" data-doi="10.1371/journal.pone.0063581.t002"><div class="img-box"><a title="Click for larger image" href="article/figure/image?size=medium&amp;id=10.1371/journal.pone.0063581.t002" data-doi="10.1371/journal.pone.0063581" data-uri="10.1371/journal.pone.0063581.t002"><img src="article/figure/image?size=inline&amp;id=10.1371/journal.pone.0063581.t002" alt="thumbnail" class="thumbnail" loading="lazy"></a><div class="expand"></div></div><div class="figure-inline-download">
          Download:
          <ul><li><a href="article/figure/powerpoint?id=10.1371/journal.pone.0063581.t002"><div class="definition-label">PPT</div><div class="definition-description">PowerPoint slide</div></a></li><li><a href="article/figure/image?download&amp;size=large&amp;id=10.1371/journal.pone.0063581.t002"><div class="definition-label">PNG</div><div class="definition-description">larger image</div></a></li><li><a href="article/figure/image?download&amp;size=original&amp;id=10.1371/journal.pone.0063581.t002"><div class="definition-label">TIFF</div><div class="definition-description">original image</div></a></li></ul></div><div class="figcaption"><span>Table 2. </span> Correlation of ESCC Clinicopathological Features with Maspin Expression and Subcellular Localization.</div><p class="caption_target"></p><p class="caption_object"><a href="https://doi.org/10.1371/journal.pone.0063581.t002">
              https://doi.org/10.1371/journal.pone.0063581.t002</a></p></div></div>

<div id="section2" class="section toc-section"><a id="s3b" name="s3b" class="link-target" title="Maspin Expression Correlates with Better Overall Postoperative Survival"></a>
<h3>Maspin Expression Correlates with Better Overall Postoperative Survival</h3>
<a id="article1.body1.sec3.sec2.p1" name="article1.body1.sec3.sec2.p1" class="link-target"></a><p>Our cohort of ESCC patients were followed up for at least 5 years, as of March 2012, with a median survival of 36.5 months. In order to test if maspin expression is associated with increased or decreased patient survival, patients were classified into two groups, those with strong maspin expression (51 cases, OMS 56) or those with weak and moderate maspin expression (33 cases, OMS 24). The corresponding median survival time for these two groups were 4511.1 months and 192.9 months, respectively, demonstrating that stronger maspin expression is associated with significantly increased patient survival and favorable prognosis. (<a href="#pone-0063581-g002"><strong>Figure 2A</strong></a>, log-rank, <em>p</em>=0.009). Since previous reports in breast <a href="#pone.0063581-Mohsin1" class="ref-tip">[23]</a> and lung cancer <a href="#pone.0063581-Frey1" class="ref-tip">[19]</a> for example, suggest that nuclear maspin is associated with better overall patient survival, we also investigated whether maspin subcellular localization correlated with the overall survival. For this purpose, the patients were classified into two corresponding groups: predominantly nuclear expression or predominantly cytoplasmic expression patients. Although the <em>p</em> value did not reach a significant difference, stronger expression of maspin in the nucleus was still associated with a more favorable patient prognosis (449.5 months vs. 214.5 months; <em>p</em>=0.051) (<a href="#pone-0063581-g002"><strong>Figures 2B and 2C</strong></a>). In general, maspin expression level correlated with less tumor local invasion. We also observed a trend for the negative correlation between maspin expression and lymph node metastasis (<a href="#pone-0063581-t002"><strong>Table 2</strong></a>). In addition, reduced nuclear maspin and increased cytoplasmic maspin were associated with lymph node metastasis. Although these data did not reach statistical significance, in part limited by the number of patients, they are consistent with the notion that the mortality of these ESCC patients result primarily from metastasis.</p>
<a class="link-target" id="pone-0063581-g002" name="pone-0063581-g002"></a><div class="figure" data-doi="10.1371/journal.pone.0063581.g002"><div class="img-box"><a title="Click for larger image" href="article/figure/image?size=medium&amp;id=10.1371/journal.pone.0063581.g002" data-doi="10.1371/journal.pone.0063581" data-uri="10.1371/journal.pone.0063581.g002"><img src="article/figure/image?size=inline&amp;id=10.1371/journal.pone.0063581.g002" alt="thumbnail" class="thumbnail" loading="lazy"></a><div class="expand"></div></div><div class="figure-inline-download">
          Download:
          <ul><li><a href="article/figure/powerpoint?id=10.1371/journal.pone.0063581.g002"><div class="definition-label">PPT</div><div class="definition-description">PowerPoint slide</div></a></li><li><a href="article/figure/image?download&amp;size=large&amp;id=10.1371/journal.pone.0063581.g002"><div class="definition-label">PNG</div><div class="definition-description">larger image</div></a></li><li><a href="article/figure/image?download&amp;size=original&amp;id=10.1371/journal.pone.0063581.g002"><div class="definition-label">TIFF</div><div class="definition-description">original image</div></a></li></ul></div><div class="figcaption"><span>Figure 2. </span> Kaplan-Meier survival curves of ESCC.</div><p class="caption_target"><a id="article1.body1.sec3.sec2.fig1.caption1.p1" name="article1.body1.sec3.sec2.fig1.caption1.p1" class="link-target"></a><p>(A) Cases stratified based on the overall maspin expression, (B) levels of maspin staining in the nucleus, and (C) the levels of maspin expression in the cytoplasm.</p>
</p><p class="caption_object"><a href="https://doi.org/10.1371/journal.pone.0063581.g002">
              https://doi.org/10.1371/journal.pone.0063581.g002</a></p></div></div>

<div id="section3" class="section toc-section"><a id="s3c" name="s3c" class="link-target" title="Maspin Expressed in ESCC Cell Lines is Tumor Suppressive"></a>
<h3>Maspin Expressed in ESCC Cell Lines is Tumor Suppressive</h3>
<a id="article1.body1.sec3.sec3.p1" name="article1.body1.sec3.sec3.p1" class="link-target"></a><p>Established ESCC cell lines offer a valuable experimental model to study the progression and underlying molecular mechanisms. Similar to the observation with early stage ESCC specimens, the level of maspin was not significantly altered in ESCC cell lines that are only weakly or moderately aggressive (T12, E450, KYSE150, and EC109) <a href="#pone.0063581-Tong1" class="ref-tip">[24]</a>, as judged by Western blotting (<a href="#pone-0063581-g003"><strong>Figure 3A</strong></a>). However, ESCC cell line KYSE510 that was significantly more invasive and grew at a faster rate had lost maspin expression (<a href="#pone-0063581-g003"><strong>Figure 3B</strong></a>).</p>
<a class="link-target" id="pone-0063581-g003" name="pone-0063581-g003"></a><div class="figure" data-doi="10.1371/journal.pone.0063581.g003"><div class="img-box"><a title="Click for larger image" href="article/figure/image?size=medium&amp;id=10.1371/journal.pone.0063581.g003" data-doi="10.1371/journal.pone.0063581" data-uri="10.1371/journal.pone.0063581.g003"><img src="article/figure/image?size=inline&amp;id=10.1371/journal.pone.0063581.g003" alt="thumbnail" class="thumbnail" loading="lazy"></a><div class="expand"></div></div><div class="figure-inline-download">
          Download:
          <ul><li><a href="article/figure/powerpoint?id=10.1371/journal.pone.0063581.g003"><div class="definition-label">PPT</div><div class="definition-description">PowerPoint slide</div></a></li><li><a href="article/figure/image?download&amp;size=large&amp;id=10.1371/journal.pone.0063581.g003"><div class="definition-label">PNG</div><div class="definition-description">larger image</div></a></li><li><a href="article/figure/image?download&amp;size=original&amp;id=10.1371/journal.pone.0063581.g003"><div class="definition-label">TIFF</div><div class="definition-description">original image</div></a></li></ul></div><div class="figcaption"><span>Figure 3. </span> The correlation of maspin expression in established human ESCC cell lines with lower rates of proliferation <em>in vitro</em>.</div><p class="caption_target"><a id="article1.body1.sec3.sec3.fig1.caption1.p1" name="article1.body1.sec3.sec3.fig1.caption1.p1" class="link-target"></a><p>(A) Western blotting of maspin in the indicated ESCC cell lines. Twenty-five micrograms of total lysate protein were loaded in each lane. Western blotting of the same membrane for house-keeping -actin was used to assess the loading variation. (B) MTT assay of the proliferation of ESCC cell lines. The data at each time point represent the average of three independent repeats. The error bars represent the standard deviation.</p>
</p><p class="caption_object"><a href="https://doi.org/10.1371/journal.pone.0063581.g003">
              https://doi.org/10.1371/journal.pone.0063581.g003</a></p></div><a id="article1.body1.sec3.sec3.p2" name="article1.body1.sec3.sec3.p2" class="link-target"></a><p>To investigate the functional significance of maspin in ESCC, we took the advantage of KYSE510 cell line that did not express maspin and stably transfected the cells with maspin-encoding pCMV-Tag2-maspin vector or an empty vector pCMV-Tag2. The maspin expression in the resulting maspin transfected cells (M-KYSE510) and the mock transfected control (V-KYSE510) are shown in <a href="#pone-0063581-g004"><strong>Figure 4A</strong></a>. As shown in <a href="#pone-0063581-g004"><strong>Figure 4B</strong></a>, maspin expression correlated with decreased cell proliferation as judged by the MTT assay. Earlier, it was reported that maspin regulated cell attachment and detachment <a href="#pone.0063581-Li1" class="ref-tip">[13]</a>, <a href="#pone.0063581-Wedel1" class="ref-tip">[25]</a>. To determine whether the effect of maspin expression on tumor growth was a result of altered colonization, cells were suspended and seeded at a low density in cell culture dish. The number of the single cell-derived colonies and number of cells per colony were evaluated under the microscope. Maspin expression did not significantly alter the colony forming ability, for the colony numbers for M-KYSE510, V-KYSE510 and the parental cells were not significantly different (data not shown). However, as shown in <a href="#pone-0063581-g004"><strong>Figure 4C</strong></a>, the size of M-KYSE510 colonies was significantly smaller compared to those derived fromV-KYSE510 cell line. Consistently, the number of cells per colony was significantly lower than those for V-KYSE510 and parental cells. The number of colonies of M-KYSE510 with more than 100 cells was approximately a half of those of V-KYSE510 or parental KYSE510cells (<em>p&lt;</em>0.01, <a href="#pone-0063581-g004"><strong>Figure 4D</strong></a>).</p>
<a class="link-target" id="pone-0063581-g004" name="pone-0063581-g004"></a><div class="figure" data-doi="10.1371/journal.pone.0063581.g004"><div class="img-box"><a title="Click for larger image" href="article/figure/image?size=medium&amp;id=10.1371/journal.pone.0063581.g004" data-doi="10.1371/journal.pone.0063581" data-uri="10.1371/journal.pone.0063581.g004"><img src="article/figure/image?size=inline&amp;id=10.1371/journal.pone.0063581.g004" alt="thumbnail" class="thumbnail" loading="lazy"></a><div class="expand"></div></div><div class="figure-inline-download">
          Download:
          <ul><li><a href="article/figure/powerpoint?id=10.1371/journal.pone.0063581.g004"><div class="definition-label">PPT</div><div class="definition-description">PowerPoint slide</div></a></li><li><a href="article/figure/image?download&amp;size=large&amp;id=10.1371/journal.pone.0063581.g004"><div class="definition-label">PNG</div><div class="definition-description">larger image</div></a></li><li><a href="article/figure/image?download&amp;size=original&amp;id=10.1371/journal.pone.0063581.g004"><div class="definition-label">TIFF</div><div class="definition-description">original image</div></a></li></ul></div><div class="figcaption"><span>Figure 4. </span> Characterization of stably transfected KYSE510 cell lines.</div><p class="caption_target"><a id="article1.body1.sec3.sec3.fig2.caption1.p1" name="article1.body1.sec3.sec3.fig2.caption1.p1" class="link-target"></a><p>(A) Western blotting of maspin and housekeeping protein -actin in the total lysates of parental KYSE510, M-KYSE510, and V-KYSE510 cells. (B) MTT assay of the proliferation of parental KYSE510, M-KYSE510, and V-KYSE510 cells, cultured in the maintenance media. (C) Representative staining of single cell-derived colonies (bottom) and the magnified image of the highlighted colonies (top) from the colony formation assay. (D) Quantification of colonies with more than &gt;100 cells/colony based on counting under microscope in the colony formation assay. Data represent the average of three independent repeats. Error bars represent the standard deviation. The difference between M-KYSE51 and V-KYSE510 (or parental KYSE510) was statistically significant (<em>p</em>&lt;0.001).</p>
</p><p class="caption_object"><a href="https://doi.org/10.1371/journal.pone.0063581.g004">
              https://doi.org/10.1371/journal.pone.0063581.g004</a></p></div><a id="article1.body1.sec3.sec3.p3" name="article1.body1.sec3.sec3.p3" class="link-target"></a><p>To further investigate whether the presence of maspin in ESCC is a gain or loss of other functions in tumor progression, we examined the effect of maspin expression on tumor cell motility and invasion. As shown by the <em>in vitro</em> wound healing assay (<a href="#pone-0063581-g005"><strong>Figure 5A</strong></a>), The M-KYSE-510 displayed a significantly attenuated rate of wound healing as compared to V-KYSE-510 or parental KYSE-510 cells. Moreover, as compared to V-KYSE-510 or parental KYSE-510 cells, M-KYSE-510 exhibited a significantly lower capacity to migrate through the Matrigel-coated transwell membrane in the <em>in vitro</em> invasion assay (<em>p</em>&lt;0.01, <a href="#pone-0063581-g005"><strong>Figures 5B and 5C</strong></a>).</p>
<a class="link-target" id="pone-0063581-g005" name="pone-0063581-g005"></a><div class="figure" data-doi="10.1371/journal.pone.0063581.g005"><div class="img-box"><a title="Click for larger image" href="article/figure/image?size=medium&amp;id=10.1371/journal.pone.0063581.g005" data-doi="10.1371/journal.pone.0063581" data-uri="10.1371/journal.pone.0063581.g005"><img src="article/figure/image?size=inline&amp;id=10.1371/journal.pone.0063581.g005" alt="thumbnail" class="thumbnail" loading="lazy"></a><div class="expand"></div></div><div class="figure-inline-download">
          Download:
          <ul><li><a href="article/figure/powerpoint?id=10.1371/journal.pone.0063581.g005"><div class="definition-label">PPT</div><div class="definition-description">PowerPoint slide</div></a></li><li><a href="article/figure/image?download&amp;size=large&amp;id=10.1371/journal.pone.0063581.g005"><div class="definition-label">PNG</div><div class="definition-description">larger image</div></a></li><li><a href="article/figure/image?download&amp;size=original&amp;id=10.1371/journal.pone.0063581.g005"><div class="definition-label">TIFF</div><div class="definition-description">original image</div></a></li></ul></div><div class="figcaption"><span>Figure 5. </span> The effects of maspin expression on cell motility and invasion.</div><p class="caption_target"><a id="article1.body1.sec3.sec3.fig3.caption1.p1" name="article1.body1.sec3.sec3.fig3.caption1.p1" class="link-target"></a><p>(A) Representative microscopic images of post-wounding monolayer cell culture at the indicated time points. (B) Representative microscopic images of the underside of the transwell invasion assay membrane. (C) Quantification of the number of invasive cells based on the counting of the invading cells shown in (B). M-KYSE510 showed significantly lower numbers of invasive cells. Data represent the average of three independent repeats. Error bars represent the standard deviations.</p>
</p><p class="caption_object"><a href="https://doi.org/10.1371/journal.pone.0063581.g005">
              https://doi.org/10.1371/journal.pone.0063581.g005</a></p></div><a id="article1.body1.sec3.sec3.p4" name="article1.body1.sec3.sec3.p4" class="link-target"></a><p>Although the level of maspin correlated with the overall survival, the biological function and underlying molecular mechanisms of maspin may not be as simple. The effects of maspin may further depend on tumor microenvironments. In addition to reducing the proliferative activity and invasive potential, maspin may also prevent tumor angiogenesis through epigenetic regulation <a href="#pone.0063581-Cher1" class="ref-tip">[26]</a><a href="#pone.0063581-Yin1" class="ref-tip">[30]</a>.</p>
<a id="article1.body1.sec3.sec3.p5" name="article1.body1.sec3.sec3.p5" class="link-target"></a><p>Earlier we have shown that maspin may directly inhibit cell surface-associated uPA to block tumor cell detachment <a href="#pone.0063581-McGowen1" class="ref-tip">[12]</a>, <a href="#pone.0063581-Cher1" class="ref-tip">[26]</a>, <a href="#pone.0063581-Biliran1" class="ref-tip">[31]</a>, <a href="#pone.0063581-Yin2" class="ref-tip">[32]</a>. Data from the Hendrix Laboratory <a href="#pone.0063581-Amir2" class="ref-tip">[33]</a> and our laboratory <a href="#pone.0063581-Bernardo1" class="ref-tip">[29]</a> further suggest that maspin may down-regulate the expression of uPA. To test whether the effect of maspin on the motility and invasiveness of ESCC cells was, at least in part, due to its effect on uPA, we performed real-time PCR for uPA. Interestingly, the level of uPA in all the cell lines tested was low, irrespective to the levels of maspin (data not shown). Considering the differences between squamous cell carcinoma and adenocarcinoma, the underlying mechanism for the inhibitory effects of maspin on ESCC invasion may not be identical to that in carcinoma cells of breast and prostate origin. To date, there is no clinical consensus about uPA as a prognostic marker for ESCC.</p>
</div>
</div>

<div xmlns:plos="http://plos.org" id="section4" class="section toc-section"><a id="s4" name="s4" data-toc="s4" class="link-target" title="Discussion"></a><h2>Discussion</h2><a id="article1.body1.sec4.p1" name="article1.body1.sec4.p1" class="link-target"></a><p>The challenge for clinicians and oncologists in terms of patient personalized medicine and plan for treatment is that early stage tumors with similar histopathological features may subsequently display dramatically different outcome. In this paper, we described the first evidence that tumor suppressor maspin expression in early stage ESCC positively correlated with overall postoperative survival of patients. In light of our <em>in vitro</em> data that maspin inhibits tumor growth and blocks tumor invasion, several important observations with human specimens suggest a unique value of maspin as a molecular prognostic marker of ESCC.</p>
<a id="article1.body1.sec4.p2" name="article1.body1.sec4.p2" class="link-target"></a><p>Overall, our data support a hypothetical model (<a href="#pone-0063581-g006"><strong>Figure 6</strong></a>) that helps explain the correlation between maspin up-regulation and better overall survival of patients with ESCC. Based on this model, maspin is expressed in early stage ESCC to retain the epithelial homeostasis. In the absence of oncogenic changes, a basal level of maspin expression is maintained in normal or benign squamous epithelial cells to counter incidental stress and transformation insults. Upon the transformation and other oncogenic changes, the basal level of maspin expression may not be sufficient to counter-balance the biological effects of oncogenes. Those epithelial cells that are still capable of up-regulating maspin expression will remain better differentiated with low potential to invade and metastasize. The balance will shift towards more malignant phenotypes in those cells that are not capable of up-regulating maspin or would eventually lose maspin expression. In contrast to molecular markers whose differential expression patterns completely coincide with histopathological features, early stage ESCC cells expressing maspin at different levels may be histologically similar. The usefulness of maspin differential expression may not be to confirm pathological diagnosis. Rather, maspin may be uniquely useful as an independent marker to predict the course of the disease progression.</p>
<a class="link-target" id="pone-0063581-g006" name="pone-0063581-g006"></a><div class="figure" data-doi="10.1371/journal.pone.0063581.g006"><div class="img-box"><a title="Click for larger image" href="article/figure/image?size=medium&amp;id=10.1371/journal.pone.0063581.g006" data-doi="10.1371/journal.pone.0063581" data-uri="10.1371/journal.pone.0063581.g006"><img src="article/figure/image?size=inline&amp;id=10.1371/journal.pone.0063581.g006" alt="thumbnail" class="thumbnail" loading="lazy"></a><div class="expand"></div></div><div class="figure-inline-download">
          Download:
          <ul><li><a href="article/figure/powerpoint?id=10.1371/journal.pone.0063581.g006"><div class="definition-label">PPT</div><div class="definition-description">PowerPoint slide</div></a></li><li><a href="article/figure/image?download&amp;size=large&amp;id=10.1371/journal.pone.0063581.g006"><div class="definition-label">PNG</div><div class="definition-description">larger image</div></a></li><li><a href="article/figure/image?download&amp;size=original&amp;id=10.1371/journal.pone.0063581.g006"><div class="definition-label">TIFF</div><div class="definition-description">original image</div></a></li></ul></div><div class="figcaption"><span>Figure 6. </span> A hypothetical model for maspin as a prognostic marker of ESCC.</div><p class="caption_target"></p><p class="caption_object"><a href="https://doi.org/10.1371/journal.pone.0063581.g006">
              https://doi.org/10.1371/journal.pone.0063581.g006</a></p></div><a id="article1.body1.sec4.p3" name="article1.body1.sec4.p3" class="link-target"></a><p>Maspin is an epithelial-specific protein. We did not detect specific maspin antigen by immunohistochemistry in stromal components in human ESCC specimens. Clinical studies to correlate maspin and tumor progression have been mostly conducted with adenocarcinoma, which is thought to be of glandular epithelial origin. Together with our current study, there are only two reports on how maspin expression correlates with the progression of squamous cell carcinoma, which derives from stratified squamous epithelial cells. The reported data with oral squamous cell carcinoma <a href="#pone.0063581-Xia1" class="ref-tip">[20]</a>, <a href="#pone.0063581-Lezzi1" class="ref-tip">[34]</a> share the following important similarities with our current study with ESCC: (i) both studies were conducted with surgically resected early stage tumor specimens; (ii) in both cases, maspin protein was detected in almost all tumor cells, and was overexpressed in some tumor cells; (iii) maspin protein was detected in both the nucleus and cytoplasm; and (iv) the overall maspin expression levels correlated with better survival of the patients. In comparison, a distinct maspin differential expression patter is observed in adenocarcinoma. Studies with tissue specimens from breast <a href="#pone.0063581-Joensuu1" class="ref-tip">[35]</a>, <a href="#pone.0063581-Sopel1" class="ref-tip">[36]</a>, prostate <a href="#pone.0063581-Pierson1" class="ref-tip">[37]</a>, and lung <a href="#pone.0063581-Frey1" class="ref-tip">[19]</a> adenocarcinoma showed that maspin is predominantly a nuclear protein in benign epithelial cells. Pre-neoplastic lesions and early stage carcinomas are commonly associated with elevated level of maspin, which is localized to both nucleus and cytoplasm <a href="#pone.0063581-Frey1" class="ref-tip">[19]</a>, <a href="#pone.0063581-Joensuu1" class="ref-tip">[35]</a>. In invasive and metastatic carcinoma maspin expression is down-regulated or lost <a href="#pone.0063581-Denk1" class="ref-tip">[38]</a><a href="#pone.0063581-Yoshizawa1" class="ref-tip">[40]</a>. To our knowledge, maspin is the only molecular marker that displays distinct differential expression patterns in the progression of different subtypes of carcinoma.</p>
<a id="article1.body1.sec4.p4" name="article1.body1.sec4.p4" class="link-target"></a><p>It is noted that carcinogenesis and tumor progression are more driven by the loss of tumor suppressors than the activation of oncogenes <a href="#pone.0063581-MacDougall1" class="ref-tip">[41]</a>. Thus, tumor suppressor genes that are mechanistically involved in tumor progression may be more insightful molecular markers for diagnosis or prediction of prognosis. A paradigm based on the studies of classic tumor suppressor genes whose loss or mutation at the genetic level contributes to carcinogenesis and tumor progression would predict that tumor suppressors would be down-regulated as long as the oncogenesis is initiated <a href="#pone.0063581-Ozaki1" class="ref-tip">[42]</a>. Therefore, the tumor suppressive functions of maspin may seem to be at odds with the observation that maspin is actually transiently up-regulated in some cells that have already acquired the histopathologic features of tumor cells. To this end, it is important to point out that maspin is primarily regulated at the level of expression and trafficking. Although maspin is not as frequently mutated as some other well-known tumor suppressor genes such as p53 <a href="#pone.0063581-FreedPastor1" class="ref-tip">[43]</a>, a specific Ser<sup>176</sup>Pro polymorphism has been identified <a href="#pone.0063581-Jang1" class="ref-tip">[44]</a> which seems to be frequent in gastric cancer and had reduced tumor suppressive potency as compared to the wild type maspin.</p>
<a id="article1.body1.sec4.p5" name="article1.body1.sec4.p5" class="link-target"></a><p><em>In vitro</em> data from this study are in line with the consensus that maspin exerts multifaceted anti-tumor effects, inhibiting tumor growth, motility, invasion, and sensitizing tumor cells to drug-induced apoptosis. Maspin may be a nuclear, cytoplasmic, cell membrane-associated, as well as secreted molecule. The multifaceted biological activities of maspin may be coordinated by its molecular partnerships and subcellular localization <a href="#pone.0063581-Bodenstine1" class="ref-tip">[45]</a><a href="#pone.0063581-Goulet2" class="ref-tip">[47]</a>. To this end, the Sheng laboratory was the first to report that (i) secreted endogenous maspin binds and inhibits single-chain tissue type plasminogen activator (sc-tPA, a zymogen) that is bound to fibrin or fibrinogen <a href="#pone.0063581-Sheng1" class="ref-tip">[48]</a>, (ii) extracellular maspin specifically binds and inhibits pro-urokinase type plasminogen activator (pro-uPA, a zymogen) that is associated with cell surface-anchored uPA receptor (uPAR) <a href="#pone.0063581-Yin2" class="ref-tip">[32]</a> and (iii) intracellular maspin specifically interacts and inhibits histone deacetylase 1 (HDAC1) <a href="#pone.0063581-Li1" class="ref-tip">[13]</a>. While the specific molecular mode of action of cytoplasmic maspin is under investigation in our lab, and earlier report suggested that cytoplasmic maspin regulates the Rho/Rac signaling network and block tumor cell motility <a href="#pone.0063581-OderoMarah1" class="ref-tip">[49]</a>. It is likely that endogenous targets of maspin may be molecular targets for cancer therapy.</p>
</div>



<div xmlns:plos="http://plos.org" class="contributions toc-section"><a id="authcontrib" name="authcontrib" data-toc="authcontrib" title="Author Contributions"></a><h2>Author Contributions</h2><p>Conceived and designed the experiments: YW SS JZ SL FF NW QZ YY. Performed the experiments: YW JZ SL FF NW QZ YY. Analyzed the data: YW SS JZ SL FF NW QZ YY. Contributed reagents/materials/analysis tools: SS SD YY. Wrote the paper: YW SS SD YY.</p></div><div xmlns:plos="http://plos.org" class="toc-section"><a id="references" name="references" class="link-target" data-toc="references" title="References"></a><h2>References</h2><ol class="references"><li id="ref1"><span class="order">1.
            </span><a name="pone.0063581-Kamangar1" id="pone.0063581-Kamangar1" class="link-target"></a>Kamangar F, Dores GM, Anderson WF (2006) Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 24: 21372150. <ul class="reflinks"><li><a href="#" data-author="Kamangar" data-cit="KamangarF%2C%20DoresGM%2C%20AndersonWF%20%282006%29%20Patterns%20of%20cancer%20incidence%2C%20mortality%2C%20and%20prevalence%20across%20five%20continents%3A%20defining%20priorities%20to%20reduce%20cancer%20disparities%20in%20different%20geographic%20regions%20of%20the%20world.%20J%20Clin%20Oncol%2024%3A%202137%E2%80%932150." data-title="Patterns%20of%20cancer%20incidence%2C%20mortality%2C%20and%20prevalence%20across%20five%20continents%3A%20defining%20priorities%20to%20reduce%20cancer%20disparities%20in%20different%20geographic%20regions%20of%20the%20world" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Patterns+of+cancer+incidence%2C+mortality%2C+and+prevalence+across+five+continents%3A+defining+priorities+to+reduce+cancer+disparities+in+different+geographic+regions+of+the+world+Kamangar+2006" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref2"><span class="order">2.
            </span><a name="pone.0063581-Parkin1" id="pone.0063581-Parkin1" class="link-target"></a>Parkin DM, Bray FI, Devesa SS (2001) Cancer burden in the year 2000. The global picture. Eur J Cancer 37 Suppl 8S466. <ul class="reflinks"><li><a href="#" data-author="Parkin" data-cit="ParkinDM%2C%20BrayFI%2C%20DevesaSS%20%282001%29%20Cancer%20burden%20in%20the%20year%202000.%20The%20global%20picture.%20Eur%20J%20Cancer%2037%20Suppl%208S4%E2%80%9366." data-title="Cancer%20burden%20in%20the%20year%202000.%20The%20global%20picture" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Cancer+burden+in+the+year+2000.+The+global+picture+Parkin+2001" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref3"><span class="order">3.
            </span><a name="pone.0063581-Hiyama1" id="pone.0063581-Hiyama1" class="link-target"></a>Hiyama T, Yoshihara M, Tanaka S, Chayama K (2007) Genetic polymorphisms and esophageal cancer risk. Int J Cancer 121: 16431658. <ul class="reflinks"><li><a href="#" data-author="Hiyama" data-cit="HiyamaT%2C%20YoshiharaM%2C%20TanakaS%2C%20ChayamaK%20%282007%29%20Genetic%20polymorphisms%20and%20esophageal%20cancer%20risk.%20Int%20J%20Cancer%20121%3A%201643%E2%80%931658." data-title="Genetic%20polymorphisms%20and%20esophageal%20cancer%20risk" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Genetic+polymorphisms+and+esophageal+cancer+risk+Hiyama+2007" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref4"><span class="order">4.
            </span><a name="pone.0063581-Xing1" id="pone.0063581-Xing1" class="link-target"></a>Xing DY, Tan W, Lin DX (2003) Genetic polymorphisms and susceptibility to esophageal cancer among Chinese population (Review). Oncology Reports 10: 16151623. <ul class="reflinks"><li><a href="#" data-author="Xing" data-cit="XingDY%2C%20TanW%2C%20LinDX%20%282003%29%20Genetic%20polymorphisms%20and%20susceptibility%20to%20esophageal%20cancer%20among%20Chinese%20population%20%28Review%29.%20Oncology%20Reports%2010%3A%201615%E2%80%931623." data-title="Genetic%20polymorphisms%20and%20susceptibility%20to%20esophageal%20cancer%20among%20Chinese%20population%20%28Review%29" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Genetic+polymorphisms+and+susceptibility+to+esophageal+cancer+among+Chinese+population+%28Review%29+Xing+2003" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref5"><span class="order">5.
            </span><a name="pone.0063581-Koshy1" id="pone.0063581-Koshy1" class="link-target"></a>Koshy M, Esiashvilli N, Landry JC, Thomas CR Jr, Matthews RH (2004) Multiple management modalities in esophageal cancer: combined modality management approaches. Oncologist 9: 147159. <ul class="reflinks"><li><a href="#" data-author="Koshy" data-cit="KoshyM%2C%20EsiashvilliN%2C%20LandryJC%2C%20ThomasCRJr%2C%20MatthewsRH%20%282004%29%20Multiple%20management%20modalities%20in%20esophageal%20cancer%3A%20combined%20modality%20management%20approaches.%20Oncologist%209%3A%20147%E2%80%93159." data-title="Multiple%20management%20modalities%20in%20esophageal%20cancer%3A%20combined%20modality%20management%20approaches" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Multiple+management+modalities+in+esophageal+cancer%3A+combined+modality+management+approaches+Koshy+2004" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref6"><span class="order">6.
            </span><a name="pone.0063581-Younes1" id="pone.0063581-Younes1" class="link-target"></a>Younes M, Henson DE, Ertan A, Miller CC (2002) Incidence and survival trends of esophageal carcinoma in the United States: racial and gender differences by histological type. Scand J Gastroenterol 37: 13591365. <ul class="reflinks"><li><a href="#" data-author="Younes" data-cit="YounesM%2C%20HensonDE%2C%20ErtanA%2C%20MillerCC%20%282002%29%20Incidence%20and%20survival%20trends%20of%20esophageal%20carcinoma%20in%20the%20United%20States%3A%20racial%20and%20gender%20differences%20by%20histological%20type.%20Scand%20J%20Gastroenterol%2037%3A%201359%E2%80%931365." data-title="Incidence%20and%20survival%20trends%20of%20esophageal%20carcinoma%20in%20the%20United%20States%3A%20racial%20and%20gender%20differences%20by%20histological%20type" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Incidence+and+survival+trends+of+esophageal+carcinoma+in+the+United+States%3A+racial+and+gender+differences+by+histological+type+Younes+2002" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref7"><span class="order">7.
            </span><a name="pone.0063581-Ashida1" id="pone.0063581-Ashida1" class="link-target"></a>Ashida A, Boku N, Aoyagi K, Sato H, Tsubosa Y, et al. (2006) Expression profiling of esophageal squamous cell carcinoma patients treated with definitive chemoradiotherapy: Clinical implications. International Journal of Oncology 28: 13451352. <ul class="reflinks"><li><a href="#" data-author="Ashida" data-cit="AshidaA%2C%20BokuN%2C%20AoyagiK%2C%20SatoH%2C%20TsubosaY%2C%20et%20al.%20%282006%29%20Expression%20profiling%20of%20esophageal%20squamous%20cell%20carcinoma%20patients%20treated%20with%20definitive%20chemoradiotherapy%3A%20Clinical%20implications.%20International%20Journal%20of%20Oncology%2028%3A%201345%E2%80%931352." data-title="Expression%20profiling%20of%20esophageal%20squamous%20cell%20carcinoma%20patients%20treated%20with%20definitive%20chemoradiotherapy%3A%20Clinical%20implications" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Expression+profiling+of+esophageal+squamous+cell+carcinoma+patients+treated+with+definitive+chemoradiotherapy%3A+Clinical+implications+Ashida+2006" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref8"><span class="order">8.
            </span><a name="pone.0063581-Lin1" id="pone.0063581-Lin1" class="link-target"></a>Lin DC, Du XL, Wang MR (2009) Protein alterations in ESCC and clinical implications: a review. Diseases of the Esophagus 22: 920. <ul class="reflinks"><li><a href="#" data-author="Lin" data-cit="LinDC%2C%20DuXL%2C%20WangMR%20%282009%29%20Protein%20alterations%20in%20ESCC%20and%20clinical%20implications%3A%20a%20review.%20Diseases%20of%20the%20Esophagus%2022%3A%209%E2%80%9320." data-title="Protein%20alterations%20in%20ESCC%20and%20clinical%20implications%3A%20a%20review" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Protein+alterations+in+ESCC+and+clinical+implications%3A+a+review+Lin+2009" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref9"><span class="order">9.
            </span><a name="pone.0063581-Yie1" id="pone.0063581-Yie1" class="link-target"></a>Yie SM, Yang H, Ye SR, Li K, Dong DD, et al. (2007) Expression of HLA-G is associated with prognosis on esophageau squamous cell carcinoma. American Journal of Clinical Pathology 128: 10021009. <ul class="reflinks"><li><a href="#" data-author="Yie" data-cit="YieSM%2C%20YangH%2C%20YeSR%2C%20LiK%2C%20DongDD%2C%20et%20al.%20%282007%29%20Expression%20of%20HLA-G%20is%20associated%20with%20prognosis%20on%20esophageau%20squamous%20cell%20carcinoma.%20American%20Journal%20of%20Clinical%20Pathology%20128%3A%201002%E2%80%931009." data-title="Expression%20of%20HLA-G%20is%20associated%20with%20prognosis%20on%20esophageau%20squamous%20cell%20carcinoma" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Expression+of+HLA-G+is+associated+with+prognosis+on+esophageau+squamous+cell+carcinoma+Yie+2007" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref10"><span class="order">10.
            </span><a name="pone.0063581-Zou1" id="pone.0063581-Zou1" class="link-target"></a>Zou Z, Anisowicz A, Hendrix MJ, Thor A, Neveu M, et al. (1994) Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science 263: 526529. <ul class="reflinks"><li><a href="#" data-author="Zou" data-cit="ZouZ%2C%20AnisowiczA%2C%20HendrixMJ%2C%20ThorA%2C%20NeveuM%2C%20et%20al.%20%281994%29%20Maspin%2C%20a%20serpin%20with%20tumor-suppressing%20activity%20in%20human%20mammary%20epithelial%20cells.%20Science%20263%3A%20526%E2%80%93529." data-title="Maspin%2C%20a%20serpin%20with%20tumor-suppressing%20activity%20in%20human%20mammary%20epithelial%20cells" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Maspin%2C+a+serpin+with+tumor-suppressing+activity+in+human+mammary+epithelial+cells+Zou+1994" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref11"><span class="order">11.
            </span><a name="pone.0063581-Amir1" id="pone.0063581-Amir1" class="link-target"></a>Amir S, Margaryan NV, Odero-Marah V, Khalkhali-Ellis Z, Hendrix MJC (2005) Maspin regulates hypoxia-mediated stimulation of uPA/uPAR complex in invasive breast cancer cells. Cancer Biology &amp; Therapy 4: 400406. <ul class="reflinks"><li><a href="#" data-author="Amir" data-cit="AmirS%2C%20MargaryanNV%2C%20Odero-MarahV%2C%20Khalkhali-EllisZ%2C%20HendrixMJC%20%282005%29%20Maspin%20regulates%20hypoxia-mediated%20stimulation%20of%20uPA%2FuPAR%20complex%20in%20invasive%20breast%20cancer%20cells.%20Cancer%20Biology%20%26%20Therapy%204%3A%20400%E2%80%93406." data-title="Maspin%20regulates%20hypoxia-mediated%20stimulation%20of%20uPA%2FuPAR%20complex%20in%20invasive%20breast%20cancer%20cells" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Maspin+regulates+hypoxia-mediated+stimulation+of+uPA%2FuPAR+complex+in+invasive+breast+cancer+cells+Amir+2005" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref12"><span class="order">12.
            </span><a name="pone.0063581-McGowen1" id="pone.0063581-McGowen1" class="link-target"></a>McGowen R, Biliran H Jr, Sager R, Sheng S (2000) The surface of prostate carcinoma DU145 cells mediates the inhibition of urokinase-type plasminogen activator by maspin. Cancer Res 60: 47714778. <ul class="reflinks"><li><a href="#" data-author="McGowen" data-cit="McGowenR%2C%20BiliranHJr%2C%20SagerR%2C%20ShengS%20%282000%29%20The%20surface%20of%20prostate%20carcinoma%20DU145%20cells%20mediates%20the%20inhibition%20of%20urokinase-type%20plasminogen%20activator%20by%20maspin.%20Cancer%20Res%2060%3A%204771%E2%80%934778." data-title="The%20surface%20of%20prostate%20carcinoma%20DU145%20cells%20mediates%20the%20inhibition%20of%20urokinase-type%20plasminogen%20activator%20by%20maspin" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=The+surface+of+prostate+carcinoma+DU145+cells+mediates+the+inhibition+of+urokinase-type+plasminogen+activator+by+maspin+McGowen+2000" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref13"><span class="order">13.
            </span><a name="pone.0063581-Li1" id="pone.0063581-Li1" class="link-target"></a>Li X, Yin S, Meng Y, Sakr W, Sheng S (2006) Endogenous inhibition of histone deacetylase 1 by tumor-suppressive maspin. Cancer Res 66: 93239329. <ul class="reflinks"><li><a href="#" data-author="Li" data-cit="LiX%2C%20YinS%2C%20MengY%2C%20SakrW%2C%20ShengS%20%282006%29%20Endogenous%20inhibition%20of%20histone%20deacetylase%201%20by%20tumor-suppressive%20maspin.%20Cancer%20Res%2066%3A%209323%E2%80%939329." data-title="Endogenous%20inhibition%20of%20histone%20deacetylase%201%20by%20tumor-suppressive%20maspin" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Endogenous+inhibition+of+histone+deacetylase+1+by+tumor-suppressive+maspin+Li+2006" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref14"><span class="order">14.
            </span><a name="pone.0063581-Bieche1" id="pone.0063581-Bieche1" class="link-target"></a>Bieche I, Girault I, Sabourin JC, Tozlu S, Driouch K, et al. (2003) Prognostic value of maspin mRNA expression in ER alpha-positive postmenopausal breast carcinomas. British Journal of Cancer 88: 863870. <ul class="reflinks"><li><a href="#" data-author="Bieche" data-cit="BiecheI%2C%20GiraultI%2C%20SabourinJC%2C%20TozluS%2C%20DriouchK%2C%20et%20al.%20%282003%29%20Prognostic%20value%20of%20maspin%20mRNA%20expression%20in%20ER%20alpha-positive%20postmenopausal%20breast%20carcinomas.%20British%20Journal%20of%20Cancer%2088%3A%20863%E2%80%93870." data-title="Prognostic%20value%20of%20maspin%20mRNA%20expression%20in%20ER%20alpha-positive%20postmenopausal%20breast%20carcinomas" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Prognostic+value+of+maspin+mRNA+expression+in+ER+alpha-positive+postmenopausal+breast+carcinomas+Bieche+2003" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref15"><span class="order">15.
            </span><a name="pone.0063581-Umekita1" id="pone.0063581-Umekita1" class="link-target"></a>Umekita Y, Ohi Y, Sagara Y, Yoshida H (2002) Expression of maspin predicts poor prognosis in breast cancer patients. International Journal of Cancer 100: 452455. <ul class="reflinks"><li><a href="#" data-author="Umekita" data-cit="UmekitaY%2C%20OhiY%2C%20SagaraY%2C%20YoshidaH%20%282002%29%20Expression%20of%20maspin%20predicts%20poor%20prognosis%20in%20breast%20cancer%20patients.%20International%20Journal%20of%20Cancer%20100%3A%20452%E2%80%93455." data-title="Expression%20of%20maspin%20predicts%20poor%20prognosis%20in%20breast%20cancer%20patients" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Expression+of+maspin+predicts+poor+prognosis+in+breast+cancer+patients+Umekita+2002" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref16"><span class="order">16.
            </span><a name="pone.0063581-Sood1" id="pone.0063581-Sood1" class="link-target"></a>Sood AK, Fletcher MS, Gruman LM, Coffin JE, Jabbari S, et al. (2002) The paradoxical expression of maspin in ovarian carcinoma. Clin Cancer Res 8: 29242932. <ul class="reflinks"><li><a href="#" data-author="Sood" data-cit="SoodAK%2C%20FletcherMS%2C%20GrumanLM%2C%20CoffinJE%2C%20JabbariS%2C%20et%20al.%20%282002%29%20The%20paradoxical%20expression%20of%20maspin%20in%20ovarian%20carcinoma.%20Clin%20Cancer%20Res%208%3A%202924%E2%80%932932." data-title="The%20paradoxical%20expression%20of%20maspin%20in%20ovarian%20carcinoma" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=The+paradoxical+expression+of+maspin+in+ovarian+carcinoma+Sood+2002" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref17"><span class="order">17.
            </span><a name="pone.0063581-Cao1" id="pone.0063581-Cao1" class="link-target"></a>Cao DF, Zhang Q, Wu LSF, Salaria SN, Winter JW, et al. (2007) Prognostic significance of maspin in pancreatic ductal adenocarcinoma: tissue microarray analysis of 223 surgically resected cases. Modern Pathology 20: 570578. <ul class="reflinks"><li><a href="#" data-author="Cao" data-cit="CaoDF%2C%20ZhangQ%2C%20WuLSF%2C%20SalariaSN%2C%20WinterJW%2C%20et%20al.%20%282007%29%20Prognostic%20significance%20of%20maspin%20in%20pancreatic%20ductal%20adenocarcinoma%3A%20tissue%20microarray%20analysis%20of%20223%20surgically%20resected%20cases.%20Modern%20Pathology%2020%3A%20570%E2%80%93578." data-title="Prognostic%20significance%20of%20maspin%20in%20pancreatic%20ductal%20adenocarcinoma%3A%20tissue%20microarray%20analysis%20of%20223%20surgically%20resected%20cases" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Prognostic+significance+of+maspin+in+pancreatic+ductal+adenocarcinoma%3A+tissue+microarray+analysis+of+223+surgically+resected+cases+Cao+2007" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref18"><span class="order">18.
            </span><a name="pone.0063581-Fitzgerald1" id="pone.0063581-Fitzgerald1" class="link-target"></a>Fitzgerald M, Oshiro M, Holtan N, Krager K, Cullen JJ, et al. (2003) Human pancreatic carcinoma cells activate maspin expression through loss of epigenetic control. Neoplasia 5: 427436. <ul class="reflinks"><li><a href="#" data-author="Fitzgerald" data-cit="FitzgeraldM%2C%20OshiroM%2C%20HoltanN%2C%20KragerK%2C%20CullenJJ%2C%20et%20al.%20%282003%29%20Human%20pancreatic%20carcinoma%20cells%20activate%20maspin%20expression%20through%20loss%20of%20epigenetic%20control.%20Neoplasia%205%3A%20427%E2%80%93436." data-title="Human%20pancreatic%20carcinoma%20cells%20activate%20maspin%20expression%20through%20loss%20of%20epigenetic%20control" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Human+pancreatic+carcinoma+cells+activate+maspin+expression+through+loss+of+epigenetic+control+Fitzgerald+2003" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref19"><span class="order">19.
            </span><a name="pone.0063581-Frey1" id="pone.0063581-Frey1" class="link-target"></a>Frey A, Soubani AO, Adam AK, Sheng S, Pass HI, et al. (2009) Nuclear, compared with combined nuclear and cytoplasmic expression of maspin, is linked in lung adenocarcinoma to reduced VEGF-A levels and in Stage I, improved survival. Histopathology 54: 590597. <ul class="reflinks"><li><a href="#" data-author="Frey" data-cit="FreyA%2C%20SoubaniAO%2C%20AdamAK%2C%20ShengS%2C%20PassHI%2C%20et%20al.%20%282009%29%20Nuclear%2C%20compared%20with%20combined%20nuclear%20and%20cytoplasmic%20expression%20of%20maspin%2C%20is%20linked%20in%20lung%20adenocarcinoma%20to%20reduced%20VEGF-A%20levels%20and%20in%20Stage%20I%2C%20improved%20survival.%20Histopathology%2054%3A%20590%E2%80%93597." data-title="Nuclear%2C%20compared%20with%20combined%20nuclear%20and%20cytoplasmic%20expression%20of%20maspin%2C%20is%20linked%20in%20lung%20adenocarcinoma%20to%20reduced%20VEGF-A%20levels%20and%20in%20Stage%20I%2C%20improved%20survival" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Nuclear%2C+compared+with+combined+nuclear+and+cytoplasmic+expression+of+maspin%2C+is+linked+in+lung+adenocarcinoma+to+reduced+VEGF-A+levels+and+in+Stage+I%2C+improved+survival+Frey+2009" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref20"><span class="order">20.
            </span><a name="pone.0063581-Xia1" id="pone.0063581-Xia1" class="link-target"></a>Xia WY, Lau YK, Hu MCT, Li L, Johnston DA, et al. (2000) High tumoral maspin expression is associated with improved survival of patients with oral squamous cell carcinoma. Oncogene 19: 23982403. <ul class="reflinks"><li><a href="#" data-author="Xia" data-cit="XiaWY%2C%20LauYK%2C%20HuMCT%2C%20LiL%2C%20JohnstonDA%2C%20et%20al.%20%282000%29%20High%20tumoral%20maspin%20expression%20is%20associated%20with%20improved%20survival%20of%20patients%20with%20oral%20squamous%20cell%20carcinoma.%20Oncogene%2019%3A%202398%E2%80%932403." data-title="High%20tumoral%20maspin%20expression%20is%20associated%20with%20improved%20survival%20of%20patients%20with%20oral%20squamous%20cell%20carcinoma" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=High+tumoral+maspin+expression+is+associated+with+improved+survival+of+patients+with+oral+squamous+cell+carcinoma+Xia+2000" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref21"><span class="order">21.
            </span><a name="pone.0063581-Woenckhaus1" id="pone.0063581-Woenckhaus1" class="link-target"></a>Woenckhaus M, Bubendorf L, Dalquen P, Foerster J, Blaszyk H, et al. (2007) Nuclear and cytoplasmic Maspin expression in primary non-small cell lung cancer. Journal of Clinical Pathology 60: 483486. <ul class="reflinks"><li><a href="#" data-author="Woenckhaus" data-cit="WoenckhausM%2C%20BubendorfL%2C%20DalquenP%2C%20FoersterJ%2C%20BlaszykH%2C%20et%20al.%20%282007%29%20Nuclear%20and%20cytoplasmic%20Maspin%20expression%20in%20primary%20non-small%20cell%20lung%20cancer.%20Journal%20of%20Clinical%20Pathology%2060%3A%20483%E2%80%93486." data-title="Nuclear%20and%20cytoplasmic%20Maspin%20expression%20in%20primary%20non-small%20cell%20lung%20cancer" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Nuclear+and+cytoplasmic+Maspin+expression+in+primary+non-small+cell+lung+cancer+Woenckhaus+2007" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref22"><span class="order">22.
            </span><a name="pone.0063581-Lockett1" id="pone.0063581-Lockett1" class="link-target"></a>Lockett J, Yin S, Li X, Meng Y, Sheng S (2006) Tumor suppressive maspin and epithelial homeostasis. J Cell Biochem 97: 651660. <ul class="reflinks"><li><a href="#" data-author="Lockett" data-cit="LockettJ%2C%20YinS%2C%20LiX%2C%20MengY%2C%20ShengS%20%282006%29%20Tumor%20suppressive%20maspin%20and%20epithelial%20homeostasis.%20J%20Cell%20Biochem%2097%3A%20651%E2%80%93660." data-title="Tumor%20suppressive%20maspin%20and%20epithelial%20homeostasis" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Tumor+suppressive+maspin+and+epithelial+homeostasis+Lockett+2006" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref23"><span class="order">23.
            </span><a name="pone.0063581-Mohsin1" id="pone.0063581-Mohsin1" class="link-target"></a>Mohsin SK, Zhang M, Clark GM, Craig Allred D (2003) Maspin expression in invasive breast cancer: association with other prognostic factors. J Pathol 199: 432435. <ul class="reflinks"><li><a href="#" data-author="Mohsin" data-cit="MohsinSK%2C%20ZhangM%2C%20ClarkGM%2C%20Craig%20AllredD%20%282003%29%20Maspin%20expression%20in%20invasive%20breast%20cancer%3A%20association%20with%20other%20prognostic%20factors.%20J%20Pathol%20199%3A%20432%E2%80%93435." data-title="Maspin%20expression%20in%20invasive%20breast%20cancer%3A%20association%20with%20other%20prognostic%20factors" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Maspin+expression+in+invasive+breast+cancer%3A+association+with+other+prognostic+factors+Mohsin+2003" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref24"><span class="order">24.
            </span><a name="pone.0063581-Tong1" id="pone.0063581-Tong1" class="link-target"></a>Tong T, Zhong YL, Kong JP, Dong LJ, Song YM, et al. (2004) Overexpression of aurora-A contributes to malignant development of human esophageal squamous cell carcinoma. Clinical Cancer Research 10: 73047310. <ul class="reflinks"><li><a href="#" data-author="Tong" data-cit="TongT%2C%20ZhongYL%2C%20KongJP%2C%20DongLJ%2C%20SongYM%2C%20et%20al.%20%282004%29%20Overexpression%20of%20aurora-A%20contributes%20to%20malignant%20development%20of%20human%20esophageal%20squamous%20cell%20carcinoma.%20Clinical%20Cancer%20Research%2010%3A%207304%E2%80%937310." data-title="Overexpression%20of%20aurora-A%20contributes%20to%20malignant%20development%20of%20human%20esophageal%20squamous%20cell%20carcinoma" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Overexpression+of+aurora-A+contributes+to+malignant+development+of+human+esophageal+squamous+cell+carcinoma+Tong+2004" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref25"><span class="order">25.
            </span><a name="pone.0063581-Wedel1" id="pone.0063581-Wedel1" class="link-target"></a>Wedel S, Hudak L, Seibel JM, Juengel E, Oppermann E, et al. (2011) Critical Analysis of Simultaneous Blockage of Histone Deacetylase and Multiple Receptor Tyrosine Kinase in the Treatment of Prostate Cancer. Prostate 71: 722735. <ul class="reflinks"><li><a href="#" data-author="Wedel" data-cit="WedelS%2C%20HudakL%2C%20SeibelJM%2C%20JuengelE%2C%20OppermannE%2C%20et%20al.%20%282011%29%20Critical%20Analysis%20of%20Simultaneous%20Blockage%20of%20Histone%20Deacetylase%20and%20Multiple%20Receptor%20Tyrosine%20Kinase%20in%20the%20Treatment%20of%20Prostate%20Cancer.%20Prostate%2071%3A%20722%E2%80%93735." data-title="Critical%20Analysis%20of%20Simultaneous%20Blockage%20of%20Histone%20Deacetylase%20and%20Multiple%20Receptor%20Tyrosine%20Kinase%20in%20the%20Treatment%20of%20Prostate%20Cancer" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Critical+Analysis+of+Simultaneous+Blockage+of+Histone+Deacetylase+and+Multiple+Receptor+Tyrosine+Kinase+in+the+Treatment+of+Prostate+Cancer+Wedel+2011" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref26"><span class="order">26.
            </span><a name="pone.0063581-Cher1" id="pone.0063581-Cher1" class="link-target"></a>Cher ML, Biliran HR, Bhagat S, Meng YH, Che MX, et al. (2003) Maspin expression inhibits osteolysis, tumor growth, and angiogenesis in a model of prostate cancer bone metastasis. Proceedings of the National Academy of Sciences of the United States of America 100: 78477852. <ul class="reflinks"><li><a href="#" data-author="Cher" data-cit="CherML%2C%20BiliranHR%2C%20BhagatS%2C%20MengYH%2C%20CheMX%2C%20et%20al.%20%282003%29%20Maspin%20expression%20inhibits%20osteolysis%2C%20tumor%20growth%2C%20and%20angiogenesis%20in%20a%20model%20of%20prostate%20cancer%20bone%20metastasis.%20Proceedings%20of%20the%20National%20Academy%20of%20Sciences%20of%20the%20United%20States%20of%20America%20100%3A%207847%E2%80%937852." data-title="Maspin%20expression%20inhibits%20osteolysis%2C%20tumor%20growth%2C%20and%20angiogenesis%20in%20a%20model%20of%20prostate%20cancer%20bone%20metastasis" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Maspin+expression+inhibits+osteolysis%2C+tumor+growth%2C+and+angiogenesis+in+a+model+of+prostate+cancer+bone+metastasis+Cher+2003" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref27"><span class="order">27.
            </span><a name="pone.0063581-Qin1" id="pone.0063581-Qin1" class="link-target"></a>Qin L, Zhang M (2010) Maspin Regulates Endothelial Cell Adhesion and Migration through an Integrin Signaling Pathway. Journal of Biological Chemistry 285: 3236032369. <ul class="reflinks"><li><a href="#" data-author="Qin" data-cit="QinL%2C%20ZhangM%20%282010%29%20Maspin%20Regulates%20Endothelial%20Cell%20Adhesion%20and%20Migration%20through%20an%20Integrin%20Signaling%20Pathway.%20Journal%20of%20Biological%20Chemistry%20285%3A%2032360%E2%80%9332369." data-title="Maspin%20Regulates%20Endothelial%20Cell%20Adhesion%20and%20Migration%20through%20an%20Integrin%20Signaling%20Pathway" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Maspin+Regulates+Endothelial+Cell+Adhesion+and+Migration+through+an+Integrin+Signaling+Pathway+Qin+2010" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref28"><span class="order">28.
            </span><a name="pone.0063581-Zhang1" id="pone.0063581-Zhang1" class="link-target"></a>Zhang M, Volpert O, Shi YH, Bouck N (2000) Maspin is an angiogenesis inhibitor. Nature Medicine 6: 196199. <ul class="reflinks"><li><a href="#" data-author="Zhang" data-cit="ZhangM%2C%20VolpertO%2C%20ShiYH%2C%20BouckN%20%282000%29%20Maspin%20is%20an%20angiogenesis%20inhibitor.%20Nature%20Medicine%206%3A%20196%E2%80%93199." data-title="Maspin%20is%20an%20angiogenesis%20inhibitor" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Maspin+is+an+angiogenesis+inhibitor+Zhang+2000" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref29"><span class="order">29.
            </span><a name="pone.0063581-Bernardo1" id="pone.0063581-Bernardo1" class="link-target"></a>Bernardo MM, Meng Y, Lockett J, Dyson G, Dombkowski A, et al. (2011) Maspin reprograms the gene expression profile of prostate carcinoma cells for differentiation. Genes Cancer 2: 10091022. <ul class="reflinks"><li><a href="#" data-author="Bernardo" data-cit="BernardoMM%2C%20MengY%2C%20LockettJ%2C%20DysonG%2C%20DombkowskiA%2C%20et%20al.%20%282011%29%20Maspin%20reprograms%20the%20gene%20expression%20profile%20of%20prostate%20carcinoma%20cells%20for%20differentiation.%20Genes%20Cancer%202%3A%201009%E2%80%931022." data-title="Maspin%20reprograms%20the%20gene%20expression%20profile%20of%20prostate%20carcinoma%20cells%20for%20differentiation" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Maspin+reprograms+the+gene+expression+profile+of+prostate+carcinoma+cells+for+differentiation+Bernardo+2011" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref30"><span class="order">30.
            </span><a name="pone.0063581-Yin1" id="pone.0063581-Yin1" class="link-target"></a>Yin SP, Li XH, Meng YH, Finley RL, Sakr W, et al. (2005) Tumor-suppressive maspin regulates cell response to oxidative stress by direct interaction with glutathione S-transferase. Journal of Biological Chemistry 280: 3498534996. <ul class="reflinks"><li><a href="#" data-author="Yin" data-cit="YinSP%2C%20LiXH%2C%20MengYH%2C%20FinleyRL%2C%20SakrW%2C%20et%20al.%20%282005%29%20Tumor-suppressive%20maspin%20regulates%20cell%20response%20to%20oxidative%20stress%20by%20direct%20interaction%20with%20glutathione%20S-transferase.%20Journal%20of%20Biological%20Chemistry%20280%3A%2034985%E2%80%9334996." data-title="Tumor-suppressive%20maspin%20regulates%20cell%20response%20to%20oxidative%20stress%20by%20direct%20interaction%20with%20glutathione%20S-transferase" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Tumor-suppressive+maspin+regulates+cell+response+to+oxidative+stress+by+direct+interaction+with+glutathione+S-transferase+Yin+2005" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref31"><span class="order">31.
            </span><a name="pone.0063581-Biliran1" id="pone.0063581-Biliran1" class="link-target"></a>Biliran H Jr, Sheng S (2001) Pleiotrophic inhibition of pericellular urokinase-type plasminogen activator system by endogenous tumor suppressive maspin. Cancer Res 61: 86768682. <ul class="reflinks"><li><a href="#" data-author="Biliran" data-cit="BiliranHJr%2C%20ShengS%20%282001%29%20Pleiotrophic%20inhibition%20of%20pericellular%20urokinase-type%20plasminogen%20activator%20system%20by%20endogenous%20tumor%20suppressive%20maspin.%20Cancer%20Res%2061%3A%208676%E2%80%938682." data-title="Pleiotrophic%20inhibition%20of%20pericellular%20urokinase-type%20plasminogen%20activator%20system%20by%20endogenous%20tumor%20suppressive%20maspin" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Pleiotrophic+inhibition+of+pericellular+urokinase-type+plasminogen+activator+system+by+endogenous+tumor+suppressive+maspin+Biliran+2001" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref32"><span class="order">32.
            </span><a name="pone.0063581-Yin2" id="pone.0063581-Yin2" class="link-target"></a>Yin S, Lockett J, Meng Y, Biliran H Jr, Blouse GE, et al. (2006) Maspin retards cell detachment via a novel interaction with the urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor system. Cancer Res 66: 41734181. <ul class="reflinks"><li><a href="#" data-author="Yin" data-cit="YinS%2C%20LockettJ%2C%20MengY%2C%20BiliranHJr%2C%20BlouseGE%2C%20et%20al.%20%282006%29%20Maspin%20retards%20cell%20detachment%20via%20a%20novel%20interaction%20with%20the%20urokinase-type%20plasminogen%20activator%2Furokinase-type%20plasminogen%20activator%20receptor%20system.%20Cancer%20Res%2066%3A%204173%E2%80%934181." data-title="Maspin%20retards%20cell%20detachment%20via%20a%20novel%20interaction%20with%20the%20urokinase-type%20plasminogen%20activator%2Furokinase-type%20plasminogen%20activator%20receptor%20system" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Maspin+retards+cell+detachment+via+a+novel+interaction+with+the+urokinase-type+plasminogen+activator%2Furokinase-type+plasminogen+activator+receptor+system+Yin+2006" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref33"><span class="order">33.
            </span><a name="pone.0063581-Amir2" id="pone.0063581-Amir2" class="link-target"></a>Amir S, Margaryan NV, Odero-Marah V, Khalkhali-Ellis Z, Hendrix MJ (2005) Maspin regulates hypoxia-mediated stimulation of uPA/uPAR complex in invasive breast cancer cells. Cancer Biol Ther 4: 400406. <ul class="reflinks"><li><a href="#" data-author="Amir" data-cit="AmirS%2C%20MargaryanNV%2C%20Odero-MarahV%2C%20Khalkhali-EllisZ%2C%20HendrixMJ%20%282005%29%20Maspin%20regulates%20hypoxia-mediated%20stimulation%20of%20uPA%2FuPAR%20complex%20in%20invasive%20breast%20cancer%20cells.%20Cancer%20Biol%20Ther%204%3A%20400%E2%80%93406." data-title="Maspin%20regulates%20hypoxia-mediated%20stimulation%20of%20uPA%2FuPAR%20complex%20in%20invasive%20breast%20cancer%20cells" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Maspin+regulates+hypoxia-mediated+stimulation+of+uPA%2FuPAR+complex+in+invasive+breast+cancer+cells+Amir+2005" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref34"><span class="order">34.
            </span><a name="pone.0063581-Lezzi1" id="pone.0063581-Lezzi1" class="link-target"></a>Lezzi G, Piattelli A, Rubini C, Goteri G, Artese L, et al. (2007) Maspin expression in oral squamous cell carcinoma. Journal of Craniofacial Surgery 18: 10391043. <ul class="reflinks"><li><a href="#" data-author="Lezzi" data-cit="LezziG%2C%20PiattelliA%2C%20RubiniC%2C%20GoteriG%2C%20ArteseL%2C%20et%20al.%20%282007%29%20Maspin%20expression%20in%20oral%20squamous%20cell%20carcinoma.%20Journal%20of%20Craniofacial%20Surgery%2018%3A%201039%E2%80%931043." data-title="Maspin%20expression%20in%20oral%20squamous%20cell%20carcinoma" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Maspin+expression+in+oral+squamous+cell+carcinoma+Lezzi+2007" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref35"><span class="order">35.
            </span><a name="pone.0063581-Joensuu1" id="pone.0063581-Joensuu1" class="link-target"></a>Joensuu KM, Leidenius MHK, Andersson LC, Heikkila PS (2009) High expression of maspin is associated with early tumor relapse in breast cancer. Human Pathology 40: 11431151. <ul class="reflinks"><li><a href="#" data-author="Joensuu" data-cit="JoensuuKM%2C%20LeideniusMHK%2C%20AnderssonLC%2C%20HeikkilaPS%20%282009%29%20High%20expression%20of%20maspin%20is%20associated%20with%20early%20tumor%20relapse%20in%20breast%20cancer.%20Human%20Pathology%2040%3A%201143%E2%80%931151." data-title="High%20expression%20of%20maspin%20is%20associated%20with%20early%20tumor%20relapse%20in%20breast%20cancer" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=High+expression+of+maspin+is+associated+with+early+tumor+relapse+in+breast+cancer+Joensuu+2009" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref36"><span class="order">36.
            </span><a name="pone.0063581-Sopel1" id="pone.0063581-Sopel1" class="link-target"></a>Sopel M (2010) The myoepithelial cell: its role in normal mammary glands and breast cancer. Folia Morphologica 69: 114. <ul class="reflinks"><li><a href="#" data-author="Sopel" data-cit="SopelM%20%282010%29%20The%20myoepithelial%20cell%3A%20its%20role%20in%20normal%20mammary%20glands%20and%20breast%20cancer.%20Folia%20Morphologica%2069%3A%201%E2%80%9314." data-title="The%20myoepithelial%20cell%3A%20its%20role%20in%20normal%20mammary%20glands%20and%20breast%20cancer" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=The+myoepithelial+cell%3A+its+role+in+normal+mammary+glands+and+breast+cancer+Sopel+2010" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref37"><span class="order">37.
            </span><a name="pone.0063581-Pierson1" id="pone.0063581-Pierson1" class="link-target"></a>Pierson CR, McGowen R, Grignon D, Sakr W, Dey J, et al. (2002) Maspin is up-regulated in premalignant prostate epithelia. Prostate 53: 255262. <ul class="reflinks"><li><a href="#" data-author="Pierson" data-cit="PiersonCR%2C%20McGowenR%2C%20GrignonD%2C%20SakrW%2C%20DeyJ%2C%20et%20al.%20%282002%29%20Maspin%20is%20up-regulated%20in%20premalignant%20prostate%20epithelia.%20Prostate%2053%3A%20255%E2%80%93262." data-title="Maspin%20is%20up-regulated%20in%20premalignant%20prostate%20epithelia" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Maspin+is+up-regulated+in+premalignant+prostate+epithelia+Pierson+2002" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref38"><span class="order">38.
            </span><a name="pone.0063581-Denk1" id="pone.0063581-Denk1" class="link-target"></a>Denk AE, Bettstetter M, Wild PJ, Hoek K, Bataille F, et al. (2007) Loss of maspin expression contributes to a more invasive potential in malignant melanoma. Pigment Cell Res 20: 112119. <ul class="reflinks"><li><a href="#" data-author="Denk" data-cit="DenkAE%2C%20BettstetterM%2C%20WildPJ%2C%20HoekK%2C%20BatailleF%2C%20et%20al.%20%282007%29%20Loss%20of%20maspin%20expression%20contributes%20to%20a%20more%20invasive%20potential%20in%20malignant%20melanoma.%20Pigment%20Cell%20Res%2020%3A%20112%E2%80%93119." data-title="Loss%20of%20maspin%20expression%20contributes%20to%20a%20more%20invasive%20potential%20in%20malignant%20melanoma" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Loss+of+maspin+expression+contributes+to+a+more+invasive+potential+in+malignant+melanoma+Denk+2007" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref39"><span class="order">39.
            </span><a name="pone.0063581-Sharma1" id="pone.0063581-Sharma1" class="link-target"></a>Sharma G, Mirza S, Parshad R, Srivastava A, Gupta SD, et al. (2011) Clinical significance of Maspin promoter methylation and loss of its protein expression in invasive ductal breast carcinoma: correlation with VEGF-A and MTA1 expression. Tumour Biol 32: 2332. <ul class="reflinks"><li><a href="#" data-author="Sharma" data-cit="SharmaG%2C%20MirzaS%2C%20ParshadR%2C%20SrivastavaA%2C%20GuptaSD%2C%20et%20al.%20%282011%29%20Clinical%20significance%20of%20Maspin%20promoter%20methylation%20and%20loss%20of%20its%20protein%20expression%20in%20invasive%20ductal%20breast%20carcinoma%3A%20correlation%20with%20VEGF-A%20and%20MTA1%20expression.%20Tumour%20Biol%2032%3A%2023%E2%80%9332." data-title="Clinical%20significance%20of%20Maspin%20promoter%20methylation%20and%20loss%20of%20its%20protein%20expression%20in%20invasive%20ductal%20breast%20carcinoma%3A%20correlation%20with%20VEGF-A%20and%20MTA1%20expression" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Clinical+significance+of+Maspin+promoter+methylation+and+loss+of+its+protein+expression+in+invasive+ductal+breast+carcinoma%3A+correlation+with+VEGF-A+and+MTA1+expression+Sharma+2011" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref40"><span class="order">40.
            </span><a name="pone.0063581-Yoshizawa1" id="pone.0063581-Yoshizawa1" class="link-target"></a>Yoshizawa K, Nozaki S, Okamune A, Kitahara H, Ohara T, et al. (2009) Loss of maspin is a negative prognostic factor for invasion and metastasis in oral squamous cell carcinoma. Journal of Oral Pathology &amp; Medicine 38: 535539. <ul class="reflinks"><li><a href="#" data-author="Yoshizawa" data-cit="YoshizawaK%2C%20NozakiS%2C%20OkamuneA%2C%20KitaharaH%2C%20OharaT%2C%20et%20al.%20%282009%29%20Loss%20of%20maspin%20is%20a%20negative%20prognostic%20factor%20for%20invasion%20and%20metastasis%20in%20oral%20squamous%20cell%20carcinoma.%20Journal%20of%20Oral%20Pathology%20%26%20Medicine%2038%3A%20535%E2%80%93539." data-title="Loss%20of%20maspin%20is%20a%20negative%20prognostic%20factor%20for%20invasion%20and%20metastasis%20in%20oral%20squamous%20cell%20carcinoma" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Loss+of+maspin+is+a+negative+prognostic+factor+for+invasion+and+metastasis+in+oral+squamous+cell+carcinoma+Yoshizawa+2009" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref41"><span class="order">41.
            </span><a name="pone.0063581-MacDougall1" id="pone.0063581-MacDougall1" class="link-target"></a>MacDougall R (2012) Vogelstein Considers Cancer Genome at Trent Lecture. NIH Record. <ul class="find-nolinks"></ul></li><li id="ref42"><span class="order">42.
            </span><a name="pone.0063581-Ozaki1" id="pone.0063581-Ozaki1" class="link-target"></a>Ozaki T, Nakagawara A (2011) p53: The Attractive Tumor Suppressor in the Cancer Research Field. Journal of Biomedicine and Biotechnology. <ul class="find-nolinks"></ul></li><li id="ref43"><span class="order">43.
            </span><a name="pone.0063581-FreedPastor1" id="pone.0063581-FreedPastor1" class="link-target"></a>Freed-Pastor WA, Prives C (2012) Mutant p53: one name, many proteins. Genes &amp; Development 26: 12681286. <ul class="reflinks"><li><a href="#" data-author="Freed-Pastor" data-cit="Freed-PastorWA%2C%20PrivesC%20%282012%29%20Mutant%20p53%3A%20one%20name%2C%20many%20proteins.%20Genes%20%26%20Development%2026%3A%201268%E2%80%931286." data-title="Mutant%20p53%3A%20one%20name%2C%20many%20proteins" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Mutant+p53%3A+one+name%2C+many+proteins+Freed-Pastor+2012" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref44"><span class="order">44.
            </span><a name="pone.0063581-Jang1" id="pone.0063581-Jang1" class="link-target"></a>Jang HL, Nam E, Lee KH, Yeom S, Son JH, et al. (2008) Maspin polymorphism associated with apoptosis susceptibility and in vivo tumorigenesis. International Journal of Molecular Medicine 22: 333338. <ul class="reflinks"><li><a href="#" data-author="Jang" data-cit="JangHL%2C%20NamE%2C%20LeeKH%2C%20YeomS%2C%20SonJH%2C%20et%20al.%20%282008%29%20Maspin%20polymorphism%20associated%20with%20apoptosis%20susceptibility%20and%20in%20vivo%20tumorigenesis.%20International%20Journal%20of%20Molecular%20Medicine%2022%3A%20333%E2%80%93338." data-title="Maspin%20polymorphism%20associated%20with%20apoptosis%20susceptibility%20and%20in%20vivo%20tumorigenesis" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Maspin+polymorphism+associated+with+apoptosis+susceptibility+and+in+vivo+tumorigenesis+Jang+2008" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref45"><span class="order">45.
            </span><a name="pone.0063581-Bodenstine1" id="pone.0063581-Bodenstine1" class="link-target"></a>Bodenstine TM, Seftor REB, Khalkhali-Ellis Z, Seftor EA, Pemberton PA, et al. (2012) Maspin: molecular mechanisms and therapeutic implications. Cancer and Metastasis Reviews 31: 529551. <ul class="reflinks"><li><a href="#" data-author="Bodenstine" data-cit="BodenstineTM%2C%20SeftorREB%2C%20Khalkhali-EllisZ%2C%20SeftorEA%2C%20PembertonPA%2C%20et%20al.%20%282012%29%20Maspin%3A%20molecular%20mechanisms%20and%20therapeutic%20implications.%20Cancer%20and%20Metastasis%20Reviews%2031%3A%20529%E2%80%93551." data-title="Maspin%3A%20molecular%20mechanisms%20and%20therapeutic%20implications" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Maspin%3A+molecular+mechanisms+and+therapeutic+implications+Bodenstine+2012" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref46"><span class="order">46.
            </span><a name="pone.0063581-Goulet1" id="pone.0063581-Goulet1" class="link-target"></a>Goulet B, Kennette W, Ablack A, Postenka CO, Hague MN, et al. (2011) Nuclear localization of maspin is essential for its inhibition of tumor growth and metastasis. Laboratory Investigation 91: 11811187. <ul class="reflinks"><li><a href="#" data-author="Goulet" data-cit="GouletB%2C%20KennetteW%2C%20AblackA%2C%20PostenkaCO%2C%20HagueMN%2C%20et%20al.%20%282011%29%20Nuclear%20localization%20of%20maspin%20is%20essential%20for%20its%20inhibition%20of%20tumor%20growth%20and%20metastasis.%20Laboratory%20Investigation%2091%3A%201181%E2%80%931187." data-title="Nuclear%20localization%20of%20maspin%20is%20essential%20for%20its%20inhibition%20of%20tumor%20growth%20and%20metastasis" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Nuclear+localization+of+maspin+is+essential+for+its+inhibition+of+tumor+growth+and+metastasis+Goulet+2011" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref47"><span class="order">47.
            </span><a name="pone.0063581-Goulet2" id="pone.0063581-Goulet2" class="link-target"></a>Goulet B, Kennette W, Ablack A, Postenka CO, Hague N, et al. (2012) Nuclear localization of maspin is essential for its inhibition of tumor growth and metastasis. Biochemistry and Cell Biology-Biochimie Et Biologie Cellulaire 90: 109109. <ul class="reflinks"><li><a href="#" data-author="Goulet" data-cit="GouletB%2C%20KennetteW%2C%20AblackA%2C%20PostenkaCO%2C%20HagueN%2C%20et%20al.%20%282012%29%20Nuclear%20localization%20of%20maspin%20is%20essential%20for%20its%20inhibition%20of%20tumor%20growth%20and%20metastasis.%20Biochemistry%20and%20Cell%20Biology-Biochimie%20Et%20Biologie%20Cellulaire%2090%3A%20109%E2%80%93109." data-title="Nuclear%20localization%20of%20maspin%20is%20essential%20for%20its%20inhibition%20of%20tumor%20growth%20and%20metastasis" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Nuclear+localization+of+maspin+is+essential+for+its+inhibition+of+tumor+growth+and+metastasis+Goulet+2012" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref48"><span class="order">48.
            </span><a name="pone.0063581-Sheng1" id="pone.0063581-Sheng1" class="link-target"></a>Sheng SJ, Truong B, Fredrickson D, Wu RL, Pardee AB, et al. (1998) Tissue-type plasminogen activator is a target of the tumor suppressor gene maspin. Proceedings of the National Academy of Sciences of the United States of America 95: 499504. <ul class="reflinks"><li><a href="#" data-author="Sheng" data-cit="ShengSJ%2C%20TruongB%2C%20FredricksonD%2C%20WuRL%2C%20PardeeAB%2C%20et%20al.%20%281998%29%20Tissue-type%20plasminogen%20activator%20is%20a%20target%20of%20the%20tumor%20suppressor%20gene%20maspin.%20Proceedings%20of%20the%20National%20Academy%20of%20Sciences%20of%20the%20United%20States%20of%20America%2095%3A%20499%E2%80%93504." data-title="Tissue-type%20plasminogen%20activator%20is%20a%20target%20of%20the%20tumor%20suppressor%20gene%20maspin" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Tissue-type+plasminogen+activator+is+a+target+of+the+tumor+suppressor+gene+maspin+Sheng+1998" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref49"><span class="order">49.
            </span><a name="pone.0063581-OderoMarah1" id="pone.0063581-OderoMarah1" class="link-target"></a>Odero-Marah VA, Khalkhali-Ellis Z, Chunthapong J, Amir S, Seftor REB, et al. (2003) Maspin regulates different signaling pathways for motility and adhesion in aggressive breast cancer cells. Cancer Biology &amp; Therapy 2: 398403. <ul class="reflinks"><li><a href="#" data-author="Odero-Marah" data-cit="Odero-MarahVA%2C%20Khalkhali-EllisZ%2C%20ChunthapongJ%2C%20AmirS%2C%20SeftorREB%2C%20et%20al.%20%282003%29%20Maspin%20regulates%20different%20signaling%20pathways%20for%20motility%20and%20adhesion%20in%20aggressive%20breast%20cancer%20cells.%20Cancer%20Biology%20%26%20Therapy%202%3A%20398%E2%80%93403." data-title="Maspin%20regulates%20different%20signaling%20pathways%20for%20motility%20and%20adhesion%20in%20aggressive%20breast%20cancer%20cells" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Maspin+regulates+different+signaling+pathways+for+motility+and+adhesion+in+aggressive+breast+cancer+cells+Odero-Marah+2003" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li></ol></div>



          <div class="ref-tooltip">
            <div class="ref_tooltip-content">

            </div>
          </div>

        </div>
      </div>
    </div>

  </section>
  <aside class="article-aside">


<!--[if IE 9]>
<style>
.dload-xml {margin-top: 38px}
</style>
<![endif]-->
<div class="dload-menu">
  <div class="dload-pdf">
    <a href="/plosone/article/file?id=10.1371/journal.pone.0063581&type=printable"
       id="downloadPdf" target="_blank">Download PDF</a>
  </div>
  <div data-js-tooltip-hover="trigger" class="dload-hover">&nbsp;
    <ul class="dload-xml" data-js-tooltip-hover="target">
      <li><a href="/plosone/article/citation?id=10.1371/journal.pone.0063581"
             id="downloadCitation">Citation</a></li>
      <li><a href="/plosone/article/file?id=10.1371/journal.pone.0063581&type=manuscript"
             id="downloadXml">XML</a>
      </li>
    </ul>

  </div>
</div>

<div class="aside-container">

<div class="print-article" id="printArticle" data-js-tooltip-hover="trigger">

  Print
  <ul class="print-options" data-js-tooltip-hover="target">
    <li><a href="#" onclick="window.print(); return false;" class="preventDefault" id="printBrowser">Print article</a></li>

<li><a href="http://surveys.plos.org/s3/reprints">Reprints</a></li>

  </ul>
</div>

<div class="share-article" id="shareArticle" data-js-tooltip-hover="trigger">
  Share
  <ul data-js-tooltip-hover="target" class="share-options" id="share-options">

<li><a href="https://www.reddit.com/submit?url=https%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0063581" id="shareReddit" target="_blank" title="Submit to Reddit"><img src="/resource/img/icon.reddit.16.png" width="16" height="16" alt="Reddit">Reddit</a></li>

<li><a href="https://www.facebook.com/share.php?u=https%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0063581&t=Elevated Maspin Expression Is Associated with Better Overall Survival in Esophageal Squamous Cell Carcinoma (ESCC)" id="shareFacebook" target="_blank" title="Share on Facebook"><img src="/resource/img/icon.fb.16.png" width="16" height="16" alt="Facebook">Facebook</a></li>


<li><a href="https://www.linkedin.com/shareArticle?url=https%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0063581&title=Elevated Maspin Expression Is Associated with Better Overall Survival in Esophageal Squamous Cell Carcinoma (ESCC)&summary=Checkout this article I found at PLOS"  id="shareLinkedIn" target="_blank" title="Add to LinkedIn"><img src="/resource/img/icon.linkedin.16.png" width="16" height="16" alt="LinkedIn">LinkedIn</a></li>

<li><a href="https://www.mendeley.com/import/?url=https%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0063581"  id="shareMendeley" target="_blank" title="Add to Mendeley"><img src="/resource/img/icon.mendeley.16.png" width="16" height="16" alt="Mendeley">Mendeley</a></li>

  <li><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0063581&text=%23PLOSONE%3A%20Elevated Maspin Expression Is Associated with Better Overall Survival in Esophageal Squamous Cell Carcinoma (ESCC)" target="_blank" title="share on Twitter" id="twitter-share-link"><img src="/resource/img/icon.twtr.16.png" width="16" height="16" alt="Twitter">Twitter</a></li>

<li><a href="mailto:?subject=Elevated Maspin Expression Is Associated with Better Overall Survival in Esophageal Squamous Cell Carcinoma (ESCC)&body=I%20thought%20you%20would%20find%20this%20article%20interesting.%20From%20PLOS ONE:%20https%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0063581"  id="shareEmail" rel="noreferrer" aria-label="Email"><img src="/resource/img/icon.email.16.png" width="16" height="16" alt="Email">Email</a></li>
<script src="/resource/js/components/tweet140.js" type="text/javascript"></script>
  </ul>
</div></div>


    <!-- Crossmark 2.0 widget -->
    <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script>
    <a aria-label="Check for updates via CrossMark" data-target="crossmark">
      <img alt="Check for updates via CrossMark" width="150" src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_BW_horizontal.svg">
    </a>
    <!-- End Crossmark 2.0 widget -->


  <div class="related-articles-container">
    <h3>
Related PLOS Articles
</h3>
    <ul class="related-articles">
        <li>
          <b>
            has CORRECTION
            
          </b>
        </li>
            <li>
<?xml version="1.0" encoding="UTF-8"?>Correction: Elevated Maspin Expression Is Associated with Better Overall Survival in Esophageal Squamous Cell Carcinoma (ESCC)              <ul class="related-article-links">
                <li class="related-article-link-page">
                  <a href="/plosone/article?id=10.1371/journal.pone.0104715">View Page</a>
                </li>
                <!--  Annotations and issue images do not have printables. They can be filtered by doi. -->
                  <li class="related-article-link-download">
                    <a href="/plosone/article/file?type=printable&id=10.1371/journal.pone.0104715"
                       target="_blank" title="PDF opens in new window">PDF</a>
                  </li>
              </ul>
            </li>
    </ul>
  </div>


<script type="text/javascript">
  var articleDoi = "10.1371/journal.pone.0063581";
  $.ajax({
    url: "https://frontpage.plos.org/wp-json/collections-api/contains",
    data: {id: articleDoi},
    context: document.body,
    timeout: 10000,
    dataType: "json",
    success: function (result, textStatus, xOptions) {
      if (result.response == "success" && result.data.collections.length > 0) {
        var articleCollectionsTemplate = _.template($('#articleCollectionsTemplate').html());
        var articleCollectionsHTML = articleCollectionsTemplate(result.data)
        $('.collections-aside-container').append(articleCollectionsHTML);
      }
    }
  });
</script>

<script type="text/template" id="articleCollectionsTemplate">
  <h3>Included in the Following <% if (collections.length == 1) { %>Collection<% } else { %>Collections<% } %></h3>
  <ul id="collectionList">
  <% _.each(collections, function (collection) { %>
    <li>
      <a href="<%= collection.permalink %>"><%= collection.title %></a>
    </li>
  <% }); %>
  </ul>
</script>

<div class="aside-container collections-aside-container">
</div>


<div class="skyscraper-container">
  <div class="title">Advertisement</div>
<!-- DoubleClick Ad Zone -->
  <div class='advertisement' id='div-gpt-ad-1458247671871-1' style='width:160px; height:600px;'>
    <script type='text/javascript'>
      googletag.cmd.push(function() { googletag.display('div-gpt-ad-1458247671871-1'); });
    </script>
  </div>
</div>




<div class="subject-areas-container">
  <h3>Subject Areas <div id="subjInfo">?</div>
    <div id="subjInfoText">
      <p>For more information about PLOS Subject Areas, click
        <a href="https://github.com/PLOS/plos-thesaurus/blob/master/README.md" target="_blank" title="Link opens in new window">here</a>.</p>
      <span class="inline-intro">We want your feedback.</span> Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!


    </div>
  </h3>
  <ul id="subjectList">
      <li>
              <a class="taxo-term" title="Search for articles about Squamous cell carcinoma"
                 href="/plosone/search?filterSubjects=Squamous+cell+carcinoma&filterJournals=PLoSONE&q=">Squamous cell carcinoma</a>
        <span class="taxo-flag">&nbsp;</span>
        <div class="taxo-tooltip" data-categoryname="Squamous cell carcinoma"><p class="taxo-explain">Is the Subject Area <strong>"Squamous cell carcinoma"</strong> applicable to this article?
          <button id="noFlag" data-action="remove">Yes</button>
          <button id="flagIt" value="flagno" data-action="add">No</button></p>
          <p class="taxo-confirm">Thanks for your feedback.</p>
        </div>
      </li>
      <li>
              <a class="taxo-term" title="Search for articles about Breast cancer"
                 href="/plosone/search?filterSubjects=Breast+cancer&filterJournals=PLoSONE&q=">Breast cancer</a>
        <span class="taxo-flag">&nbsp;</span>
        <div class="taxo-tooltip" data-categoryname="Breast cancer"><p class="taxo-explain">Is the Subject Area <strong>"Breast cancer"</strong> applicable to this article?
          <button id="noFlag" data-action="remove">Yes</button>
          <button id="flagIt" value="flagno" data-action="add">No</button></p>
          <p class="taxo-confirm">Thanks for your feedback.</p>
        </div>
      </li>
      <li>
              <a class="taxo-term" title="Search for articles about Lung and intrathoracic tumors"
                 href="/plosone/search?filterSubjects=Lung+and+intrathoracic+tumors&filterJournals=PLoSONE&q=">Lung and intrathoracic tumors</a>
        <span class="taxo-flag">&nbsp;</span>
        <div class="taxo-tooltip" data-categoryname="Lung and intrathoracic tumors"><p class="taxo-explain">Is the Subject Area <strong>"Lung and intrathoracic tumors"</strong> applicable to this article?
          <button id="noFlag" data-action="remove">Yes</button>
          <button id="flagIt" value="flagno" data-action="add">No</button></p>
          <p class="taxo-confirm">Thanks for your feedback.</p>
        </div>
      </li>
      <li>
              <a class="taxo-term" title="Search for articles about Cytoplasmic staining"
                 href="/plosone/search?filterSubjects=Cytoplasmic+staining&filterJournals=PLoSONE&q=">Cytoplasmic staining</a>
        <span class="taxo-flag">&nbsp;</span>
        <div class="taxo-tooltip" data-categoryname="Cytoplasmic staining"><p class="taxo-explain">Is the Subject Area <strong>"Cytoplasmic staining"</strong> applicable to this article?
          <button id="noFlag" data-action="remove">Yes</button>
          <button id="flagIt" value="flagno" data-action="add">No</button></p>
          <p class="taxo-confirm">Thanks for your feedback.</p>
        </div>
      </li>
      <li>
              <a class="taxo-term" title="Search for articles about Esophageal cancer"
                 href="/plosone/search?filterSubjects=Esophageal+cancer&filterJournals=PLoSONE&q=">Esophageal cancer</a>
        <span class="taxo-flag">&nbsp;</span>
        <div class="taxo-tooltip" data-categoryname="Esophageal cancer"><p class="taxo-explain">Is the Subject Area <strong>"Esophageal cancer"</strong> applicable to this article?
          <button id="noFlag" data-action="remove">Yes</button>
          <button id="flagIt" value="flagno" data-action="add">No</button></p>
          <p class="taxo-confirm">Thanks for your feedback.</p>
        </div>
      </li>
      <li>
              <a class="taxo-term" title="Search for articles about Prostate cancer"
                 href="/plosone/search?filterSubjects=Prostate+cancer&filterJournals=PLoSONE&q=">Prostate cancer</a>
        <span class="taxo-flag">&nbsp;</span>
        <div class="taxo-tooltip" data-categoryname="Prostate cancer"><p class="taxo-explain">Is the Subject Area <strong>"Prostate cancer"</strong> applicable to this article?
          <button id="noFlag" data-action="remove">Yes</button>
          <button id="flagIt" value="flagno" data-action="add">No</button></p>
          <p class="taxo-confirm">Thanks for your feedback.</p>
        </div>
      </li>
      <li>
              <a class="taxo-term" title="Search for articles about Gastric cancer"
                 href="/plosone/search?filterSubjects=Gastric+cancer&filterJournals=PLoSONE&q=">Gastric cancer</a>
        <span class="taxo-flag">&nbsp;</span>
        <div class="taxo-tooltip" data-categoryname="Gastric cancer"><p class="taxo-explain">Is the Subject Area <strong>"Gastric cancer"</strong> applicable to this article?
          <button id="noFlag" data-action="remove">Yes</button>
          <button id="flagIt" value="flagno" data-action="add">No</button></p>
          <p class="taxo-confirm">Thanks for your feedback.</p>
        </div>
      </li>
      <li>
              <a class="taxo-term" title="Search for articles about Gastrointestinal cancers"
                 href="/plosone/search?filterSubjects=Gastrointestinal+cancers&filterJournals=PLoSONE&q=">Gastrointestinal cancers</a>
        <span class="taxo-flag">&nbsp;</span>
        <div class="taxo-tooltip" data-categoryname="Gastrointestinal cancers"><p class="taxo-explain">Is the Subject Area <strong>"Gastrointestinal cancers"</strong> applicable to this article?
          <button id="noFlag" data-action="remove">Yes</button>
          <button id="flagIt" value="flagno" data-action="add">No</button></p>
          <p class="taxo-confirm">Thanks for your feedback.</p>
        </div>
      </li>
  </ul>
</div>
<div id="subjectErrors"></div>
  </aside>
</div>




</main>
<footer id="pageftr">
  <div class="row">
    <div class="block x-small">

<ul class="nav nav-secondary">
    <li class="ftr-header"><a href="https://plos.org/publications/journals/">Publications</a></li>
    <li><a href="/plosbiology/" id="ftr-bio">PLOS Biology</a></li>
    <li><a href="/plosmedicine/" id="ftr-med">PLOS Medicine</a></li>
    <li><a href="/ploscompbiol/" id="ftr-compbio">PLOS Computational Biology</a></li>
    <li><a href="/plosgenetics/" id="ftr-gen">PLOS Genetics</a></li>
    <li><a href="/plospathogens/" id="ftr-path">PLOS Pathogens</a></li>
    <li><a href="/plosone/" id="ftr-one">PLOS ONE</a></li>
    <li><a href="/plosntds/" id="ftr-ntds">PLOS Neglected Tropical Diseases</a></li>
  </ul>
    </div>
    <div class="block x-small">

<ul class="nav nav-secondary">
    <li class="ftr-header">&nbsp;</li>
    <li><a href="/climate/" id="ftr-climate">PLOS Climate</a></li>
    <li><a href="/digitalhealth/" id="ftr-digitalhealth">PLOS Digital Health</a></li>
    <li><a href="/globalpublichealth/" id="ftr-globalpublichealth">PLOS Global Public Health</a></li>
    <li><a href="/sustainabilitytransformation/" id="ftr-sustainabilitytransformation">PLOS Sustainability and Transformation</a></li>
    <li><a href="/water/" id="ftr-water">PLOS Water</a></li>
  </ul>
    </div>
    <div class="block xx-small">	


<ul class="nav nav-tertiary">
  <li>
    <a href="https://plos.org" id="ftr-home">Home</a>
  </li>
  <li>
    <a href="https://blogs.plos.org" id="ftr-blog">Blogs</a>
  </li>
  <li>
    <a href="https://collections.plos.org/" id="ftr-collections">Collections</a>
  </li>
  <li>
    <a href="mailto:webmaster@plos.org" id="ftr-feedback">Give feedback</a>
  </li>
  <li>
    <a href="/plosone/lockss-manifest" id="ftr-lockss">LOCKSS</a>
  </li>
</ul>
    </div>
    <div class="block xx-small">

<ul class="nav nav-primary">
  <li><a href="https://plos.org/privacy-policy" id="ftr-privacy">Privacy Policy</a></li>
  <li><a href="https://plos.org/terms-of-use" id="ftr-terms">Terms of Use</a></li>
  <li><a href="https://plos.org/advertise/" id="ftr-advertise">Advertise</a></li>
  <li><a href="https://plos.org/media-inquiries" id="ftr-media">Media Inquiries</a></li>
  <li><a href="https://plos.org/contact" id="ftr-contact">Contact</a></li>
</ul>
    </div>
  </div>
  <div class="row">
    <p>

<img src="/resource/img/logo-plos-footer.png" alt="PLOS" class="logo-footer"/>


<span class="footer-non-profit-statement">PLOS is a nonprofit 501(c)(3) corporation, #C2354500, based in San Francisco, California, US</span>    </p>
    <div class="block">

&nbsp;
<!--
  Webapp build:  3.7.29-SNAPSHOT at 20220301175124 by root, commit: addc5e2
  Service build: 2.6.0-SNAPSHOT at 20220222171921 by root, commit: 20f030d
  -->
    </div>
  </div>
 
<script src="/resource/js/global.js" type="text/javascript"></script>
</footer>




<script type="text/javascript">
  var ArticleData = {
    doi: '10.1371/journal.pone.0063581',
    title: '<article-title xmlns:mml=\"http://www.w3.org/1998/Math/MathML\" xmlns:xlink=\"http://www.w3.org/1999/xlink\">Elevated Maspin Expression Is Associated with Better Overall Survival in Esophageal Squamous Cell Carcinoma (ESCC)<\/article-title>',
    date: 'May 22, 2013'
  };
</script>
<script src="/resource/js/components/show_onscroll.js" type="text/javascript"></script>
<script src="/resource/js/vendor/spin.js" type="text/javascript"></script>
<script src="/resource/js/pages/article.js" type="text/javascript"></script>
<script src="/resource/js/pages/article_sidebar.js" type="text/javascript"></script>
<script src="/resource/js/pages/article_references.js" type="text/javascript"></script>
<script src="/resource/js/vendor/foundation/foundation.dropdown.js" type="text/javascript"></script>
  <script src="/resource/js/components/table_open.js" type="text/javascript"></script>

        <script src="/resource/js/components/figshare.js" type="text/javascript"></script>
  <script src="/resource/js/vendor/jquery.panzoom.min.js" type="text/javascript"></script>
  <script src="/resource/js/vendor/jquery.mousewheel.js" type="text/javascript"></script>

  <script src="/resource/js/components/lightbox.js" type="text/javascript"></script>

  <script src="/resource/js/pages/article_body.js" type="text/javascript"></script>


<!-- This file should be loaded before the renderJs, to avoid conflicts with the FigShare, that implements the MathJax also. -->

<!--  mathjax configuration options  -->
<!-- more can be found at http://docs.mathjax.org/en/latest/ -->
<script type="text/x-mathjax-config">
MathJax.Hub.Config({
  "HTML-CSS": {
    scale: 100,
    availableFonts: ["STIX","TeX"],
    preferredFont: "STIX",
    webFont: "STIX-Web",
    linebreaks: { automatic: false }
  },
  jax: ["input/MathML", "output/HTML-CSS"]
});
</script>

<script type="text/javascript" src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=MML_HTMLorMML"></script>

<div class="reveal-modal-bg"></div>
</body>
</html>
